<SEC-DOCUMENT>0001387131-18-006333.txt : 20181119
<SEC-HEADER>0001387131-18-006333.hdr.sgml : 20181119
<ACCEPTANCE-DATETIME>20181119171027
ACCESSION NUMBER:		0001387131-18-006333
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		46
CONFORMED PERIOD OF REPORT:	20180930
FILED AS OF DATE:		20181119
DATE AS OF CHANGE:		20181119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NANOPHASE TECHNOLOGIES Corp
		CENTRAL INDEX KEY:			0000883107
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS PRIMARY METAL PRODUCTS [3390]
		IRS NUMBER:				363687863
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22333
		FILM NUMBER:		181193310

	BUSINESS ADDRESS:	
		STREET 1:		1319 MARQUETTE DRIVE
		CITY:			ROMEOVILLE
		STATE:			IL
		ZIP:			60446
		BUSINESS PHONE:		6303231200

	MAIL ADDRESS:	
		STREET 1:		1319 MARQUETTE DRIVE
		CITY:			ROMEOVILLE
		STATE:			IL
		ZIP:			60446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOPHASE TECHNOLOGIES CORPORATION
		DATE OF NAME CHANGE:	19970305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>nanx-10q_093018.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 10pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<HR ALIGN="CENTER" NOSHADE SIZE="1" STYLE="color: Black; width: 25%; margin-top: 0; margin-bottom: 0">




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.25pt"><B>Form
10-Q</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<HR ALIGN="CENTER" NOSHADE SIZE="1" STYLE="color: Black; width: 25%; margin-top: 0; margin-bottom: 0">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 0; text-indent: 0; width: 0.25in; vertical-align: top"><FONT STYLE="letter-spacing: -0.15pt"><B>&#9746;</B></FONT></TD>
    <TD STYLE="text-align: left; padding-left: 0; text-indent: 0; vertical-align: top"><FONT STYLE="letter-spacing: -0.15pt"><B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">For the
Quarterly Period Ended: <B>September 30, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal; font-style: normal">or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt; width: 0.25in"><B>&#9744;</B></TD>
    <TD STYLE="text-align: left; padding-left: 0; text-indent: 0"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) <FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">of
the Securities Exchange Act of 1934</FONT></B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">For the
transition period from <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> to&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">Commission
File Number: <B>000-22333</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 26pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.3pt"><B>Nanophase
Technologies Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt"><B>36-3687863</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">(State or other jurisdiction of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1319 Marquette Drive, Romeoville, Illinois
60446</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices, and
zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(630) 771-6708</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark
whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2)&nbsp;has been subject to such filing requirements for the past 90 days. Yes&nbsp;&#9746;&nbsp;&nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark
whether the registrant has submitted electronically every Interactive Data File
required to be submitted pursuant to Rule&nbsp;405 of Regulation S-T during the preceding 12 months (or for such shorter
period that the registrant was required to submit such files).&nbsp; Yes &#9746; &nbsp;No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,
or an emerging growth company. See the definitions of &ldquo;accelerated filer&rdquo;, &ldquo;large accelerated filer&rdquo;,
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%; font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Large accelerated
    filer&nbsp;&nbsp;&#9744;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Accelerated filer&nbsp;&#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Non-accelerated filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Smaller reporting company&nbsp;&#9746;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Emerging growth company&nbsp;&#9744;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </FONT> &#9744;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">No
</FONT>&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of November 19th, 2018,
there were 33,911,792 shares outstanding of common stock, par value $.01, of the registrant.<FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt"><B>NANOPHASE
TECHNOLOGIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt"><B>QUARTER
ENDED SEPTEMBER 30, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.15pt"><B>INDEX&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.55in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 75%; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt"><U>Page</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify"><A HREF="#A001"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">PART I - FINANCIAL INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A002"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 1.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A002"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Unaudited Consolidated Condensed Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A003"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Unaudited Consolidated Condensed Balance Sheets as of September 30, 2018 and December 31, 2017</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A004"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Unaudited Consolidated Condensed Statements of Operations for the three and nine months ended September 30, 2018 and 2017</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A005"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Unaudited Consolidated Condensed Statements of Cash Flows for the nine months ended September 30, 2018 and 2017</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A006"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Notes to Unaudited Consolidated Condensed Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A007"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 2.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A007"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations </FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A008"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 3.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A008"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Quantitative and Qualitative Disclosures About Market Risk</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A009"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 4.&nbsp;&nbsp;&nbsp;</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A009"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Controls and Procedures</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">15</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify"><A HREF="#A010"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">PART II - OTHER INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A011"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 1.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A011"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Legal Proceedings</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A012"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 1A.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A012"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Risk Factors</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A013"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 2.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A013"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Unregistered Sales of Equity Securities and Use of Proceeds</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A014"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 3.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A014"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Defaults Upon Senior Securities.</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A015"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 4.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A015"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Mine Safety Disclosures.</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A016"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 5.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A016"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Other Information.</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#A017"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Item 6.</FONT></A></TD>
    <TD STYLE="text-align: justify"><A HREF="#A017"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">Exhibits.</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">17</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.25in; text-align: justify"><A HREF="#A018"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">SIGNATURES</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; letter-spacing: -0.15pt">18</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Courier New, Courier, Monospace; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="A001"></A>PART I  &ndash;
FINANCIAL INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify"><A NAME="A002"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Item 1.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Financial Statements</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NANOPHASE TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="A003"></A>CONSOLIDATED CONDENSED
BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Unaudited)&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(in thousands except share and per share
data)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Current assets:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 62%; text-align: left; text-indent: -10pt; padding-left: 20.1pt">Cash and cash equivalents</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,034</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,955</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Trade accounts receivable, less allowance for doubtful accounts of &nbsp;$5 on September&nbsp;30, 2018 and December 31, 2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,115</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Inventories, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,091</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,385</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">255</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">169</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,297</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,624</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Equipment and leasehold improvements, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,761</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,624</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Other assets, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">16</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">18</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.65pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,074</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,266</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center; padding-left: 0.65pt">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.65pt">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20.1pt">Line of credit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">300</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Current portion of capital lease obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">197</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">143</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,916</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,038</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">980</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">543</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,593</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,024</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Long-term portion of capital lease obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">416</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Long-term deferred rent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">361</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">410</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Asset retirement obligations</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">189</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">184</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total long-term liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,046</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,010</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.65pt">Stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20.1pt">Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Common stock, $.01 par value, 42,000,000 shares
    authorized; 33,911,792 shares issued and outstanding on September 30, 2018 and 33,847,793 on December 31, 2017 </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">339</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,737</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,563</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(96,641</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(95,669</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total stockholders' equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,435</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,232</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.65pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,074</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,266</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>See Notes to Financial Statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NANOPHASE TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="A004"></A>CONSOLIDATED CONDENSED
STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Unaudited)</B><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(in thousands except share
and per share data) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three months ended<BR>
September 30,</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nine months ended<BR>
September 30,</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Revenue:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 43%; text-align: left; text-indent: -10pt; padding-left: 20.1pt">Product revenue</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">3,998</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2,524</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">10,908</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">9,525</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Other revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">24</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">261</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">128</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">327</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,785</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,036</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,852</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.65pt">Operating expense:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Cost of revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,965</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,200</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,164</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,862</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,057</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">585</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,990</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Research and development expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">416</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">494</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,513</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,354</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20.1pt">Selling, general and administrative expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">765</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">725</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,299</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,185</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.65pt">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(124</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(634</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(940</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(549</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.65pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">Other, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.65pt">Loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(136</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(643</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(972</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(574</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.65pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.65pt">Net Loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(136</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(643</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(972</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(574</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.65pt">Net income/(loss) per basic shares</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Weighted average number of basic common shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,879,097</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,239,678</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,858,184</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,234,735</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0.65pt">Net income/(loss) per diluted share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.03</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Weighted average number of diluted common shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,879,097</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,239,678</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,858,184</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,234,735</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>See Notes to Financial Statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NANOPHASE TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="A005"></A>CONSOLIDATED CONDENSED
STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(in thousands)</B><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid"> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Nine months ended<BR>
September 30,</B></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Operating activities:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 62%; text-align: left; padding-left: 0.75pt">Net loss</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(972</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(574</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Adjustment to reconcile net income loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30.15pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">239</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30.15pt">Stock compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">140</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20.1pt">Changes in assets and liabilities related to operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30.15pt">Trade accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(802</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,147</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -10pt; padding-left: 30.15pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(706</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(104</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30.15pt">Prepaid expenses and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(84</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30.15pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">333</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30.15pt">Accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">386</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">166</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(921</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(866</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.75pt">Investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Proceeds from disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">136</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Acquisition of equipment and leasehold improvements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(115</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(121</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Net cash (used in) provided by investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(115</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">15</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.75pt">Financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Principal payments on capital leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(114</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Proceeds from line of credit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Payments on line of credit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Proceeds from exercise of stock options and sale of common stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">14</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">115</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">142</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Decrease in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(921</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(709</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,955</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,779</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Cash and cash equivalents at end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,034</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,070</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.75pt">Supplemental cash flow information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Interest paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">32</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.75pt">Supplemental non-cash investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.75pt">Accounts payable incurred for the purchase of equipment and leasehold improvements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.75pt">Proceeds from capital leases</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">248</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">307</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>See Notes to Financial Statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NANOPHASE TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="A006"></A>NOTES TO CONSOLIDATED
CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(in thousands, except share and per share
data or as otherwise noted herein)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0.05in; text-align: justify"><B>(1) Basis of Presentation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">The
accompanying unaudited consolidated condensed interim financial statements of Nanophase Technologies Corporation (&ldquo;Nanophase&rdquo;
or the &ldquo;Company&rdquo;, including &ldquo;we&rdquo;, &ldquo;our&rdquo; or &ldquo;us&rdquo;) along with its wholly-owned subsidiary,
Sol&eacute;sence&reg;, reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management,
are necessary for a fair presentation of our financial position and operating results for the interim periods presented. Operating
results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected
for the year ending December 31, 2018 or any interim period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">These
financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December
31, 2017, included in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2017, as filed with the Securities
and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>(2) Description of Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify; text-indent: 0.5in">Nanophase is a leader
in advanced materials technologies, with its primary strategic focus being in developing and providing engineered solutions for
various applications of micromaterials (&ldquo;nano&rdquo; and &ldquo;non-nano&rdquo; in scale) for use in protecting human skin
from the harmful and damaging effects of the sun. We also produce a variety of materials for use in diverse markets other than
those using our materials as active ingredients for sun protection. These other markets include: industrial coatings applications,
abrasion-resistant additives, medical diagnostics, and a variety of surface finishing (polishing) applications, including optics.
<FONT STYLE="font-weight: normal">We have expanded our offerings beyond active ingredients to include targeted full formulations
of skin care products, marketed and sold by our wholly-owned subsidiary, Sol&eacute;sence&reg;, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">We
target markets in which we believe practical solutions may be found using our products. We work closely with current and potential
customers in these target markets to identify their material and performance requirements and market our advanced materials to
various end-use applications manufacturers, and our Sol&eacute;sence&reg; solutions to cosmetics and skin care brands. Recently
developed technologies have made certain new products possible and opened potential new markets. During 2015 we were granted a
patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product development in personal
care, with first revenue recognized during 2016. In addition, through the creation of our Sol&eacute;sence&reg;, LLC subsidiary,
we utilize this particle surface treatment to manufacture and sell fully developed solutions to targeted customers in the cosmetics
and skin care industry, in addition to the additives we have traditionally sold in the personal care area.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Although
our primary strategic focus has been the North American market, we currently sell material to customers overseas and have been
working to expand our reach within foreign markets. The Company was incorporated in Illinois on November 25, 1989 and became a
Delaware corporation during November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">While
product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities
are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as &ldquo;other revenue&rdquo;
in our Statements of Operations, as it does not represent revenue directly from our materials or fully formulated products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(3) Revenues</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018,
we adopted Accounting Standards Updates (&ldquo;ASU&rdquo;) 2014-09 and 2015-14, <I>Revenue from Contract with Customers (Topic
606)</I>, using the modified retrospective method applied to those contracts that were not <B>completed</B> as of January 1, 2018.
Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not
adjusted and continue to be reported in accordance with our historical accounting under the Financial Accounting Standards Board
(&ldquo;FASB&rdquo;) Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 605. Based on our contract evaluation, we determined
that there was no need to record any changes to our opening retained earnings due to the impact of our adoption of Topic 606. The
adoption of Topic 606 did not have a material impact on our consolidated condensed financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues are recognized
at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration
we expect to receive in exchange for those goods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We generally expense sales
commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling,
general and administrative expenses. Customers&rsquo; deposits, deferred revenue and other receipts are deferred and recognized
when the revenue is realized and earned. Cash payments to customers are classified as reductions of revenue in our statements of
operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We do not disclose the
value of the unsatisfied performance obligations for contracts with an original expected length of one year or less or contracts
for which we recognize revenue that we have the right to invoice for goods completed.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(4) Earnings (Loss) Per Share</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Earnings
(Loss) Per Share is computed using the Treasury Stock Method. Options to purchase approximately 1,119,000 and 820,000 shares of
common stock that were outstanding as of September 30, 2018 for the three and nine months ended September 30, 2018, respectively,
were not included in the computation of diluted earnings (loss) per share, as the impact of such shares would be anti-dilutive.
Options to purchase approximately 750,000 and 796,000 shares of common stock that were outstanding as of September 30, 2017 were
not included in the computation of loss per share for the three and nine months ended September 30, 2017, respectively, as the
impact of such shares would be anti-dilutive. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(5) Financial Instruments</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">We
follow FASB ASC Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 820, <I>Fair Value Measurements and Disclosures</I>,
which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs)
used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires
significant management judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">Our
financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with
a promissory note with no related borrowings, any borrowings on the LB&amp;T working capital line of credit, each described in
Note 6. Subsequent to September 30, 2018, the Company has secured a term loan and a revolving loan, each described in Note 6. The
fair values of all financial instruments were not materially different from their carrying values. There were no financial assets
or liabilities adjusted to fair value on September 30, 2018 or December 31, 2017.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">(6) Notes and Lines of Credit</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During July 2014, we entered
into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our obligations under our
facility lease agreement. No borrowings have been incurred under this promissory note. Should any borrowings occur in the future,
the interest rate would be the prime rate plus 1%, with the bank having the right to &ldquo;set off&rdquo; or apply unpaid balances
against our checking account if we fail to meet our obligations under any borrowings under the note. It is our intention to renew
this note annually, for as long as we need to pursuant to the terms of our facility lease agreement. Because there were no amounts
outstanding at any time during 2018 or 2017, we have recorded no related liability on our balance sheet. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During March 2015, we entered
into a Business Loan Agreement (the &ldquo;Line of Credit Agreement&rdquo;) with Libertyville Bank and Trust Company, a Wintrust
Community Bank (&ldquo;LB&amp;T&rdquo;), our primary bank. This Line of Credit Agreement was subsequently amended on April 13,
2015 and was extended on each of March 4, 2016 and February 14, 2017. Under the Line of Credit Agreement, as amended, LB&amp;T
provided a maximum of $300 or 75% of our eligible accounts receivable, whichever was less, of revolving credit, collateralized
by a senior priority lien on our accounts receivable, inventory, equipment, general intangibles and fixtures. Interest on any borrowings
was the prime rate at the time plus 1%. Availability to draw on the line required us to have at least $1 million in cash, including
any amounts borrowed, at LB&amp;T on the date of any advance. Advances could only occur at the beginning or end of a fiscal quarter
and had to be repaid in full within five days of the advance. Borrowings on this line were $300 on December 31, 2017. These borrowings
were repaid in January 2018. The Line of Credit Agreement expired on March 4, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On March&nbsp;26, 2018,
we executed a new Business Loan Agreement (the &ldquo;New Line of Credit Agreement&rdquo;), dated as of March 4, 2018, with LB&amp;T,
which replaces the Line of Credit Agreement with LB&amp;T that expired on March 4, 2018. Under the New Line of Credit Agreement,
LB&amp;T will provide a maximum of (i) $500 or (ii) two times the sum of (a) 75% our eligible accounts receivables and (b) our
cash deposited with LB&amp;T, whichever is less,&nbsp;of revolving credit to us, collateralized by a senior priority lien on our
accounts receivables, inventory, equipment, general intangibles and fixtures. Interest is payable monthly on any advances at a
floating interest rate of the prime rate at the time plus 1%. We must have $1 million in cash, inclusive of the borrowed amount,
at LB&amp;T on the date of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be repaid
in full within five business days of the advance. The New Line of Credit Agreement expires in March&nbsp;2019. While the New Line
of Credit Agreement is in effect, we cannot, among other things, engage in any business activities substantially different than
those in which we are presently engaged, and there are limitations imposed on our ability to, among other things, incur additional
indebtedness for borrowed money, including capital leases, sell, transfer, mortgage, assign, pledge, lease or grant a security
interest in or encumber any of our assets, sell with recourse any of our accounts other than to LB&amp;T, cease operations, merge,
transfer, acquire or consolidate with any other entity, change our name, dissolve or transfer or sell collateral outside the ordinary
course of business, pay any cash dividends, loan, invest in or advance money or assets to any other person or entity, purchase,
create or acquire any interest in any other entity, or incur any obligation as a surety or guarantor other than in the ordinary
course of business, in each case without LB&amp;T&rsquo;s prior written consent. We borrowed $500 on this line on September 28,
2018 and repaid it on October 1st, 2018. The amount outstanding on the loan was $300 on December 31, 2017 which was paid in full
on January 9, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 19, 2018, we
entered into a Business Loan Agreement (the &ldquo;Master Agreement&rdquo;) with Beachcorp, LLC. The Master Agreement relates to
two loan facilities, each evidenced by a separate promissory note dated as of November 16, 2018: a term loan to the Company of
up to $500 to be disbursed in a single advance (the &ldquo;Term Loan&rdquo;) with a fixed annual interest rate of 8.25%, payable
quarterly, accruing from the date of such advance and with principal due on December 31, 2020; and an asset-based revolving loan
facility for the Company of up to $2,000 (the &ldquo;Revolver Facility&rdquo;), with floating interest accruing at the prime rate
plus 3% (8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable of the Company, and with all
principal and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured by all the unencumbered assets
of the Company and subordinated to LB&amp;T&rsquo;s secured interest under the New Line of Credit Agreement. The Master Agreement
substantially restricts the Company&rsquo;s ability to incur additional indebtedness during the terms of both the Term Loan and
the Revolver Facility. As of the date of this filing, there were no amounts borrowed on either of the loans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0.05in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0.05in; text-align: justify"><B>(7) Inventories</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Inventories
consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,<BR>
2018</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>December
31,<BR>
2017 </B></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 62%; text-align: left">Raw materials</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,086</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">543</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Finished goods</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,026</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">863</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,112</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Allowance for excess inventory quantities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(21</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(21</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,091</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,385</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months
ended March 31, 2018, $246 was reclassified from Prepaid Expenses to Raw Materials. For comparison purposes, $246 has been reclassified
from Prepaid Expenses to Raw Materials as of December 31, 2017 in the table above. Our balance sheet as of December 31, 2017 has
also been updated to reflect this reclassification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>(8) Share-Based Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
follow </FONT>FASB ASC Topic 718<FONT STYLE="font-family: Times New Roman, Times, Serif">, </FONT><I>Compensation &ndash; Stock
Compensation</I><FONT STYLE="font-family: Times New Roman, Times, Serif">, in which compensation expense is recognized only for
share-based payments expected to vest. We recognized compensation expense related to stock options of $58 and $146 for the three
and nine months ended September 30, 2018, respectively, compared to $45 and $140 for the three and nine months ended September
30, 2017, respectively. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of September 30, 2018,
there was approximately $449 of total unrecognized compensation cost related to non-vested share-based compensation arrangements
granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.2 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Stock Options and Stock Grants</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the nine months ended September 30, 2018, 63,999 shares of common stock were issued pursuant to stock option exercises for proceeds
of $29,000. During the nine months ended September 30, 2017, 45,334 shares of common stock were issued pursuant to stock option
exercises for proceeds of $14,000. During the nine months ended September 30, 2018, 570,500 options were granted compared to the
507,600 </FONT>stock options were granted during the same period in 2017. During the nine months ended September 30, 2018, 188,504
stock options expired, and 31,601 stock options were forfeited compared to 7,000 stock options expiring and 37,568 forfeited during
the same period in 2017. We had 3,428,000 stock options outstanding at a weighted average exercise price of $0.67 on September
30, 2018, compared to 3,141,000 stock options outstanding at a weighted average exercise price of $0.79 on December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The following table
illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the
periods presented:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><B>For the nine months ended</B></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><B>September 30,<BR>
    2018</B></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><B>September 30,<BR>
    2017</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left; padding-left: 5.4pt">Weighted-average risk-free interest rates:</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: center; padding-left: 5.4pt">2.9%</TD><TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 14%; text-align: center; padding-left: 5.4pt">2.1%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Dividend yield:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">&mdash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">&mdash;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Weighted-average expected life of the option:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">7 years</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">7 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Weighted-average expected stock price volatility:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">94%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">94%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Weighted-average fair value of the options granted:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">$0.64</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 5.4pt">$0.55</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As of September 30, 2018, we did not have any
unvested restricted stock or performance shares outstanding. No stock options were granted in the three-month periods end September
30, 2018 and 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>(9) Significant Customers and Contingencies </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Revenue from our
three largest customers constituted approximately 74%, 12% and 4%, respectively, of our total revenue for the three months ended
September 30, 2018, and approximately 74%, 8% and 4%, respectively, of our total revenue for the nine months ended September 30,
2018. Amounts included in accounts receivable on September 30, 2018 relating to these three customers were approximately $1,170,
$388 and $149, respectively. Revenue from these three customers constituted approximately 58%, 0% and 8%, respectively, of our
total revenue for the three months ended September 30, 2017, and approximately 67%, 0%, and 7% of our total revenue for the nine
months ended September 30, 2017. Amounts included in accounts receivable on September 30, 2017 relating to these three customers
were approximately $1,196, $0 and $174 respectively. The loss of one of these significant customers, a significant decrease in
revenue from one or more of these customers, or the failure to attract new customers could have a material adverse effect on our
business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We currently have
exclusive supply agreements with BASF Corporation (&ldquo;BASF&rdquo;), our largest customer, that have contingencies outlined
which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer
intended to provide capacity sufficient to meet the customer&rsquo;s production needs. This outcome may occur if we fail to meet
certain performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition
covenants in one of our supply agreements with BASF &ldquo;trigger&rdquo; a technology transfer right (license and equipment sale
at BASF&rsquo;s option) in the event (a) that earnings for the twelve-month period ending with our most recently published quarterly
financial statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b)
of an acceleration of any debt maturity having a principal amount of more than $10 million. Our supply agreements with BASF also
&ldquo;trigger&rdquo; a technology transfer right in the event of our insolvency, as further defined within the agreements. In
the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of
the equipment&rsquo;s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades
to it, or 115% of the equipment&rsquo;s net book value, depending on the equipment and related products.</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We believe that we have
sufficient cash and credit availability (See Liquidity and Capital Resources in Management&rsquo;s Discussion and Analysis in Part
I, Item 2 of this Form 10-Q for a further discussion, as well as the description of our loan and credit agreements described in
Note 6) to operate our business during the remainder of 2018. If a triggering event were to occur and BASF elected to proceed with
the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold
using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace
that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant
to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would
probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences
would occur if we were determined to have materially breached certain other provisions of the supply agreements with BASF. Any
such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe
that our employees are a critical component of our success and it could be difficult to replace them quickly. Upon the occurrence
of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its
impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including with respect to
avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">We expect to expend resources on research, development
and product testing, and in expanding current capacity or capability for new business. In addition, we may incur significant costs
in preparing, filing, prosecuting, maintaining and enforcing our patents and other proprietary rights. We may need additional financing
if we were to lose an existing customer or suffer a significant decrease in revenue from one or more of our customers or because
of currently unknown capital requirements, new regulatory requirements or the need to meet the cash requirements discussed above
to avoid a triggering event under our BASF agreement. Given our expected growth in our Sol&eacute;sence<SUP>&reg;</SUP>&nbsp;business,
we may also have temporary working capital demands that we cannot fund with existing capital, while remaining in compliance with
the covenants included in our BASF agreement described above. If necessary, we may seek funding through public or private financing
and through contracts with governmental entities or other companies. Additional financing may not be available on acceptable terms
or at all, and any such additional financing could be dilutive to our shareholders. If we are unable to obtain adequate funds,
we may be required to delay, scale-back or eliminate some of our manufacturing and marketing operations or we may need to obtain
funds through arrangements on less favorable terms. Such circumstances could raise doubt as to our ability to continue as a going
concern. If we obtain funding on unfavorable terms, we may be required to relinquish rights to some of our intellectual property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>(10) Business Segmentation and Geographical Distribution </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenue from international
sources approximated $152 and $335 for the three and nine months ended September 30, 2018, respectively, compared to $276 and $956
for the three and nine months ended September 30, 2017, respectively. All this revenue was product revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our operations comprise
a single business segment and all our long-lived assets are located within the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>(11) New Accounting Pronouncements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">During February 2016, the FASB issued ASU No.
2016-02 (&ldquo;ASU 2016-02&rdquo;), <I>Leases (Topic 842)</I>. This standard requires the recognition of assets and liabilities
arising from lease transactions on the balance sheet and the disclosure of key information about leasing arrangements. Accordingly,
a lessee will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease
obligation. Both the asset and liability will initially be measured at the present value of the future minimum lease payments over
the lease term. Subsequent measurement, including the presentation of expenses and cash flows, will depend on the classification
of the lease as either a finance or an operating lease. Initial costs directly attributable to negotiating and arranging the lease
will be included in the asset. For leases with a term of 12 months or less, a lessee can make an accounting policy election by
class of underlying asset to not recognize an asset and corresponding liability. Lessees will also be required to provide additional
qualitative and quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising from leases. These
disclosures are intended to supplement the amounts recorded in the financial statements and provide additional information about
the nature of an organization&rsquo;s leasing activities. The amendments in this standard are effective for fiscal years, and interim
periods within those fiscal years, beginning after December 15, 2018, which is our first quarter of 2019, with early adoption permitted.
We review new accounting standards as issued. We are in the process of evaluating the impact this standard will have on our financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 0.75in"><A NAME="A007"></A>Item 2.</TD>
    <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Overview</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Nanophase is a leader in
advanced materials technologies, with its primary strategic focus being in developing and providing engineered solutions for various
applications of micromaterials (&ldquo;nano&rdquo; and &ldquo;non-nano&rdquo; in scale) for use in protecting human skin from the
harmful and damaging effects of the sun. We also produce a variety of materials for use in diverse markets other than those using
our materials as active ingredients for sun protection. These other markets include: industrial coatings applications, abrasion-resistant
additives, medical diagnostics, and a variety of surface finishing (polishing) applications, including optics. Through our increasing
focus on skin care ingredients, and enabled by our own patented and proprietary technologies, we have expanded our offerings beyond
active ingredients to include targeted full formulations of skin care products, marketed and sold by our wholly-owned subsidiary,
Sol&eacute;sence&reg;, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We target markets in which
we believe practical solutions may be found using our products. We work closely with current and potential customers in these target
markets to identify their material and performance requirements and market our materials to various end-use applications manufacturers,
and our Sol&eacute;sence&reg; solutions to cosmetics and skin care brands. Recently developed technologies have made certain new
products possible and opened potential new markets. For example, we have applied our expertise at producing precisely defined nanomaterials
to now create and sell larger, &ldquo;non-nano&rdquo; material products. Our focus is on customer need where we believe we have
an advantage, as opposed to finding uses for one particular technology. We expect growth in end-user (manufacturing customers,
including customers of our customers) adoption in 2018 and beyond. Our initiatives in targeted market areas are progressing at
differing rates of speed, but we have been broadly moving through testing and development cycles, and in a number of cases believe
we are approaching first revenue or next stage revenue with particular customers in the sun care-related applications referenced
above. For example, during 2015 we were granted a patent on a new type of particle surface treatment (coating), which became the
cornerstone of our new product development in personal care, with first revenue recognized during 2016. In addition, through the
creation of our Sol&eacute;sence&reg;, LLC subsidiary, we use this particle surface treatment to manufacture and sell fully developed
solutions to targeted customers in the cosmetics and skin care industry, in addition to the additives we have traditionally sold
in to the sun care area. During the second quarter of 2018, Sol&eacute;sence&reg; supported the launch of three fully developed
products for its customers. We are currently focusing the greatest part of our business development efforts on building and expanding
our Sol&eacute;sence&reg; brand and product suite. We believe that successful introduction of our finished skin care products and
materials with manufacturers may lead to follow-on orders for other finished products and materials in these applications. We expect
that we will both work more deeply with current customers and attract additional customers, which should help us achieve growth
in these markets in 2018 and beyond.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At the same time, we look
for opportunities to partner with established entities in order to further our mutual goals. During June 2017, we entered into
a series of agreements with Eminess Technologies, Inc. (&ldquo;ETI&rdquo;), an entity that is well established in selling materials
for surface finishing (polishing) applications. We intend to continue serving this market through supplying materials, while devoting
the greatest share of our business- and product-development resources to support our Sol&eacute;sence&reg; brand and expand our
suite of sun care-related products. These agreements are intended to accomplish both, by allowing us to maximize existing production
assets and technology, while supporting strategic growth in sun care applications. ETI will sell our products, in some cases by
making and selling those products themselves under an exclusive license and paying us a royalty, and in other cases through an
exclusive supply arrangement with us. ETI purchased equipment from us for $36,000 and paid us a one-time fee of $250,000 for assisting
ETI in its development of dispersion technology relevant to polishing solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Results of Operations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Total revenue increased
to $4,022,000 for the three months ended September 30, 2018, compared to $2,785,000 for the same period in 2017. Total revenue
increased to $11,036,000 for the nine months ended September 30, 2018 from $9,852,000 for same period in 2017. A substantial majority
of our revenue for each of the periods was from our largest customers, in particular, sales to our largest customer in personal
care and sunscreen applications. Revenue from out top three customers constituted approximately 70%, 12% and 4%, respectively,
of our total revenue for the three months ended September 30, 2018, and approximately 74%, 8% and 4%, respectively, of our total
revenue for the nine months ended September 30, 2018. Revenue from these three customers constituted approximately 58%, 0% and
3%, respectively, of our total revenue for the three months ended September 30, 2017, and approximately 66%, 0%, and 3% of our
total revenue for the nine months ended September 30, 2017. Product revenue, the primary component of our total revenue, increased
to $3,998,000 for the three months ended September 30, 2018 compared to $2,524,000 for the three months ended September 30, 2017.
Product revenue increased to $10,908,000 for the nine months ended September 30, 2018, compared to $9,525,000 for the same period
in 2017. The increase in total revenue and in product revenue for the three months ended September 30, 2018, relative to the three
months ended September 30, 2017, reflects the shutdown in July 2017 to install a new product coating blender, which adversely impacted
revenue for the three months ended September 30, 2017. Because the shutdown was substantially mitigated by shifting fulfillment
of customer orders to before and after the shutdown, however, it had a lesser impact on revenue for the nine months ended September
30, 2017, so that the increase in revenue for the nine months ended September 30, 2018, relative to the nine months ended September
30, 2017, results primarily from our Sol&eacute;sence&reg; products launches in 2018, which represented approximately 9% of our
year to date product revenue, and an increase in the demand for minerals-based sunscreen products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other revenue decreased
to $24,000 for the three months ended September 30, 2018, compared to $261,000 for the same period in 2017. Other revenue decreased
to $128,000 for the nine months ended September 30, 2018, compared to $327,000 for the same period in 2017. Other revenue is comprised
primarily of shipping costs paid by customers and includes fee-based development projects completed during the first half of 2018.
This also applies to the same period in 2017 when we received an intellectual property transfer fee of $250,000 from a customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Cost of revenue generally
includes costs associated with commercial production and customer development arrangements. Cost of revenue increased to $2,965,000
for the three months ended September 30, 2018, compared to $2,200,000 for the same period in 2017. Cost of revenue increased to
$8,164,000 for the first nine months of 2018, compared to $6,862,000 for the same period in 2017. The increases in cost of revenue
in 2018 were primarily driven by higher wages, price inflation on materials including zinc metal, and manufacturing inefficiencies
related to <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT> product launches.
While we typically pass through costs to our customers, we cannot always pass through 100% of pricing increases on raw materials,
and even with pass throughs, our gross margin percentage is negatively impacted by higher material costs. We expect to continue
new materials development and finished cosmetics products, primarily using our material synthesis and dispersion technologies for
supplying and developing new active ingredients for sun care, as well as applying our expanding formulations expertise in developing
fully formulated Sol&eacute;sence&reg; products during 2018 and beyond. At current revenue levels we have generated a positive
gross margin, though margins have been impeded by not having enough revenue to efficiently absorb manufacturing overhead that is
required to work with current customers and expected future customers. In order to support future revenue projections, we believe
we need a $200,000 to $300,000 capital equipment investment before the end of the year. The extent to which margins may grow, as
a percentage of total revenue, will be dependent upon revenue mix, revenue volume, our ability to manage costs and pass commodity
market-driven raw materials increases on to customers, and the speed and efficiency with which we are able to scale up production
for our Sol&eacute;sence&reg; products. We expect that product revenue volume increases will result in our fixed manufacturing
costs being more efficiently absorbed, which should lead to increased margins. We expect to continue to focus on reducing controllable
variable product manufacturing costs, with potential variability related to the commodity metals markets, but may or may not realize
absolute dollar gross margin growth through 2018 and beyond, dependent upon the factors discussed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Research and development
expense, which includes all expenses relating to the technology and advanced engineering groups, primarily consists of costs associated
with the development or acquisition of new product applications and finished product formulations for our <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>
business. As an example, we have been, and continue to be, engaged in product development work for our new fully-formulated finished
skincare products marketed through <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>.
Much of this work has led to several new products and additional potential new products. We are also engaged in a series of in-vitro,
ex-vivo, and in-vivo tests to determine the productivity of our <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>
products, as well as to provide our customers with support for consumer inquiries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Research and development
expense decreased to $416,000 and increased to $1,513,000 for the three and nine months ended September 30, 2018, respectively,
compared to $494,000 and $1,354,000, respectively, for the same periods in 2017. The primary reasons for these increases were increased
wages due to personnel added during 2018 and increased outside product testing and evaluation costs related to our <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>
products. We expect quarterly research and development expense to decline during the remainder of 2018, as we expect the initial
effort required to launch the <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>
solutions to lessen, particularly with respect to external testing and validation costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Selling, general and administrative
expense increased to $765,000 and $2,299,000 for the three and nine months ended September 30, 2018, respectively, compared to
$725,000 and $2,185,000, respectively, for the same periods in 2017. The increased costs were associated with launching the <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>
brand. We expect selling, general and administrative expense to remain at current levels during the remainder of 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Inflation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We believe inflation has
not had a material effect on our operations or financial position. However, supplier price increases and wage and benefit inflation,
both of which represent a significant component of our costs of operations, may have a material effect on our operations and financial
position in 2018 and beyond if we are unable to pass through any applicable increases under our present contracts or through to
our markets in general.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Liquidity and Capital Resources</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Our cash and cash equivalents amounted to $1,034,000
on September 30, 2018, compared to $1,955,000 on December 31, 2017. The net cash used in our operating activities was $921,000
for the nine months ended September 30, 2018, compared to $866,000 for the same period in 2017. The net use of cash during both
periods was driven primarily by a significant increase in unabsorbed manufacturing costs and an increase in accounts receivable
and inventory at the end of the respective period. Net cash used in investing activities was $115,000 during the nine months ended
September 30, 2018, compared to net cash provided by investing activities of $15,000 for the nine months ended September 30, 2017.
We paid $114,000 for capital lease obligations during the nine months ended September 30, 2018 compared to $122,000 in the same
period in 2017. Net cash provided by financing activities was $115,000 during the nine months ended September 31, 2018, compared
to net cash provided by financing activities of $142,000 for the nine months ended September 30, 2017. We paid the $300,000 outstanding
balance under our line of credit as of December 31, 2017 on January 9, 2018, the $200,000 outstanding balance as of March 31, 2018
on April 4, 2018, the $500,000 outstanding balance as of June 30, 2018 on July 2, 2018 and the $500,000 outstanding balance as
of September 30, 2018 on October 1<SUP>st</SUP>, 2018. Proceeds for capital leases for the nine months ended September 30, 2018
and 2017 were $248,000 and $307,000 respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 19, 2018, we
entered into a Business Loan Agreement (the &ldquo;Master Agreement&rdquo;) with Beachcorp, LLC. The Master Agreement relates to
two loan facilities, each evidenced by a separate promissory note dated as of November 19, 2018: a term loan to the Company of
up to $500,000 to be disbursed in a single advance (the &ldquo;Term Loan&rdquo;) with a fixed annual interest rate of 8.25%, payable
quarterly, accruing from the date of such advance and with principal due on December 31, 2020; and an asset-based revolving loan
facility for the Company of up to $2,000,000 (the &ldquo;Revolver Facility&rdquo;), with floating interest at prime rate plus 3%
(8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable of the Company, and with all principal
and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured by all the unencumbered assets of the
Company and subordinated to LB&amp;T&rsquo;s secured interest under the New Line of Credit Agreement. The Master Agreement substantially
restricts the Company&rsquo;s ability to incur additional indebtedness during the terms of both the Term Loan and the Revolver
Facility. Management expects to use the funds from the Term Loan and the Revolver Facility to fund capital equipment and working
capital. There are no covenants associated with this Business Loan Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our supply agreements with our largest customer,
BASF, contain certain financial covenants which could potentially impact our liquidity. The most restrictive financial covenants
under these agreements require that we maintain a minimum of $1 million in cash, cash equivalents and certain investments, and
that we not have the acceleration of any debt maturity having a principal amount of more than $10 million, in order to avoid triggering
the customer&rsquo;s potential right to transfer certain technology and equipment to that customer at a contractually-defined price.
We had approximately $1,034,000 in cash on September 30, 2018, with $500,000 in borrowings under our line of credit. This line
of credit was entered into during March 2018 and it will expire in March 2019. This supply agreement and its covenants are more
fully described in Note 9, and our current credit availability is more fully described in Note 6, to our Financial Statements in
Part I, Item 1 of this Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">We believe that cash
from operations, available credit and cash on hand will be adequate to fund our operations through the remainder of 2018.
Given our expected growth in our Sol&eacute;sence<SUP>&reg;</SUP>&nbsp;business, we are monitoring the temporary working
capital demands that this could create, with timing being the most critical variable. Our actual future capital requirements
in 2018 and beyond will depend on many factors, including customer acceptance of our current and potential advanced
materials, applications and products, continued progress in research and development activities and product testing programs,
the magnitude of these activities and programs, and the costs necessary to increase and expand our manufacturing capabilities
and to market and sell our advanced materials, applications and products. Other important issues that will drive future
capital requirements will be the development of new markets and new customers as well as the potential for significant
unplanned growth with existing customers. Depending on the success of certain projects, we expect that capital spending
relating to currently known capital needs for the remainder of 2018 will be between $200,000 and $300,000, and we could enter
into one or more financing leases to finance these acquisitions, subject to the provisions of our various loan agreements. If
those projects are delayed or ultimately prove unsuccessful, or if we fail to obtain financing on terms acceptable to us, we
would expect our capital spending to be below the lower end of that range. Similarly, substantial success in business
development projects may cause the actual capital investment for the remainder of 2018 to exceed the top of this range.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Should events arise that make it appropriate
for us to seek additional financing, such additional financing may not be available on acceptable terms or even at all, and any
such additional financing could be dilutive to our stockholders. Such financing could be necessitated by such things as the loss
of one or more existing customers; a significant decrease in revenue from one or more of our customers; temporary working capital
demands resulting from our expected growth in our Sol&eacute;sence<SUP>&reg;</SUP>&nbsp;business that we cannot fund with existing
capital; currently unknown capital requirements in light of the factors described above; new regulatory requirements that are outside
our control; the need to meet previously discussed cash requirements to avoid a triggering event under our BASF agreement, or various
other circumstances coming to pass that we currently do not anticipate. The failure to have access to sufficient capital to fund
our business plans may result in a curtailment or other change in those plans, and under such circumstances, may raise doubt as
to our ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September 30, 2018,
we had a net operating loss carryforward of approximately $97 million for income tax purposes. Because we may have experienced
&quot;ownership changes&quot; within the meaning of the U.S. Internal Revenue Code in connection with our various prior equity
offerings, future utilization of this carryforward may be subject to certain limitations as defined by the Internal Revenue Code.
If not utilized, the carryforward will expire at various dates between January 1, 2019 and December 31, 2037. As a result of the
annual limitation and uncertainty as to the amount of future taxable income that will be earned prior to the expiration of the
carryforward, we have concluded that it is likely that a majority of this carryforward will expire before ultimately becoming available
to reduce income tax liabilities. Changes in Illinois state law that began in 2011 will impact net loss carryforward duration and
utilization on the state tax level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Off&#8722;Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">We
have not created, and are not party to, any special-purpose or off-balance sheet entities for the purposes of raising capital,
incurring debt or operating our business. We do not have any off-balance sheet arrangements or relationships with entities that
are not consolidated into our financial statements that are reasonably likely to materially affect our liquidity or the availability
of capital resources.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">As
more fully described in Note 6 to our Financial Statements, in Part I, Item I of this Form 10-Q, during 2014 we entered into a
letter of credit and promissory note for up to $30,000 supporting our obligations under our facility lease agreement. No borrowings
have been incurred under this promissory note. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Safe Harbor Provision</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We want to provide investors
with more meaningful and useful information. As a result, this Quarterly Report on Form 10-Q contains and incorporates by reference
certain &quot;forward-looking statements&quot;, as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;). These statements reflect our current expectations of the future results of our operations, performance
and achievements. Forward-looking statements are covered under the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. We have tried, wherever possible, to identify these statements by using words such as &quot;anticipates&quot;,
&quot;believes&quot;, &quot;estimates&quot;, &quot;expects&quot;, &quot;plans&quot;, &quot;intends&quot; and similar expressions.
These statements reflect management's current beliefs and are based on information now available to it. Accordingly, these statements
are subject to certain risks, uncertainties and contingencies that could cause our actual results, performance or achievements
in 2018 and beyond to differ materially from those expressed in, or implied by, such statements. These risks, uncertainties and
factors include, without limitation: our ability to be consistently profitable despite the losses we have incurred since our incorporation;
a decision by a customer to cancel a purchase order or supply agreement in light of our dependence on a limited number of key customers;
the terms of our supply agreements with BASF, which could trigger a requirement to transfer technology and/or sell equipment to
that customer; our potential inability to obtain working capital when needed on acceptable terms or at all; our ability to obtain
materials at costs we can pass through to our customers, including Rare Earth elements, specifically cerium oxide, as well as high
purity zinc; uncertain demand for, and acceptance of, our nanocrystalline materials and So<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">l&eacute;sence&reg;</FONT>
products; our manufacturing capacity and product mix flexibility in light of customer demand; our limited marketing experience,
including with our suite of <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">Sol&eacute;sence&reg;</FONT>
products; changes in development and distribution relationships; the impact of competitive products and technologies; our dependence
on patents and protection of proprietary information; the resolution of litigation or other legal proceedings in which we may become
involved; our ability to maintain an appropriate electronic trading venue for our securities; and the impact of any potential new
governmental regulations that could be difficult to respond to or costly to comply with. In addition, our forward-looking statements
could be affected by general industry and market conditions and growth rates. Readers of this Quarterly Report on Form 10-Q should
not place undue reliance on any forward-looking statements. Except as required by federal securities laws, we undertake no obligation
to update or revise these forward-looking statements to reflect new events or uncertainties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; font-weight: bold; text-align: justify; font-size: 11pt; layout-grid-mode: line"><A NAME="A008"></A><FONT STYLE="font-size: 10pt">Item 3.</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: justify; font-size: 11pt; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Not required for a smaller reporting company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; font-size: 12pt; text-align: justify; text-indent: 0in"><A NAME="A009"></A><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Controls and Procedures</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Disclosure controls </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are responsible for
establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed
by us in the reports filed by us under the Exchange Act is: (a)&nbsp;recorded, processed, summarized and reported within the time
periods specified in the SEC&rsquo;s rules and forms; and (b)&nbsp;accumulated and communicated to our management, including our
principal executive and principal financial officers, to allow timely decisions regarding required disclosures. It should be noted
that in designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter
how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that our
management necessarily was required to apply its judgment regarding the design of our disclosure controls and procedures. As of
the end of the period covered by this report, we conducted an evaluation, under the supervision (and with the participation) of
our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation
of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation,
our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at
reaching that level of reasonable assurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Internal control over financial reporting
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s management,
including the CEO and CFO, confirm that there was no change in the Company&rsquo;s internal control over financial reporting during
the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="A010"></A>PART II &ndash;&nbsp;OTHER
INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; font: bold 12pt Courier New, Courier, Monospace; layout-grid-mode: line; text-align: justify"><A NAME="A011"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</FONT></TD>
    <TD STYLE="font: bold 12pt Courier New, Courier, Monospace; layout-grid-mode: line; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings </FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-weight: normal">We are not
a party to any pending legal proceedings or claims that we believe will result in a material adverse effect on our business, financial
condition, or operating results. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; padding-right: 0; text-align: justify"><A NAME="A012"></A><B>Item 1A.</B></TD>
    <TD STYLE="padding-right: 2in; text-align: justify"><B>Risk Factors</B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.5pt 0 0; text-align: justify; text-indent: 0.5in">In addition to
the information set forth in this Quarterly Report on Form 10-Q and before deciding to invest in, or retain, shares of our common
stock, you also should carefully review and consider the information contained in our other reports and periodic filings that we
make with the Securities and Exchange Commission, including, without limitation, the information contained under the caption Part
I, Item 1A &ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended December 31, 2017. Those risk factors
could materially affect our business, financial condition and results of operations. Additional risks and uncertainties that we
do not currently know about, we currently believe are immaterial or we have not predicted may also harm our business operations
or adversely affect us. If any of these risks or uncertainties occur, our business, financial condition, results of operations,
cash flows or stock price could be materially adversely affected. There have been no material changes from the risk factors previously
disclosed in our Annual Report on Form 10-K for the year ended December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify"><A NAME="A013"></A><B>Item 2.</B></TD>
    <TD STYLE="text-align: justify"><B>Unregistered Sales of Equity Securities and Use of Proceeds</B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in"><A NAME="A014"></A><B>Item 3.</B></TD>
    <TD><B>Defaults Upon Senior Securities</B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; font-weight: bold; text-align: justify; font-size: 11pt; layout-grid-mode: line"><A NAME="A015"></A><FONT STYLE="font-size: 10pt">Item 4.</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: justify; font-size: 11pt; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Mine Safety Disclosures</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Not applicable.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; font-weight: bold"><A NAME="A016"></A>Item 5.</TD>
    <TD STYLE="font-weight: bold">Other Information</TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Form 8-K Item 1.01 Entry into a Material Definitive Agreement.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 19, 2018, we
entered into a Business Loan Agreement (the &ldquo;Master Agreement&rdquo;) with Beachcorp, LLC. Beachcorp, LLC is a newly formed
affiliate of Bradford T. Whitmore. As of [March 14,] 2018, Mr. Whitmore, together with his affiliates, Grace Brothers, Ltd. and
Grace Investments, Ltd., beneficially owned approximately [47%] of the outstanding shares of our common stock. In addition, R.
Janet Whitmore, one of our directors since 2003 and a stockholder, is the sister of Mr. Whitmore.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Master Agreement relates
to two loan facilities: a term loan to the Company of up to $500,000 to be disbursed in a single advance (the &ldquo;Term Loan&rdquo;)
with a fixed annual interest rate of 8.25%, payable quarterly, accruing from the date of such advance and with principal due on
December 31, 2020; and an asset-based revolving loan facility for the Company of up to $2,000,000 (the &ldquo;Revolver Facility&rdquo;),
with floating interest at prime rate plus 3% (8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable
of the Company, and with all principal and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured
by all the unencumbered assets of the Company and subordinated to LB&amp;T&rsquo;s secured interest under the New Line of Credit
Agreement. The Master Agreement substantially restricts the Company&rsquo;s ability to incur additional indebtedness during the
terms of both the Term Loan and the Revolver Facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 19, 2018 and
in order to evidence the Term Loan pursuant to the Master Agreement, the Company made a promissory note in the principal amount
of up to $500,000 payable to the order of Beachcorp, LLC, of which the terms are consistent with the Master Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 19, 2018 and
in order to evidence the Revolver Facility pursuant to the Master Agreement, the Company made a promissory note in the principal
amount of up to $2,000,000 payable to the order of Beachcorp, LLC, of which the terms are consistent with the Master Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Form 8-K Item 2.03 Creation of a Direct Financial Obligation</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The foregoing disclosures
in this Item 5 under the caption &ldquo;Form 8-K Item 1.01 Entry into a Material Definitive Agreement&rdquo; are incorporated
by reference. As of the date of this filing, the borrowed amounts under both the Term Loan and the Revolver Facility are zero
dollars.&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; font-weight: bold; text-align: justify; font-size: 11pt; layout-grid-mode: line"><A NAME="A017"></A><FONT STYLE="font-size: 10pt">Item 6.</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: justify; font-size: 11pt; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Exhibits</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">EXHIBIT INDEX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: -2in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="width: 23%; font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 10.1</FONT></TD>
    <TD STYLE="width: 70%; font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Business Loan Agreement, dated November 19, 2018, between the Company and Beachcorp, LLC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 10.2</FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Promissory Note, dated November 19, 2018, made by the Company and payable to the order of Beachcorp, LLC to evidence a term loan in the original principal amount of up to $500,000.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 10.3</FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Promissory Note, dated November 19, 2018, made by the Company and payable to the order of Beachcorp, LLC to evidence revolving borrowings in a principal amount of up to $2,000,000.&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex31-1.htm">Exhibit 31.1</A></FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex31-2.htm">Exhibit 31.2</A> </FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex32.htm">Exhibit 32</A></FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350.&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit 101</FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace"><FONT STYLE="font-family: Times New Roman, Times, Serif">The following materials from Nanophase Technologies Corporation&rsquo;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, formatted in XBRL (Extensible Business Reporting Language): (1) the Balance Sheets, (2) the Statements of Operations, (3) the Statements of Cash Flows, and (4) the Notes to Unaudited Financial Statements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0.05in; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="A018"></A>SIGNATURES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif">NANOPHASE TECHNOLOGIES CORPORATION</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: November 19, 2018</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>/s/&nbsp;&nbsp;JESS A. JANKOWSKI</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 0.2in">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Jess A. Jankowski</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: November 19, 2018</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>/s/ JAIME ESCOBAR</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.2in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jaime Escobar</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #000033"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #000033"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #000033"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #000033"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>BUSINESS LOAN AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: left"><A HREF="nanx-10q_093018.htm">Nanophase Technologies Corporation 10-Q</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUSINESS
LOAN AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
BUSINESS LOAN AGREEMENT dated as of November 19, 2018 by and between NANOPHASE TECHNOLOGIES CORPORATION, a Delaware corporation
(&ldquo;Borrower&rdquo;), and BEACHCORP, LLC, a Delaware limited liability company (&ldquo;Lender&rdquo;). </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PREAMBLE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>Borrower desires to enter into certain secured financial transactions with Lender for the financing of its business and Lender
desires to enter into said transactions as more specifically described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> in consideration of the mutual promises contained herein, Borrower and Lender adopt the Preamble as part of this
Agreement and Borrower and Lender agree to be bound legally, further agreeing to the following terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
1:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENTS
REGARDING THE LOANS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>The
Loans.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Generally.
</B>Borrower has applied to Lender for Loans and other financial accommodations and, subject to the terms and conditions hereof
and the Related Documents, Lender has agreed to make Loans to Borrower for such purposes as provided for herein. Borrower understands
and agrees that: (i) in granting, renewing, or extending any Loan, Lender is relying upon Borrower's representations, warranties,
and agreements, as set forth in this Agreement and (ii) all such Loans shall be and shall remain subject to the terms and conditions
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Term
Loan.</B> Lender will make a $500,000.00 non-revolving term loan (the &ldquo;Term Loan&rdquo;) to Borrower. Borrower shall make
quarterly payments of interest only, with the first such payment due on December 31, 2018 and then on the last day of each calendar
quarter thereafter with a final payment of all principal and unpaid interest due on December 31, 2020 (the &ldquo;Term Maturity
Date&rdquo;). The Term Loan shall be evidenced by the Term Note. The Term Loan may be prepaid at any time without penalty or fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revolving
Loans.</B> Lender will make Loans on a revolving basis (individually a &ldquo;Revolving Loan&rdquo; and collectively the &ldquo;Revolving
Loans&rdquo;) to Borrower until the Revolving Maturity Date in such amounts as Borrower may request in accordance with this Agreement;
<B><I>provided</I></B> that the aggregate outstanding principal amount of Revolving Loans may not exceed at any time the lesser
of (i) the $2,000,000.00 and (ii) the Borrowing Base. Each Revolving Loan shall be in the minimum amount of $10,000.00. Borrower
shall pay interest on the Loans in accordance with Section 1.5 hereof, with payment thereof in arrears to be made on the last
day of each calendar quarter, with the first such payment due on December 31, 2018. Each Revolving Loan shall be repaid in full
on the sooner of (a) a determination that the Revolving Loans exceed the Borrowing Base, and (b) the Revolving Maturity Date.
The Revolving Loans shall be evidenced by the Revolving Note. The Revolving Loans may be prepaid at any time without penalty or
fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Borrowing
Procedures.</B> Whenever Borrower desire to incur a Revolving Loan, it shall give the Lender written or telephonic notice thereof
(in the case of telephonic notice, promptly confirmed in writing to Lender), which notice must be received by the Lender prior
to 11:00 a.m. (Chicago time), at least one (1) Business Day prior to the proposed date such Loan is to be incurred. Each such
notice (&ldquo;Notice of Borrowing&rdquo;) shall be irrevocable, include a current Borrowing Base Certificate and AR Report, and
shall further specify the aggregate principal amount of the Revolving Loan to be made and the date of the proposed Revolving Loan
(which shall be a Business Day).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
in any way limiting the obligation of Borrower to confirm in writing any Notice of Borrowing given by telephone, the Lender may
act prior to receipt of written confirmation without liability upon the basis of such telephonic notice believed by the Lender
in good faith to be from an authorized officer of Borrower entitled to give telephonic notices under this Agreement on behalf
of Borrower. In each such case, the Lender's record of the terms of such telephonic notice shall be conclusive absent manifest
error. No later than 5:00 p.m. (Chicago time) on the date specified in each Notice of Borrowing, the Lender will make available
the amount of each Loan requested to be made on such date in the manner provided below. All amounts relating to any Loan incurred
by Borrower shall be made available to Borrower in immediately available funds by depositing such funds into the Borrower&rsquo;s
designated account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fees
and Expenses. </B>Whether or not the transactions contemplated hereby shall be consummated, Borrower shall assume and pay upon
demand all out-of-pocket expenses incurred by Lender in connection with the preparation of loan documents and the making of the
Loan, including without limitation the following: (a) all closing costs, fees, and disbursements; (b) all fees and expenses of
Lender's legal counsel; and (c) all title examination fees, appraisal fees, and filing and recording fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Recordkeeping.
</B>Lender shall record in its records, the date and amount of each Loan made by the Lender, and each repayment thereof. The aggregate
unpaid principal amount so recorded shall be rebuttable presumptive evidence of the principal amount owing and unpaid on the Notes.
The failure to so record any such amount or any error in so recording any such amount shall not, however, limit or otherwise affect
the obligations of Borrower hereunder or under any Note to repay the principal amount of the Loan(s) evidenced by such Note together
with all interest accruing thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Interest.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Interest
on Loan. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(</FONT>i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unpaid principal amount of the Term Loan shall bear interest from the date thereof until the Term Maturity Date (whether by acceleration
or otherwise) at 8.25% fixed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The unpaid principal amount of the aggregate outstanding balance of the Revolving Loan
shall bear interest from the date of each advance thereof until the Revolving Maturity Date, at the Prime Rate plus 3.0% floating,
but in no case less than 8.25%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Default
Interest. </B>Notwithstanding the above provisions, if an Event of Default is in existence, all outstanding amounts of principal
and, to the extent permitted by law, all overdue interest, in respect of each and every Loan shall bear interest, payable on demand,
at the Default Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Accrual
and Payment of Interest. </B>Interest shall accrue from and including the date provided in Section 1.5(a) above to, but excluding,
the date of any prepayment or repayment thereof, and shall be payable in accordance with Section 1.1 and on demand after maturity
or following an Event of Default. Interest is paid for the period a Loan is outstanding</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Computations
of Interest. </B>All computations of interest on all Loans and other amounts owing hereunder shall be made on the actual number
of days elapsed divided by 365/6 days (i.e., that is, by applying the ratio of the interest rate divided by 365 days (or 366 if
applicable), multiplied by the funds advanced and outstanding, multiplied by the actual number of days the funds advanced are
outstanding).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Maximum
Interest Rate.</B> In no event shall the amount of interest paid hereunder, together with all amounts reserved, charged, or taken
by Lender as compensation for fees, services, or expenses incidental to the making, negotiation, or collection of the Loans evidenced
hereby exceed the maximum rate of interest on the unpaid balance hereof allowable by applicable law. If any sum is collected in
excess of the applicable maximum rate, the excess collected shall be applied to reduce the principal amount of the Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Late
Charges. If any payment is ten (10) days or more late, Borrower will be charged 5.0% of the payment amount or $100.00, whichever
is greater.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Mandatory
Prepayments.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Sale,
Casualty, or Condemnation. </B>Borrower (or, in the case of subsection (ii) below, if the Lender is holding the proceeds of insurance
or condemnation as additional collateral pursuant hereto or any Related Document, the Lender) shall make a prepayment of the Loans
(first to the Term Loan and then to the Revolving Loans) upon the occurrence of any of the following, at the following times and
in the following amounts:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Within
ten (10) days after any sale, transfer or other disposition by Borrower of any tangible asset (other than the sales of inventory
in the ordinary course of business) valued in excess of $100,000.00 (or of any value during the continuance of an Unmatured Default
or Event of Default), in an amount equal to one hundred percent (100%) of the net cash proceeds of such sale, transfer or other
disposition; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Within
ten (10) days after the receipt of any insurance or condemnation proceeds (or other similar recoveries) by Borrower or by the
Lender (to the extent the Lender is holding the insurance or condemnation proceeds as additional collateral pursuant hereto or
any Related Document) from any casualty loss incurred by Borrower or condemnation of property valued in excess of $100,000.00
(or of any value during the continuance of an Unmatured Default or Event of Default), in an amount equal to one hundred percent
(100%) of such insurance or condemnation proceeds (or other similar recoveries) net of any collection expenses; provided, that
this requirement shall not apply to the extent that Lender has agreed to allow Borrower to use such proceeds for the repair or
restoration of the affected property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Overadvances.
</B>Borrower shall immediately prepay the Revolving Loans in the event that the outstanding balance of the Revolving Loans exceeds
the lesser of (i) $2,000,000.00, and (ii) the Borrowing Base.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Term.</B>
This Agreement shall continue thereafter until all Indebtedness of Borrower to Lender has been performed in full and the parties
terminate this Agreement in writing or this Agreement is terminated by Lender as otherwise provided for herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Setoff.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Borrower
agrees that, upon the occurrence and during the continuance of any Event of Default, the Lender is hereby authorized, at any time
and from time to time, without notice to the Borrower, (i) to set off against and to appropriate and apply to the payment of any
and all Indebtedness (whether matured or unmatured, fixed or contingent or liquidated or unliquidated) any and all amounts which
the Lender is obligated to pay over to the Borrower (whether matured or unmatured, and, in the case of deposits, whether general
or special, time or demand and however evidenced), and (ii) pending any such action, to the extent necessary, to deposit such
amounts with the Lender as Collateral to secure such Indebtedness, and to dishonor any and all checks and other items drawn against
any deposits so held, as the Lender in its sole discretion may elect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
rights of the Lender under this Section 1.9 are in addition to all other rights and remedies which the Lender may otherwise have
hereunder or in law or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Application
of Payments.</B> Upon the occurrence of an Unmatured Default or Event of Default, all monies received by Lender pursuant to this
Agreement shall be applied by Lender to any Indebtedness of Borrower (and in whatever order), as Lender shall determine, and the
Borrower does hereby irrevocably agree that the Lender shall have the continuing exclusive right to apply and reapply any and
all payments received at any time or times hereafter, whether with respect to the Collateral or otherwise, against the Borrower's
Indebtedness in such manner as the Lender may deem advisable, notwithstanding any entry by the Lender upon any of its books and
records. Lender shall within a reasonable time period account to Borrower for any sum remaining after the Indebtedness shall be
paid in full. Upon written demand of the Borrower, the Lender shall within a reasonable time period provide a written explanation
to the Borrower reasonably describing how such monies were applied and in what order. Until checks and other instruments delivered
to Lender in payment or on account of Borrower's obligations and the Indebtedness are actually paid to Lender, Borrower agrees
that such items constitute conditional payment only. Without limiting any of Lender's other rights provided herein, Lender may
bill Borrower for accrued interest or make advances of principal hereunder for payment of accrued interest, as and when due. For
purposes of this Agreement, all payments on the Loans or other amounts due under this Agreement or any Related Document shall
be made in immediately available funds prior to 12:30 p.m. (Chicago time) on the day when due. If such payments or other amounts
due are received by Lender on a day other than a Business Day or after 12:30 p.m. (Chicago time) on a Business Day such payments
or other amounts shall be deemed to be applied by Lender on account of the Indebtedness on the next Business Day following receipt
in Lender's account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECTION
2:</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BORROWER'S
REPRESENTATION AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Representations
and Warranties.</B> Borrower represents and warrants to Lender as of the date of this Agreement and as of the date of each disbursement
of Loan proceeds:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Organization.
</B>Borrower is a corporation which is duly organized, validly existing, and in good standing under the laws of the State of Delaware.
Borrower has the full power and authority to own its properties and to transact the businesses in which it is presently engaged
or presently proposes to engage. Borrower also is duly qualified as a foreign corporation and is in good standing in all jurisdictions
where it conducts business. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Authorization.</B>
The execution, delivery, and performance of this Agreement and all Related Documents by Borrower have been duly authorized by
all necessary corporate action by Borrower (as applicable); do not require the consent or approval of any other Person, regulatory
authority or governmental body; and do not conflict with, result in a violation of, or constitute a default under (i) any provision
of its articles of incorporation or organization, or bylaws or operating agreement, or any agreement or other instrument binding
upon Borrower or (ii) any law, governmental regulation, court decree, or order applicable to Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Compliance
with Law; Governmental Approvals and Permits.</B> Borrower (i) is in compliance with all applicable provisions of law, and (ii)
to the extent required by applicable law, has, and is current and in good standing with respect to, all governmental approvals,
permits, certificates, inspections, consents and franchises necessary to continue to conduct its operations as it heretofore conducted
and to own or lease and operate the property now owned or leased by it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Solvency.</B>
Borrower has sufficient capital to carry on all operations and transactions in which it engages or is about to engage, is solvent
and will continue to be solvent after the creation of the Security Interest in the Collateral in favor of Lender created by this
Agreement or any Related Document and the making of the Loan pursuant hereto, and is able to pay its debts as they mature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial
Statements; Material Adverse Change; Projections.</B> Except as disclosed in writing by Borrower to Lender, all financial data
and other information furnished by Borrower to Lender, will be taken from the books and records of Borrower and are true, accurate
and correct in all material respects. The Financials fairly present the assets, liabilities and financial condition and results
of operations of Borrower described therein as of the dates thereof and were prepared on a basis consistent with the preparation
of the Borrower&rsquo;s financial statements for prior periods; there are no omissions or other facts or circumstances which are
or may be material as of the date of the Financials, and there has been no material and adverse change in the Collateral, assets,
liabilities or financial condition of Borrower since the date of the Financials; there exist no outstanding advances to any Person
not reflected in the Financials; except as set forth in the Financials, there are no actions or proceedings which are pending,
or, to the best of Borrower's knowledge, threatened against Borrower; to the best of Borrower&rsquo;s knowledge, there are no
actions or proceedings which are pending or threatened against any other Person which might result in any material adverse change
in Borrower&rsquo;s financial condition or materially and adversely affect its operations, its assets or the Collateral; except
as stated in the Financials Borrower has no other liabilities and has not guaranteed the obligations of any other Person. Any
financial projections delivered to Lender by or on behalf of Borrower were, at the time of delivery to Lender, reasonable forecasts
based upon good business judgment and all facts and information known to Borrower and its consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>No
Default.</B> Borrower is not in default, nor, to the best of Borrower&rsquo;s knowledge, is any third party in default, under
or with respect to any contract, agreement, lease or other instrument to which Borrower is a party. No Unmatured Default or Event
of Default has occurred and is continuing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Legal
Effect.</B> This Agreement and all of the Related Documents constitute legal, valid and binding obligations of Borrower enforceable
against Borrower in accordance with their respective terms in all applicable jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Properties.</B>
Except for (i) Security Interests in favor of Lender created by this Agreement or any Related Document, (ii) Security Interests,
claims and other encumbrances as set forth on the attached Schedule&nbsp;2.1(h), and (iii) property tax liens for taxes not presently
due and payable, Borrower owns and has good title to all of Borrower's properties and assets free and clear of all Security Interests,
claims and other encumbrances, and has not executed any Security Agreements or financing statements relating to such properties.
All of Borrower's properties are titled in Borrower's legal name. Borrower has authority to encumber the Collateral in the manner
and form herein provided. The Borrower shall defend and protect the Collateral against and from all claims and demands of all
Persons at any time claiming any interest therein adverse to the Lender. No financing statement or other document similar in effect
covering all or any part of the Collateral is on file in any recording or filing office, other than those identifying the Lender
as the secured party or as set forth in Schedule 2.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Litigation
and Claims.</B> No litigation, proceeding, suit, action, or claim against Borrower is pending or threatened, and no other event
has occurred which may adversely affect Borrower's financial condition, or operations of the Borrower, or properties, including
the Collateral, other than litigation, proceedings, suits, actions, claims, or other events, if any, that have been disclosed
to and acknowledged by Lender in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Tax
Matters.</B> Borrower has duly filed or properly extended all federal, state and other governmental tax returns which it is required
by law to file; all taxes and other sums which may be due to the United States, any state or other governmental authority have
been fully paid (including, without limitation, all reasonable estimations of penalties or late payment charges or interest).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Lien
Priority.</B> The Security Interest in favor of the Lender provided in this Agreement or any Related Document is a valid and perfected
first priority security interest in the Collateral except as set forth in Schedule 2.1(h), and all filings and other actions necessary
to perfect such Security Interest have been duly taken and all such filings hereof reasonably identify the Collateral. Unless
otherwise disclosed to Lender in writing on the attached Schedule 2.1(h), Borrower has not entered into or granted any Security
Agreements, or permitted the filing or attachment of any Security Interests on or affecting any of the Collateral directly or
indirectly securing repayment of the Loan or other obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Location
of Borrower's Offices, Records and Collateral.</B> All places of business, and if Borrower has more than one place of business,
an indication of its chief executive office, and the office or offices where Borrower keeps its records concerning the Collateral
is located at those locations set forth on the attached Schedule&nbsp;2.1(l) which shall include a listing of all previous locations
for the past five (5) years and a listing of any Collateral locations that are not places of business.  If any change in the place
or places of business of the Borrower, or its chief executive office, or the office where the Borrower keeps its records concerning
the Collateral will occur, the Borrower shall provide the Lender with, at Borrower's sole cost and expense, such financing statements
and other documents as the Lender shall request in connection with such change in order to maintain Lender's first priority perfected
security interest in the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(m)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Names.</B>
The Borrower&rsquo;s exact legal name is as set forth in the first paragraph of this Agreement. Borrower has not used in the
past five (5) years, and shall not hereafter use, any name other than the name set forth in the first paragraph of this
Agreement (including, without limitation, any tradename, assumed name, any fictitious or any similar name) without first
giving Lender thirty (30) days prior written notice. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Information.</B>
All information heretofore or contemporaneously herewith furnished by Borrower to Lender for the purposes of or in connection
with this Agreement or any transaction contemplated hereby is, and all information hereafter furnished by or on behalf of Borrower
to Lender will be, true and accurate in every material respect on the date as of which such information is dated or certified;
and none of such information is or will be incomplete by omitting to state any material fact necessary to make such information
not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(o)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Employee
Benefit Plans.</B> Each employee benefit plan as to which Borrower may have liability complies with all applicable requirements
of law and regulations, and (i) no &ldquo;Reportable Event&rdquo; nor &ldquo;Prohibited Transaction&rdquo; (as defined in ERISA)
has occurred with respect to any such plan, (ii) Borrower has not withdrawn from any such plan or initiated steps to do so, (iii)
no steps have been taken to terminate any such plan, and (iv) there are no unfunded liabilities other than those previously disclosed
to Lender in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(p)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Representations
and Warranties Concerning Accounts.</B> With respect to the Accounts, Borrower represents and warrants to Lender that, unless
Borrower otherwise notifies Lender pursuant to a writing in form and substance acceptable to Lender in its reasonable determination
and prior to Lender's crediting such Account as part of the Borrowing Base that: (i) Each Account represented by Borrower to be
an Eligible Account for purposes of this Agreement conforms to the requirements of the definition of an Eligible Account; (ii)
All Account information listed on schedules or certificates delivered to Lender will be true and correct, subject to immaterial
variance; (iii) Borrower has not made any agreement with any Account Debtor for any deduction from such Eligible Account, and
to Borrower's knowledge, there are no setoffs, counterclaims or disputes existing or asserted with respect to such Eligible Account;
(iv) to Borrower's knowledge, there are no facts, events or occurrences which in any way impair the validity or enforcement of
any Eligible Account or tend to reduce the amount payable thereunder from the face amount shown on any schedule of Accounts or
Borrowing Base Certificate and on all contracts, invoices and statements delivered to Lender with respect thereto; (v) Borrower
has no knowledge of any fact or circumstance which would impair the validity or collectability of any Eligible Account; and (vi)
to Borrower's knowledge, there are no proceedings or actions which are threatened or pending against any Account Debtor which
questions the enforceability of the Account Debtor's obligations with respect to any Eligible Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Survival
of Representations and Warranties.</B> Borrower understands and agrees that Lender is relying upon the above representations and
warranties in making the Loans to Borrower. Borrower agrees that the foregoing representations and warranties shall be continuing
in nature and shall remain in full force and effect until, unless otherwise specified herein, such time as Borrower's Loans and
the Notes shall be paid in full, or until this Agreement shall be terminated in the manner provided above, whichever is the last
to occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECTION
3:</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BORROWER'S
COVENANTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Borrower's
Affirmative Covenants.</B> Borrower covenants and agrees with Lender that, while this Agreement is in effect, Borrower will:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Notice
of Material Events.</B> Notify Lender as promptly as possible, and in any event within five (5) Business Days after the Borrower
has knowledge thereof, of (i) the occurrence of any Unmatured Default or Event of Default, (ii) any action, litigation, claim,
proceeding, or dispute (A) against or affecting the Collateral, (B) against or affecting Borrower seeking the payment of money
by Borrower, whether in the form of damages, liens, penalties or costs, in an amount in excess of $25,000.00, or (C) in any way
regarding the construction, creation, operation or use of the Collateral (regardless of the amount claimed therein), (iii) any
action, litigation, claim, proceeding or dispute involving Borrower and any court, board, commission, agency or instrumentality
of any federal, state or local government or any agency or subdivision thereof, which if adversely resolved could be reasonably
expected to result in a material adverse effect on Borrower's business, assets, operations or financial condition, (iv) any material
adverse change in Borrower's financial condition or operations, or (v) any event, occurrence or other matter which has had a materially
adverse effect or which could have a materially adverse effect on any part of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial
Records.</B> Maintain its books and records in accordance with GAAP, applied on a consistent basis, and permit Lender to examine
and audit Borrower's books and records at all reasonable times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial
Statements and Borrowing Base Certificate.</B> Furnish Lender with, as soon as available, but in no event later than 5:00p.m.
(Chicago time) on the second Business Day of each calendar week, an AR Report for the previous week, prepared and certified as
true and correct by Borrower's chief financial officer or other officer or person acceptable to Lender, together with copies of
each new Account reported thereon. All financial reports required to be provided under this Agreement shall be prepared in accordance
with GAAP, applied on a consistent basis, and certified by Borrower as being true and correct. In addition, in connection with
each Revolving Loan advance, Borrower shall furnish Lender with a current Borrowing Base Certificate and AR Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Additional
Information.</B> Furnish such additional information and statements, lists of assets and liabilities, agings of receivables and
payables, inventory schedules, budgets, forecasts, tax returns, and other reports with respect to Borrower's financial condition
and business operations as Lender may request from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Insurance.</B>
Maintain, or cause to be maintained, all risk casualty insurance, public liability insurance, and such other insurance as
Lender may require with respect to Borrower's properties and operations, in form, amounts, coverages and with insurance companies
reasonably acceptable to Lender, but in all cases with respect to casualty insurance, in amounts not less than the full replacement
value of the property covered. Borrower, upon request of Lender, will deliver to Lender from time to time the policies or certificates
of insurance in form satisfactory to Lender, including stipulations that coverages will not be cancelled or diminished without
at least thirty (30) days prior written notice to Lender. In connection with all policies covering assets in which Lender holds
or is offered a Security Interest for the Loan, Borrower will provide Lender with such loss payable or other endorsements as Lender
may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other
Agreements.</B> Pay its indebtedness and liabilities in accordance with good business practices and otherwise comply with all
terms and conditions of all other agreements, whether now or hereafter existing, between Borrower and any other party and notify
Lender immediately in writing of any default in connection with any other such agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Loan
Proceeds.</B> Use all Loan proceeds solely as provided for herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Taxes,
Charges and Liens.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pay
and discharge when due all of its indebtedness and obligations, including without limitation, all assessments, taxes, governmental
charges, levies and liens, of every kind and nature, imposed upon any portion of the transactions contemplated hereby, or on Borrower,
the Collateral or Borrower&rsquo;s other properties, income, or profits, prior to the date on which penalties would attach, and
all lawful claims that, if unpaid, might become a lien or charge upon any of Borrower's properties, income, or profits. Provided,
however, Borrower will not be required to pay and discharge any such assessment, tax, charge, levy, lien or claim (collectively
the &ldquo;Charges&rdquo;) so long as: (A) the legality of the same shall be promptly contested in good faith by appropriate proceedings;
(B) Borrower shall have deposited with Lender cash, a sufficient corporate surety bond or other security satisfactory in form
and substance to Lender in an amount adequate to provide for the release of such Charge plus any interest, costs, attorneys' fees
or other amounts that could accrue as a result of foreclosure or sale of the Collateral; (C) such contest operates to suspend
collection of the Charge; and (D) none of the Collateral is subject to forfeiture or loss of any Security Interest (or the priority
thereof) by reason of the institution or prosecution of such contest as determined by Lender. Borrower, upon demand of Lender,
will furnish to Lender evidence of payment of the indebtedness and obligations, including any assessments, taxes, charges, levies,
liens and claims and will authorize the appropriate obligor or governmental official to deliver to Lender at any time a written
statement of any indebtedness and obligations including any Charges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cause
all claims for labor done and materials and services furnished in connection with the Collateral to be fully paid and discharged
in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Performance.</B>
Perform and comply with all terms, conditions, and provisions set forth in this Agreement, the Related Documents, and in all other
instruments and agreements between Borrower and Lender in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Reserved.
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Inspection.</B>
Permit employees or agents of Lender at any reasonable time to inspect any and all Collateral and Borrower's other properties
and to examine or audit Borrower's books, accounts, and records and to make copies and memoranda of Borrower's books, accounts,
and records. If Borrower now or at any time hereafter maintains any records (including without limitation computer generated records
and computer software programs for the generation of such records) in the possession of a third party, Borrower, upon request
of Lender, shall notify such party to permit Lender free access to such records at all reasonable times and to provide Lender
with copies of any records it may request, all at Borrower's expense. In addition to any rights provided for herein, Lender shall
be permitted to have a field audit performed on Borrower's books and records on an annual basis, at Borrower's sole expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Additional
Assurances.</B> Make, execute and deliver to Lender such promissory notes, mortgages, deeds of trust, security agreements, financing
statements, instruments, documents and other agreements as Lender or its attorneys may reasonably request to evidence and secure
(as contemplated herein or in any of the Related Documents) the Indebtedness and to perfect all Security Interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(m)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Defense
of Title.</B> Forever defend the title to the Collateral against the claims of all Persons. In the event any action or proceeding
is commenced that questions Borrower's title or the interest of Lender under any Security Agreement, Borrower shall defend the
action at Borrower's expense. Borrower may be the nominal party in such proceeding, but Lender shall be entitled to participate
in the proceeding and to be represented in the proceeding by counsel of Lender's own choice, and Borrower will deliver, or cause
to be delivered, to Lender such instruments as Lender may request from time to time to permit such participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Collection
Arrangement. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Borrower shall direct all of its Account Debtors to make all electronic payments on the Accounts directly to a special account
maintained by Borrower with Libertyville Bank (the &ldquo;Collection Account&rdquo;) which shall be under the control of Lender
as provided for in the Blocked Account Agreement. Borrower will immediately deposit all payments made on the Accounts, and received
by the Borrower, in the identical form in which such payments were made, whether by cash or check, into the Collection Account.
If the Borrower, a Subsidiary or any director, officer, employee, agent or the Borrower or any Subsidiary, or any other Person
acting for or in concert with the Borrower shall receive any monies, checks, notes, drafts or other payments relating to or as
proceeds of Accounts or other Collateral, the Borrower and each such Person shall receive all such items in trust for, and as
the sole and exclusive property of, the Lender and, immediately upon receipt thereof, shall remit the same (or cause the same
to be remitted) in kind to the Collection Account. The Borrower agrees that all payments made to such Collection Account or otherwise
received by Borrower, whether in respect of the Accounts or as proceeds of other Collateral or otherwise, will be applied as provided
in this Agreement. The Borrower agrees to pay all fees, costs and expenses in connection with opening and maintaining the Collection
Account (including, but not limited to, any fees or expenses of Lender). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ii)</B><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>So
long as no Unmatured Default or Event of Default shall have occurred hereunder and remain continuing, Borrower shall be permitted
to withdraw from the Collection Account collected funds therein up to an amount equal to the amount by which the Borrowing Base
exceeds the outstanding principal balance of the Revolving Loans at such time, subject to demonstration thereof by submission
of a new Borrowing Base Certificate and AR Report for that purpose. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Borrower's
Negative Covenants.</B> Borrower covenants and agrees with Lender that while this Agreement is in effect, Borrower shall not,
without the prior written consent of Lender, or as otherwise provided for herein:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Transfers
and Liens.</B> Except in connection with the Libertyville Loans, sell, transfer, mortgage, assign, pledge, lease, grant a Security
Interest in, or create, suffer or permit any encumbrance of, any of Borrower's assets (other than the sale of inventory by Borrower
in the ordinary course of business).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Continuity
of Operations.</B> (i) Engage in any business activities substantially different than those in which Borrower is
presently engaged, (ii) change its name without giving Lender thirty (30) days prior written notice, (iii) change its state of
organization, (iv) change its place of business, its chief executive office, or its mailing address, (v) change its
organizational identification number (if it has one), or (vi) cease operations, liquidate, merge or consolidate with any
other entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Change
in Ownership; Amend Organizational Documents.</B> Allow any change in ownership of Borrower or the classification of such ownership
interests, or amend, modify or supplement Borrower&rsquo;s organizational documents or agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Loans</B>,
<B>Acquisitions and Indebtedness.</B> (i) Loan money or assets, (ii) purchase or acquire any interest in any other Person, or
(iii) incur, assume or have outstanding any obligation as surety, borrower or guarantor except (A) Indebtedness owing to Lender,
(B) Indebtedness or liabilities of a nature existing on the date hereof and disclosed in the Financials, including the Libertyville
Loans and capitalized equipment leases, and (C) trade indebtedness incurred in the ordinary course of business and not inconsistent
with prior practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Distributions.</B>
(i) Make any distribution to partners, shareholders or members in their capacity as such, or (ii) pay any dividends on Borrower's
stock, if any, or (iii) purchase or retire any of Borrower's outstanding shares, partnership interests or membership interests
or otherwise alter or amend Borrower's capital structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Investments.
</B>Make any investment in or extend credit to any Person, other than trade credit on customary terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Transactions
with Affiliates.</B> Enter into, or be a party to, any transaction or arrangement, including, without limitation, the purchase,
sale, lease or exchange of property or the rendering of any service, with any of its Affiliates except after prior written notice
to Lender and then only in the ordinary course of and pursuant to the reasonable
requirements of Borrower's business and upon fair and reasonable terms no less favorable to the Borrower than would be obtained
in a comparable arm's-length transaction with any Person or entity not its Affiliate. Notwithstanding the foregoing, so long as
such Affiliate as granted a Security Interest in favor of Lender with respect to the Indebtedness of Borrower, transactions with
such Affiliate shall be permitted with notice to Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Salary.
</B>Increase any regular or bonus compensation to, or confer any other economic benefit on, any of the officers, directors, members,
partners, or shareholders of the Borrower outside the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Security
Interests.</B> Allow any of its assets to become subject to any Security Interest other than in favor of Lender (other than the
liens identified on Schedule 2.1(h)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Contracts.</B>
Enter into any contract, license or agreement with respect to or in any way relating to the Collateral on terms other than those
customarily contained in similar contracts, licenses or agreements between unrelated parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Libertyville
Loan.</B> Amend the material terms of the Libertyville Loans such that Borrower&rsquo;s financial obligations thereunder are materially
more onerous than on the date hereof, or in any way in which Borrower would be permitted to (i) draw more funds thereunder than
available on the date hereof, or (ii) draw funds more frequently than on the date hereof. Borrower shall promptly provide copies
of all amendments to the Libertyville Loans to Lender. </FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
4:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL
AGREEMENTS REGARDING LOANS AND COLLATERAL</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Distribution
of Casualty Insurance, Eminent Domain and Condemnation Proceeds.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Application
of Insurance Proceeds.</B> Borrower shall promptly notify Lender of any loss or damage to the Collateral estimated to equal or
exceed $100,000.00. Lender may make proof of loss if Borrower fails to do so within fifteen (15) days of the casualty. Whether
or not Lender's Collateral is impaired, Lender may, at its election, apply the proceeds to the reduction of the Indebtedness,
payment of any lien affecting the Collateral, or the restoration and repair of the Collateral. If Lender elects to apply the proceeds
to restoration and repair, Borrower shall repair or replace the damaged or destroyed Collateral in a manner satisfactory to Lender
and in such case Lender shall, upon satisfactory proof of such expenditure and the lien free completion of such restoration or
repair, pay or reimburse Borrower from the proceeds for the reasonable cost of restoration or repair if no Unmatured Default or
Event of Default exists hereunder. Any proceeds which have not been disbursed within 180 days after their receipt and which Lender
has not committed to the repair or restoration of the Collateral shall be applied to the Indebtedness. If Lender holds any proceeds
after payment in full of the Indebtedness, such proceeds shall be paid to Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Application
of Net Eminent Domain and Condemnation Proceeds.</B> If all or any part of the Collateral is condemned by eminent domain proceedings
or by any proceeding or purchase in lieu of condemnation, Lender may at its election require that all or any portion of the net
proceeds of the award be applied to the Indebtedness or the repair or replacement of the Collateral. The net proceeds of the award
shall mean the award after payment of all costs, expenses, and attorneys' fees incurred by Lender in connection with the condemnation
or eminent domain proceeding or purchase in lieu thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
to Advance Funds.</B> When any event occurs that Lender determines may endanger the fulfillment of any condition or covenant in
this Agreement, Lender may require Borrower to furnish, within ten (10) days after delivery of a written request, adequate security
to eliminate, reduce, or indemnify Lender against such event. In addition, upon such occurrence, Lender may advance funds or agree
to undertake to advance funds to any party to eliminate, reduce, or indemnify Lender against, such danger. All sums paid by Lender
pursuant to such agreements or undertakings shall be for Borrower's account and shall be without prejudice to Borrower's rights,
if any, to receive such funds from the party to whom paid. All sums expended by Lender in the exercise of its option to protect
Lender's interests shall be payable to Lender on demand together with interest from the date of the Loan at the Default Rate.
In addition, any advance of funds under this Agreement including, without limitation, direct disbursements to any third party
of sums due, shall be deemed to have been expended by or on behalf of Borrower and to have been secured by the Security Agreements.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
5:</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDITIONS
PRECEDENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Delivery
of Documents.</B> In addition to any other conditions precedent set forth herein or in any Related Document, Lender's obligation
to make any Loan is subject to, in addition to delivery of the executed Agreement and Notes and payment of all commitment fees
and costs and expenses of Lender (including attorneys' fees), delivery of the following documents, each to be in form and substance
satisfactory to Lender:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Security
Agreement.</B> The duly executed Commercial Security Agreement of Borrower (and each Grantor as applicable) dated of even date
herewith, together with all documents and instruments deemed necessary by Lender to enable Lender to perfect its Security Interests
in any and all of the Collateral granted therein including, but not limited to, the Control Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Blocked
Account Agreement.</B> The duly executed Blocked Account Agreement among Lender, Borrower and Libertyville Bank, together with
all documents and instruments deemed necessary by Lender with respect thereto, including all account documentation related to
the Collection Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Insurance.</B>
Evidence of all insurance required under this Agreement, issued in an amount and by a company acceptable to Lender, containing
a loss payable or other endorsement satisfactory to Lender insuring Lender as loss payee, together with such other endorsements
as may be required by Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)</B><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Organizational
Documents and Agreements, Resolutions, Articles, By-Laws, etc.</B> Certified copies of all documents, agreements or instruments
pertaining to Borrower&rsquo;s incorporation, organization, existence operation or governance, together with certified copies
of such documents, agreements or instruments for Borrower's constituents and board of director or other appropriate resolutions,
certificates of incumbency and good standing certificates for all parties, as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Approvals
and Consents.</B>Approval of all necessary governmental or regulatory agencies which may have jurisdiction over (i) the Borrower,
any of Borrower's constituents, any Grantor or any of the Collateral or (ii) Lender or its ability to enforce its rights under
this Agreement or any of the Related Documents, and all necessary third party consents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Landlord&rsquo;s
Agreements.</B> Within sixty (60) days of the date hereof, the duly executed Landlord&rsquo;s Agreement from each of
Borrower&rsquo;s landlords.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Libertyville
Loans.</B> Copies of the documents evidencing the Libertyville Loans, together with a subordination agreement acceptable to Libertyville
Bank and Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other.
</B> Such other documents as the Lender may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Certificates;
No Unmatured Defaults or Events of Default.</B> In addition to the satisfaction of the conditions precedent set forth in Section
5.1, and any condition precedent set forth in any Related Document, Lender's obligation to make any Loan is subject to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Certificate.
</B>Delivery of a certificate from the chief executive officer of Borrower dated the date of the requested Loan, certifying that
(i) each representation and warranty contained herein or in any of the Related Documents is true and correct as if made on the
date of such certificate, and (ii) no Unmatured Default or Event of Default has occurred and remains continuing hereunder or under
any Related Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>No
Unmatured Defaults or Events of Default.</B> No Unmatured Default or Event of Default having occurred and be continuing hereunder
or under any Related Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Borrowing
Base Certificate and AR Report. </B>Lender shall have received the most recent Borrowing Base Certificate and AR Report required
to be delivered pursuant to this Agreement, which, in connection with the initial Loans made hereunder at closing, shall show
availability in an amount acceptable to Lender (after giving effect to the Revolving Loans to be made to Borrower at closing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
6:</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVENTS
OF DEFAULT AND REMEDIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Events
of Default.</B> Each of the following (an &ldquo;Event of Default&rdquo;) shall constitute an Event of Default under this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Default
on Indebtedness.</B> Failure of Borrower to make any payment within ten (10) days of when due hereunder, under the Note, or under
any Related Document. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other
Defaults.</B> Failure of Borrower or any Grantor to comply with or to perform when due any other term, obligation, covenant or
condition contained in this Agreement or in any of the Related Documents, or failure of Borrower or any Grantor to comply with
or to perform any other term, obligation, covenant or condition contained in any other agreement between Lender and Borrower,
and/or Grantor. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Default
in Favor of Third Parties.</B> Should Borrower or any Grantor default under any loan, extension of credit, security agreement,
purchase or sales agreement, or any other agreement, in favor of any other creditor or Person that may materially affect any of
Borrower's or any Grantor's property or Borrower's or any Grantor's ability to repay the Loan, as applicable, or perform their
respective obligations under this Agreement or any of the Related Documents. Any default or event of default under any of the
Libertyville Loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>False
Statements.</B> Any warranty, representation, or statement made or furnished to Lender by or on behalf of Borrower or any Grantor
under this Agreement or the Related Documents is untrue, misleading or incorrect in any material respect, either now or at the
time made or furnished or any schedule, certificate, statement, report, document, financial data, notice, or writing furnished
at any time by the Borrower to the Lender is untrue, misleading or incorrect in any material respect, on the date as of which
the facts set forth therein are stated or certified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Defective
Collateralization; Material Agreements.</B> (i) This Agreement or any of the Related Documents (i) ceases to be in full force
and effect (including failure of any Security Agreement to create a valid and perfected Security Interest) at any time and for
any reason or (ii) shall be, or sought to be, held invalid by any court of law, government or public ministry, shall be in default,
or any Person shall seek to materially limit, modify or revoke such agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Insolvency;
Dissolution.</B> Borrower shall be unable to pay its debts as they mature. The dissolution or termination of Borrower's or any
Grantor's existence as a going business, insolvency, appointment of a receiver for any part of Borrower's or any Grantor's property,
any assignment for the benefit of creditors, any type of creditor workout, or the commencement of any proceeding under any bankruptcy
or insolvency laws by or against Borrower or any Grantor, other than an involuntary proceeding which is dismissed, stayed or indemnified
against within forty-five (45) days of the commencement of such proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Creditor
Proceedings.</B> Commencement of foreclosure, whether by judicial proceeding, self-help, repossession or any other method, by
any creditor of Borrower or any creditor of any Grantor against any Collateral securing the Indebtedness, including, without limitation,
a garnishment, attachment, levy, seizure, writ or distress warrant or the like (collectively, a &ldquo;creditor proceeding&rdquo;).
However, this Event of Default shall not apply to such creditor proceeding if Section 3.1(h) applies thereto and is being contested
in accordance therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Judgments.
</B>A judgment or order for the payment of money in excess of One Hundred Thousand Dollars ($100,000.00) shall be rendered against
Borrower or any Grantor and either (i) enforcement proceedings shall have been commenced by any creditor under such judgment or
order, or (ii) a stay of such judgment or order shall not be in effect for any period of thirty (30) consecutive days or (iii)
Borrower or such Grantor, as applicable, have not taken the steps provided for in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Material
Adverse Change.</B> Lender shall have determined in good faith (which determination shall be conclusive) that (i) a material adverse
change has occurred in the business, operations or financial condition of the Borrower, (ii) the prospect of payment or performance
of any obligation or agreement of the Borrower hereunder or under any of the Notes is materially impaired or (iii) a material
adverse change has occurred in the condition, value or operation of any of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Effect
of an Unmatured Default or an Event of Default.</B> If any Unmatured Default or Event of Default shall occur, all commitments
and obligations of Lender under this Agreement or the Related Documents or any other agreement between Lender and the Borrower
immediately will terminate and with respect to an Event of Default, at Lender's option, all Loans immediately will become due
and payable, all without notice of any kind to Borrower, except that in the case of an Event of Default of the type described
in subsection&nbsp;6.1(f) above, such acceleration shall be automatic and not optional. Upon the occurrence of any Event of Default
and at any time thereafter, Lender may, at its option, but without any obligation to do so, and in addition to any other right
Lender may have, do any one or more of the following without notice to any party: (a) institute appropriate proceedings to enforce
the performance of this Agreement; (b) withhold further disbursement of any Loan hereunder or under any other agreement with Borrower;
(c) expend funds necessary to remedy the Unmatured Default or Event of Default; (d) take possession of the Collateral and operate
same; (e) accelerate maturity of the Notes and/or Indebtedness and demand payment of all sums due under the Notes and/or Indebtedness;
(f) bring an action on the Notes and/or Indebtedness; (g) foreclose on its Security Interests in any manner available under law;
and (h) exercise any other right or remedy which it has under the Notes or Related Documents, or which is otherwise available
at law or in equity or by statute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
7:</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS;
MISCELLANEOUS PROVISIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Definitions.</B>
The following words shall have the following meanings when used in this Agreement. Terms not otherwise defined in this Agreement
shall have the meanings attributed to such terms in the Illinois Uniform Commercial Code to the extent the same are used or defined
therein (810 ILCS 1/1 <U>et seq.</U> as amended from time to time, the &ldquo;Uniform Commercial Code&rdquo; or &ldquo;UCC&rdquo;).
All references to dollar amounts shall mean amounts in lawful money of the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Account
Debtor. </B> The words &ldquo;Account Debtor&rdquo; means the Person who is obligated on or under an Account or, if appropriate,
chattel paper or general intangible, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts.
</B>The word &ldquo;Accounts&rdquo; means &ldquo;accounts&rdquo; as such term is defined in the UCC, including without limitation,
all rights to payment for goods sold or leased or services rendered, whether or not earned by performance and all rights in respect
of the Account Debtor, including, without limitation, all such rights in which Borrower has any right, title or interest by reason
of the purchase thereof by Borrower, and including, without limitation, all such rights constituting or evidenced by any Account,
chattel paper, general intangible, instrument, contract, invoice, purchase order, draft, acceptance, intercompany account, note,
security agreement, or other evidence of indebtedness or security, together with (a) any collateral assigned, hypothecated or
held to secure any of the foregoing and the rights under any security agreement granting a security interest in such collateral,
(b) all goods, the sale of which gave rise to any of the foregoing, and (c) all powers of attorney for the execution of any evidence
of indebtedness or security or other writing in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Affiliate.</B>
The word &ldquo;Affiliate&rdquo; means, with respect to any Person (the &ldquo;subject&rdquo;), any Person (i) which directly
or indirectly controls or is controlled by, or is under common control with, the subject, (ii) which beneficially owns or holds
5% or more of the equity interest of the subject, or (iii) 5% or more of the equity interest of which is beneficially owned or
held by the subject or its Affiliates. The term &ldquo;control&rdquo; means the possession, directly or indirectly, individually
or in concert with others, of the power to direct or cause the direction of the management and policies of a Person, whether through
the ownership of voting securities, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agreement.</B>
The word &ldquo;Agreement&rdquo; means this Business Loan Agreement, including the Preamble, as this Business Loan Agreement may
be amended or modified from time to time, together with all exhibits and schedules attached to this Business Loan Agreement from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AR
Report.</B> The words &ldquo;AR Report&rdquo; means a report from Borrower setting forth the details for each of the Accounts,
payments received, etc. in form and substance required by Lender. The current form of the AR Report is attached hereto as <B><U>Exhibit
A</U>.</B> Each AR Report shall be accompanied by copies of invoices for any newly reported Accounts. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Blocked
Account Agreement.</B> The words &ldquo;Blocked Account Agreement&rdquo; mean the Control Agreement for the Collection
Account among Borrower, Lender and Libertyville Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Borrower.</B>
The word &ldquo;Borrower&rdquo; has the meaning set forth in the initial paragraph of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Borrowing
Base.</B> The words &ldquo;Borrowing Base&rdquo; mean an amount equal to the total of (a) ONE HUNDRED PERCENT (100%) of the unpaid
Net Face Amount (further net of such reserves and allowances as the Lender deems necessary in its discretion) of all Eligible
Accounts owned by Borrower, plus (b) the positive collected balance in the Collection Account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Borrowing
Base Certificate. </B>The words &ldquo;Borrowing Base Certificate&rdquo; mean a certificate, certified by an appropriate officer
of Borrower to be true and complete, setting forth the Borrowing Base as of the date on which that certificate is prepared, and
otherwise being in form and detail satisfactory to the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Day. </B>The words &ldquo;Business Day&rdquo; mean any day of the year on which Lender is open for business in Evanston, Illinois.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charges.
</B>The word &ldquo;Charges&rdquo; has the meaning set forth in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collateral.</B>
The word &ldquo;Collateral&rdquo; means and includes without limitation all property and assets granted as collateral security
for any portion of the Indebtedness, whether real or personal property, whether granted directly or indirectly, whether granted
now or in the future, and whether granted in the form of a security interest, mortgage, deed of trust, assignment, pledge, chattel
mortgage, chattel trust, factor's lien, equipment trust, conditional sale, trust receipt, lien, charge, lien or title retention
contract, lease or consignment intended as a security device, or any other security or lien interest whatsoever, whether created
by law, contract, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Collection
Account.</B> The words &ldquo;Collection Account&rdquo; have the meaning set forth in Section 21(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Control
Agreement.</B> The words &ldquo;Control Agreement&rdquo; mean an Account Control Agreement among Borrower, Lender
and Libertyville Bank providing Lender with springing control over a depository account maintained by Borrower at
Libertyville Bank in form and substance acceptable to Lender. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Default
Rate.</B> The words &ldquo;Default Rate&rdquo; mean the rate of interest then applicable to the Loan <B>plus</B> five percent
(5.0%) per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligible
Account. </B> The words &ldquo;Eligible Account&rdquo; mean any duly invoiced Account of which Borrower is the sole owner and
in which the Lender has an enforceable and duly perfected first priority Security Interest, except any such Account:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that is not payable in installments and that shall not have been paid in full within ninety (90) days after the date first invoiced
to the Account Debtor or fifteen (15) days after its due date, which ever first elapses;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that is payable in installments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if the Account Debtor thereon is then obligated to Borrower on other Accounts that are excepted under clause (i);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if the payment of which by the Account Debtor is not, or does not remain, unconditional;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if and to the extent that the Account Debtor has asserted a defense or offset of any kind against the payment thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that according to its terms may be paid by the Account Debtor by an offset of any claim of the Account Debtor or any other Person
against Borrower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that arises other than in the ordinary course of Borrower's business or where the product or services has not yet been delivered
to the purchaser thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if the Account Debtor thereon is an Affiliate, director, officer, employee, or agent of Borrower or of any Affiliate of Borrower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if the Account Debtor thereon is insolvent or is the subject of any insolvency proceeding or is, at the time in question, in default
in any way on an existing obligation (except any obligation classified as an Account) to Borrower;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">reserved</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">if the Account Debtor thereon is a resident of any jurisdiction denying creditors access to its courts in the absence of qualification
to transact business therein or the filing of a so-called &ldquo;notice of business activities report&rdquo; or other similar
filing, unless Borrower has taken all action required by the jurisdiction in question to have access to its courts, unless specifically
approved by Lender;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">which is subject to any law (including, without limitation, the Assignment of Claims Act of 1940 (31 USC 3272, <U>et seq</U>.
and 41 USC 15 <U>et seq</U>.), rule, regulation, order, or agreement now or hereafter in effect that restricts or requires notice
of or consent to assignment, unless all such required notices shall have been given, all such required consents shall have been
obtained, and all other requirements shall have been complied with so that the Lender shall have the unconditional right to enforce
the Account against the Account Debtor thereon;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">is subject to any Security Interest securing payment or performance of any obligation other than the Indebtedness owing to Lender
or the Libertyville Loans;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that is described in any financing statement naming any Person other than the Lender or Libertyville Bank as the secured party
of record;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that is not evidenced by an invoice dated no later than thirty (30) days following the sale of product or provision of services;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">that is not payable in United States Dollars; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 10pt 1in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the Lender has determined, in good faith, that (A) the creditworthiness of the Account Debtor is not acceptable to Lender, or
(B) the collection or validity of the Accounts have become impaired for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Event
of Default.</B> The words &ldquo;Event of Default&rdquo; have the meaning set forth in Section 6.1. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financials.
</B>The word &ldquo;Financials&rdquo; means those financial statements delivered to Lender by or on behalf of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GAAP.</B>
The word &ldquo;GAAP&rdquo; means generally accepted accounting principles set forth in the opinions and pronouncements of the
Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the
Financial Accounting Standards Board (or any successor authority) that are applicable to the circumstances as of the date of determination,
but for the calculation of any financial covenant or ratio, GAAP means such principals as in effect as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grantor.</B>
The word &ldquo;Grantor&rdquo; means, without limitation, each and all of the Persons granting a Security Interest in any Collateral
for the Indebtedness, including without limitation all Borrowers granting such a Security Interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indebtedness.</B>
The word &ldquo;Indebtedness&rdquo; means and includes without limitation all Loans, together with all other obligations, debts
and liabilities of Borrower to Lender, or any one or more of them, of any and every kind and nature, as well as all claims by
Lender against Borrower, or any one or more of them relating to or arising from the transactions contemplated by this Agreement;
whether now or hereafter existing, voluntary or involuntary, due or not due, absolute or contingent, liquidated or unliquidated
whether arising by operation of law, under this Agreement, or acquired by Lender from any other source; whether Borrower may be
liable individually or jointly with others; whether Borrower may be obligated as a guarantor, surety, or otherwise; whether recovery
upon such Indebtedness may be or hereafter may become barred by any statute of limitations; and whether such Indebtedness may
be or hereafter may become otherwise unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inventory.
</B>The word &ldquo;Inventory&rdquo; means all &ldquo;inventory&rdquo; as such term is defined in the UCC, including, without
limitation, all materials, inventories, and finished goods, wherever located, whether in transit, held by others for Borrower&rsquo;s
account, covered by warehouse receipts, purchase orders and contracts, or in the possession of any carriers, forwarding agents,
truckers, warehousemen, vendors, customers on a consignment basis or other Persons, including, without limitation, all raw materials,
work in process, finished merchandise, supplies, goods, stores, incidentals, office supplies and packaging materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lender.</B>
The word &ldquo;Lender&rdquo; has the meaning set forth in the initial paragraph of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Libertyville
Bank.</B> The words &ldquo;Libertyville Bank&rdquo; mean Libertyville Bank &amp; Trust Company, its successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Libertyville
Loans.</B> The words &ldquo;Libertyville Loans&rdquo; mean, collectively, (a) the $500,000.00 revolving line of credit made available
by Libertyville Bank to Borrower pursuant to the Business Loan Agreement (Asset Based) dated March 4, 2018 as it may be amended
(as permitted hereby) or extended, (b) the $300,000.00 line of credit made available by Libertyville Bank to Borrower pursuant
to the Business Loan Agreement dated February 24, 2017 as it may be amended (as permitted hereby) or extended and the (c) $30,000.00
line of credit made available by Libertyville Bank to Borrower pursuant to the Business Loan Agreement dated July 7, 2014 as it
may be amended (as permitted hereby) or extended. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loan.</B>
The word &ldquo;Loan&rdquo; or &ldquo;Loans&rdquo; means any and all loans and financial accommodations from Lender to Borrower
related to or arising out of the loan transactions contemplated by this Agreement, whether now or hereafter existing, and however
evidenced, including without limitation those loans and financial accommodations described on any exhibit or schedule attached
to this Agreement from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maturity
Date.</B> The words &ldquo;Maturity Date&rdquo; mean either the Term Maturity Date or the Revolving Maturity Date, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
Face Amount.</B> The words &ldquo;Net Face Amount&rdquo; means the face amount of an Account less any allowances, discounts or
deductions available to an Account Debtor or any other deduction that Borrower may make available, including so called 2/10 (or
similar) discounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes.</B>
The word &ldquo;Notes&rdquo; means (a) the Term Note and (b) the Revolving Note, together with all renewals of, extensions of,
modifications of, refinancings of, consolidations of, and substitutions for such promissory notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notice
of Borrowing.</B> The words &ldquo;Notice of Borrowing&rdquo; have the meaning set forth in Section&nbsp;1.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Person.
</B>The word &ldquo;Person&rdquo; means an individual or a corporation, partnership, trust, incorporated or unincorporated association,
joint venture, joint stock company, limited liability company, government (or any instrumentality, division, agency, body or political
subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
Documents.</B> The words &ldquo;Related Documents&rdquo; mean and include without limitation all promissory notes, credit agreements,
loan agreements, guaranties, security agreements, mortgages, deeds of trust, collateral assignments, financing statements, and
all other instruments, agreements and documents, whether now or hereafter existing, executed in connection with the Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revolving
Loan.</B> The words &ldquo;Revolving Loan&rdquo; have the meaning set forth in Section&nbsp;1.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revolving
Maturity Date.</B> The words &ldquo;Revolving Maturity Date&rdquo; mean March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revolving
Note.</B> The words &ldquo;Revolving Note&rdquo; mean the Promissory Note (Revolving Note) from Borrower to Lender dated of even
date herewith in the principal amount of $2,000,000.00, together with all renewals of, extensions of, modifications of, refinancings
of, consolidations of, and substitutions for such promissory note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
Agreement.</B> The words &ldquo;Security Agreement&rdquo; mean and include without limitation any agreements, promises, covenants,
arrangements, understandings or other agreements, whether created by law, contract, or otherwise, evidencing, governing, representing,
or creating a Security Interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
Interest.</B> The words &ldquo;Security Interest&rdquo; mean and include without limitation any type of collateral security, whether
in the form of a lien, charge, mortgage, deed of trust, assignment, pledge, chattel mortgage, chattel trust, factor's lien, equipment
trust, conditional sale, trust receipt, lien or title retention contract, lease or consignment intended as a security device,
or any other security or lien interest, claim or encumbrance whatsoever, whether created by law, contract, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
Maturity Date.</B> The words &ldquo;Term Maturity Date&rdquo; has the meaning set forth in Section&nbsp;1.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
Note.</B> The words &ldquo;Term Note&rdquo; mean the Promissory Note (Term Note) from Borrower to Lender dated of even date herewith
in the principal amount of $500,000.00, together with all renewals of, extensions of, modifications of, refinancings of, consolidations
of, and substitutions for such promissory note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unmatured
Default.</B> The words &ldquo;Unmatured Default&rdquo; mean an event or circumstance which with the giving of notice, the passage
of time, or both, would, unless cured or waived, constitute an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other
Terms.</B> Any accounting term used in this Agreement shall have, unless otherwise specifically provided herein, the meaning customarily
given such term in accordance with GAAP, and all financial computations hereunder shall be computed, unless otherwise specifically
provided herein, in accordance with GAAP consistently applied. That certain terms or computations are explicitly modified by the
phrase &ldquo;in accordance with GAAP&rdquo; shall in no way be construed to limit the foregoing. The words &ldquo;herein,&rdquo;
&ldquo;hereof&rdquo; and &ldquo;hereunder&rdquo; and other words of similar import refer to this Agreement as a whole, including
the exhibits and schedules hereto, as the same may from time to time be amended, modified or supplemented and not to any particular
section, subsection or clause contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -12pt 0 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Miscellaneous
Provisions.</B> The following miscellaneous provisions are a part of this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Interpretation;
Joint and Several Obligations.</B> To the extent that this Agreement is executed by more than one Borrower, all words used herein
in the singular shall be deemed to have been used in the plural and those used in the masculine shall be deemed to have been used
in the feminine where the context and construction so require. The terms &ldquo;Borrower,&rdquo; and &ldquo;Grantor&rdquo; shall
mean all or any one or more of them. The phrase &ldquo;to the best of Borrower&rsquo;s knowledge,&rdquo; or words of similar import,
shall mean actual knowledge following due inquiry. Each Borrower shall be fully bound by the terms of this Agreement, the obligations
hereunder being joint and several. Lender shall have the right to proceed immediately against any Borrower with respect to any
breach of this Agreement by such Borrower or any other Borrower and Lender is not required to take any action or proceeding of
any kind against all the Borrowers or any of the property, real or personal, of any Borrower before proceeding against such Borrower
or any other Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Entire
Agreement; Amendments.</B> This Agreement, together with any Related Documents, constitutes the entire understanding and agreement
of the parties as to the matters set forth in this Agreement. No alteration of or amendment to this Agreement shall be effective
unless given in writing and signed by the party or parties sought to be charged or bound by the alteration or amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Applicable
Law. This Agreement and all acts, agreements, certificates, assignments, transfers and transactions hereunder, and all rights
of the parties hereto, shall be governed as to validity, enforcement, interpretation, construction, effect and in all other respects
by the internal laws and decisions of the State of Illinois, including, but not limited to, laws regulating interest, loan charges,
commitment fees and brokerage commissions (without regard to conflicts of law principles). It is acknowledged and agreed by Borrower
and Lender that the loan transaction evidenced hereby bears a reasonable relationship to the State of Illinois. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Consent
to Jurisdiction.</B> To induce Lender to accept this Agreement, Borrower irrevocably agrees that, subject to Lender's election,
<B>ALL ACTIONS OR PROCEEDINGS IN ANY WAY ARISING OUT OF OR RELATED TO THIS AGREEMENT WILL BE LITIGATED IN COURTS HAVING SITUS
IN COOK or WILL COUNTY, ILLINOIS. BORROWER HEREBY CONSENTS AND SUBMITS TO THE JURISDICTION OF ANY COURT LOCATED WITHIN COOK or
WILL COUNTY, ILLINOIS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(e)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Caption
Headings.</B> Caption headings in this Agreement are for convenience purposes only and are not to be used to interpret or define
the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Consent
to Loan Assignment or Participation.</B> Borrower agrees and consents to Lender's sale or transfer, whether now or later, of one
or more interests in the Indebtedness to one or more purchasers, whether related or unrelated to Lender. Lender may provide, without
any limitation whatsoever, to any one or more purchasers, or potential purchasers, any information or knowledge Lender may have
about Borrower or about any other matter relating to the Indebtedness, and Borrower hereby waives any rights to privacy it may
have with respect to such matters. Borrower additionally waives any and all notices of sale of interests, as well as all notices
of any repurchase of such interests. Borrower also agrees that the purchasers of any such interests will be considered as the
absolute owners of such interests in the Indebtedness and will have all the rights granted under the agreement or agreements governing
the sale of such interests. Borrower agrees that either Lender or such purchaser may enforce Borrower's obligations with respect
to the Indebtedness irrespective of the failure or insolvency of any holder of any interest therein. Borrower further agrees that
the purchaser of any such interests may enforce its interests irrespective of any personal claims or defenses that Borrower may
have against Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(g)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Costs
and Expenses.</B> Borrower agrees to pay upon demand all of Lender's out-of-pocket expenses, including attorneys' fees, incurred
in connection with this Agreement or any Collateral or in connection with the Indebtedness under this Agreement. Lender may engage
an agent to help collect the Indebtedness and to enforce this Agreement and the Related Documents, and Borrower will reimburse
Lender therefor. This includes, subject to any limits under applicable law, Lender's attorneys' fees and legal expenses, whether
or not there is a lawsuit, including attorneys' fees for bankruptcy proceedings (including efforts to modify or vacate any automatic
stay or injunction), appeals, and any anticipated post-judgment collection services. Borrower also will pay any court costs, in
addition to all other sums provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(h)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Advice
of Counsel; Joint Interpretation. </B>The Borrower acknowledges that it has been advised by its counsel with respect to this transaction,
this Agreement, and the Related Documents, including, without limitation, all waivers contained herein and therein. The parties
acknowledge that each party and its counsel have reviewed this Agreement and the Related Documents and that the normal rule of
construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation
of this Agreement, the Related Documents, or any amendments or exhibits thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Notices.</B>
Except as otherwise provided herein, whenever it is provided herein that any notice, demand, request, consent, approval, declaration
or other communication shall or may be given to or served upon any of the parties by another, or whenever any of the parties desires
to give or serve upon another any communication with respect to this Agreement, each such notice, demand, request, consent, approval,
declaration or other communication shall be in writing and shall be delivered in person (by personal delivery, delivery service
or reputable overnight courier service), or telecopied and confirmed immediately in writing by a copy mailed by United States
mail, postage prepaid, addressed as hereafter set forth, or mailed by registered or certified mail, return receipt requested,
postage prepaid, addressed as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 1.5in; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
to Lender, at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1603
Orrington Avenue, Suite 900</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evanston,
IL 60201</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Bradford T. Whitmore</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
847-733-1230 <BR>
Fax: 847-733-0339</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 1.5in; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
to Borrower, at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1319
Marquette Drive</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Romeoville,
IL 60446</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Jess Jankowski</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
630-771-6702 <BR>
Fax: 630-771-0825</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
at such other address as may be substituted by notice given as herein provided. The giving of any notice required hereunder may
be waived in writing by the party entitled to receive such notice. Every notice, demand, request, consent, approval, declaration
or other communication hereunder shall be deemed to have been duly given or secured on the date on which (i) personally delivered
(whether in person, by delivery service, or by reputable overnight courier service), (ii) the date of the telecopy transmission
(provided the confirmation mailing was sent as provided herein), or (iii) on the date of receipt if sent by the United States
mail. Failure or delay in delivering copies of any notice, demand, request, consent, approval, declaration or other communication
to the Persons designed above to receive copies, if any, shall in no way adversely affect the effectiveness of such notice, demand,
request, consent, approval, declaration or other communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(j)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Consent
to Service of Documents. BORROWER HEREBY AGREES AND CONSENTS THAT, IN ADDITION TO ANY METHODS OF SERVICE OF PROCESS PROVIDED FOR
UNDER APPLICABLE LAW, ALL SERVICE OF PROCESS IN ANY SUIT, ACTION OR PROCEEDING IN ANY ILLINOIS OR FEDERAL COURT INVOLVING LENDER
IN ANY WAY (WHETHER FOR THIS TRANSACTION OR OTHERWISE) MAY BE MADE BY EITHER (A) CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT
REQUESTED, DIRECTED TO BORROWER AT THE ADDRESS INDICATED HEREIN, AND SERVICE SO MADE SHALL BE COMPLETE FIVE DAYS AFTER THE SAME
SHALL HAVE BEEN SO MAILED OR (B) THROUGH BORROWER&rsquo;S ATTORNEY, DAVID L. WEINSTEIN, AT SUCH ADDRESS AS MAY
BE ON RECORD WITH THE SUPREME COURT OF ILLINOIS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(k)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Severability.</B>
If a court of competent jurisdiction finds any provision of this Agreement to be invalid or unenforceable as to any Person or
circumstance, such finding shall not render that provision invalid or unenforceable as to any other Persons or circumstances.
If feasible, any such offending provision shall be deemed to be modified to be within the limits of enforceability or validity;
however, if the offending provision cannot be so modified, it shall be stricken and all other provisions of this Agreement in
all other respects shall remain valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(l)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Subsidiaries
and Affiliates of Borrower.</B> To the extent the context of any provisions of this Agreement makes it appropriate, including
without limitation any representation, warranty or covenant, the word &ldquo;Borrower&rdquo; as used herein shall include all
subsidiaries of Borrower, if any. Notwithstanding the foregoing however, under no circumstances shall this Agreement be construed
to require Lender to make any Loan or other financial accommodation to any subsidiary or Affiliate of Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(m)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Successors
and Assigns.</B> This Agreement shall be binding upon, and inure to the benefit of, the parties and their successors and assigns
and shall inure to the benefit of Lender, its successors and assigns. Borrower shall not, however, have the right to assign its
rights under this Agreement or any interest therein, without the prior written consent of Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(n)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Survival.</B>
All warranties, representations, and covenants made by Borrower in this Agreement or in any certificate or other instrument delivered
by Borrower to Lender under this Agreement shall be considered to have been relied upon by Lender and will survive the making
of the Loan and delivery to Lender of the Related Documents, regardless of any investigation made by Lender or on Lender's behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(o)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Time
is of the Essence.</B> Time is of the essence in the performance of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(p)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Agency.</B>
Nothing in this Agreement shall be construed to constitute the creation of a partnership or joint venture between Lender and Borrower
or any Person. Lender is not an agent or representative of Borrower. This Agreement does not create a contractual relationship
with and shall not be construed to benefit or bind Lender in any way with or create any contractual duties by Lender to any contractor,
subcontractor, materialman, laborer, or any other Person other than Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(q)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Merger.</B>
There shall be no merger of the interest or estate created by this Agreement or any Related Document with any other interest or
estate in the Collateral at any time held by or for the benefit of Lender in any capacity, without the written consent of Lender.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(r)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Indemnity.</B>
Whether or not the transactions contemplated hereby shall be consummated, Borrower agrees to defend, protect and indemnify Lender,
its participants and each of their assigns, and each of their respective directors, officers, employees, affiliates and agents
(collectively, &ldquo;Indemnified Persons&rdquo;) from and against, and agrees to hold each such Indemnified Person harmless from,
any and all losses, claims, damages, obligations, judgments, penalties, and liabilities and related costs and expenses, including,
without limitation, reasonable counsel fees and expenses, incurred by such Indemnified Person arising out of any claim, action,
suit, litigation, investigation or proceeding (whether or not such Indemnified Person is a party thereto), which may be imposed
on, incurred by, or asserted against any Indemnified Person (whether direct, indirect or consequential and whether based on any
federal or state laws or other statutory regulations, including, without limitation, securities, environmental and commercial
laws and regulations, under common law or in equity, or in contract or otherwise) in any manner relating to or arising out of
this Agreement, the Related Documents, or any act, event or transaction related or attendant hereto or thereto, the making and
the management of the Loan or the use or intended use of the proceeds of the Loan hereunder; <U>provided</U>, <U>however</U>,
that such indemnity shall not apply to any such losses, claims, damages, or liabilities or related expenses determined by a court
of competent jurisdiction to have arisen from the gross negligence or willful misconduct of such Indemnified Person. The agreements
of Borrower in this subsection shall be in addition to any of the Indebtedness that Borrower may otherwise have. All amounts due
under this subsection shall be payable as incurred upon written demand therefor, shall be added to the Indebtedness of the Borrower
and shall bear interest at the Default Rate, and shall be secured by the Collateral. To the extent that the undertaking to indemnify,
pay and hold harmless set forth in this subsection may be unenforceable because it is violative of any law or public policy, the
Borrower shall contribute the maximum portion which it is permitted to pay and satisfy under applicable law, to the payment and
satisfaction of all matters incurred by the Indemnified Persons. The provisions of and undertakings and indemnifications set out
in this Section shall survive the satisfaction and payment of the Indebtedness of the Borrower and the termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(s)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Waiver
and Consents.</B> Lender shall not be deemed to have waived any rights under this Agreement or under the Related Documents unless
such waiver is given in writing and signed by Lender. No delay or omission on the part of Lender in exercising any right shall
operate as a waiver of such right or any other right. A waiver by Lender of a provision of this Agreement shall not prejudice
or constitute a waiver of Lender's right otherwise to demand strict compliance with that provision or any other provision of this
Agreement. No prior waiver by Lender, nor any course of dealing between Lender and Borrower, or between Lender and any Grantor,
shall constitute a waiver of any of Lender's rights or of any obligations of Borrower or of any Grantor as to any future transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(t)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Lender's
Discretion.</B> Whenever this Agreement requires either Lender's consent, election, approval or similar action or otherwise vests
in Lender the authority to make decisions and/or determinations, such actions shall be made or withheld in Lender's sole and absolute
discretion, unless specifically provided otherwise and the granting of any consent, election, approval or similar action by Lender
in any instance shall not constitute continuing consent, election, approval or similar action in subsequent instances where such
is required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(u)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Payments
Set Aside.</B> To the extent that the Borrower makes a payment or payments to the Lender or the Lender enforces its Security Interest
or exercises its rights of setoff, and such payment or payments or the proceeds of such enforcement or setoff or any part thereof
are subsequently invalidated, declared to be fraudulent or preferential, set aside and/or required to be repaid to a trustee,
receiver or any other party under any bankruptcy law, state or federal law, common law or equitable cause, then to the extent
of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(v)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Waiver
of Demand.</B> Demand, presentment, protest and notice of nonpayment are hereby waived by the Borrower, except as otherwise expressly
provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(w)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Conflict
of Terms.</B> Except as otherwise expressly provided in this Agreement and except as otherwise expressly provided in the Related
Documents by specific reference to the applicable provision of this Agreement, if any provision in this Agreement is in conflict
with, or inconsistent with, any provision in the Related Documents or the Commitment Letter, the provision in this Agreement shall
govern and control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(x)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Counterparts.</B>
This Agreement and all Related Documents may be executed in any number of separate counterparts, each of which shall, collectively
and separately, constitute one agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(y)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Waiver
of Jury Trial. BORROWER AND LENDER EACH WAIVE ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY
RIGHTS (i) UNDER THIS AGREEMENT OR ANY RELATED DOCUMENT OR UNDER ANY AMENDMENT, INSTRUMENT, DOCUMENT OR AGREEMENT WHICH MAY IN
THE FUTURE BE DELIVERED IN CONNECTION WITH THIS AGREEMENT OR RELATED DOCUMENT OR (ii) ARISING FROM ANY BANKING RELATIONSHIP EXISTING
IN CONNECTION WITH THIS AGREEMENT, AND AGREE THAT ANY SUCH ACTION OR PROCEEDING WILL BE TRIED BEFORE A COURT AND NOT BEFORE A
JURY. BORROWER AGREES THAT IT WILL NOT ASSERT ANY CLAIM AGAINST LENDER OR ANY OTHER PERSON INDEMNIFIED UNDER THIS AGREEMENT ON
ANY THEORY OF LIABILITY FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL OR PUNITIVE DAMAGES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(signatures
to follow)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BORROWER
ACKNOWLEDGES HAVING READ ALL THE PROVISIONS OF THIS BUSINESS LOAN AGREEMENT, AND BORROWER AGREES TO ITS TERMS. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BORROWER:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NANOPHASE
TECHNOLOGIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                            JESS A. JANKOWSKI</FONT></P></TD>
    <TD STYLE="width: 75%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Jess
A. Jankowski</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LENDER:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BEACHCORP,
LLC </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
BRADFORD T. WHITMORE</FONT></P></TD>
    <TD STYLE="width: 75%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bradford
T. Whitmore</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUSINESS
LOAN AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIST
OF EXHIBITS AND SCHEDULES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
A</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form of AR Report</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 2.1(h)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">General List and Description of Security Interests, Claims and Other Encumbrances</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 2.1(l)</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Places of Business, Chief Executive Office, Location of Records and Collateral Locations</FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Exhibit A&nbsp;&nbsp;-&nbsp;&nbsp;Form of AR Report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<IMG SRC="ex10-1_report.jpg" ALT="" STYLE="width: 800; height: 79">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: -2in">Schedule 2.1(h)&nbsp;&nbsp;-&nbsp;&nbsp;General
List and Description of Security Interests, Claims and Other Encumbrances</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: -2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Courier New, Courier, Monospace; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liens in connection with the Libertyville
Loans</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Courier New, Courier, Monospace; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liens or encumbrances in connection with
capitalized leases below:</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
2.1(l)&nbsp;&nbsp;-&nbsp;&nbsp;Places of Business, Chief Executive Office, Location of Records and Collateral Locations</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Courier New, Courier, Monospace; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse:
    1277 Naperville Drive, Romeoville IL</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; text-align: justify; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Landlord:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 29%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RB
    Properties</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 56%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6475
    Joliet Road</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
    A100</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Countryside,
    IL 60525</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Barton</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">708-582-6276</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    Dates:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/1/16
    - 8/31/19</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal
    Option:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    to renew one three year period</FONT></TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Courier New, Courier, Monospace; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt;   text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Romeoville: 1319 Marquette Drive, Romeoville IL</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; text-align: justify; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Landlord:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 29%"><FONT STYLE="font-family: Times New Roman, Times, Serif">MLRP 1319 Marquette LLC</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 56%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">RE Development Solutions, Inc.</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">P.O. Box 5598</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Woodridge, IL 60517</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ramsey Elshafei</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">630-707-0209</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lease Dates:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">1/1/16 - 12/31/19</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Renewal Options:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option to renew for one period of five years.</FONT></TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Courier New, Courier, Monospace; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Burr Ridge: 453 Commerce Street, Burr Ridge IL</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; text-align: justify; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Landlord:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 29%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Village of Burr Ridge</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 56%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">7660 County Line Road</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Burr Ridge, IL 60527</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Steven Stricker</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">630-654-8181 ext. 2000</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lease Dates:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/15/2017-9/15/21</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Renewal Options:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option to renew one three year period</FONT></TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 28; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>PROMISSORY NOTE
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: left"><A HREF="nanx-10q_093018.htm">Nanophase Technologies Corporation 10-Q</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>PROMISSORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>(Term
Note)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><B>Principal Amount: $500,000.00</B></TD>
    <TD STYLE="width: 50%; text-align: right; vertical-align: bottom"><B>Date of Note: November 19, 2018</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">PROMISE
TO PAY. NANOPHASE TECHNOLOGIES CORPORATION, a Delaware corporation (&#8220;Borrower&#8221;), hereby promises to pay to BEACHCORP,
LLC, a Delaware limited liability company (&#8220;Lender&#8221;), or order, in lawful money of the United States of America, the
principal amount of FIVE HUNDRED THOUSAND AND 00/100 DOLLARS ($500,000.00) together with interest on the unpaid principal balance
from the date hereof, until paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>LOAN.</B>
This Note evidences Borrower&#8217;s Term Loan under the Business Loan Agreement dated as of November 19, 2018 between Borrower
and Lender (as it may be amended from time to time, the &#8220;Loan Agreement&#8221;). Capitalized terms used herein, but not
otherwise defined herein, shall have the meaning given them in the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>PAYMENT.
</B>Borrower will repay the Loan(s) evidenced hereby in accordance with the terms of the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>INTEREST.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 -11pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Interest
on the Loans.</B> Borrower shall pay interest on the Loan(s) in accordance with the terms of the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 -11pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Default
Interest. </B>Notwithstanding the above provisions, if an Event of Default is in existence, all outstanding amounts of principal
and, to the extent permitted by law, all overdue interest, in respect of each and every Loan shall bear interest, payable on demand,
at the Default Rate under the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>EVENTS
OF DEFAULT.</B> A default in the performance of any obligation hereunder or any Event of Default under the Loan Agreement shall
constitute an Event of Default hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>LENDER'S
RIGHTS.</B> Upon the occurrence of an Event of Default, Lender may declare the entire unpaid principal balance on this Note and
all accrued unpaid interest immediately due, without notice, and then Borrower will pay that amount, together with any Prepayment
Fee which Borrower would be required to pay. Lender may hire or pay someone else to help collect this Note if Borrower does not
pay. Borrower also will pay Lender that amount. This includes, subject to any limits under applicable law, Lender's attorneys'
fees and legal expenses whether or not there is a lawsuit, including attorneys' fees and legal expenses for bankruptcy proceedings
(including efforts to modify or vacate any automatic stay or injunction), appeals, and any anticipated post-judgment collection
services. Borrower also will pay any court costs, in addition to all other sums provided by law. <B>This Note has been delivered
to Lender and accepted by Lender in the State of Illinois. If there is a lawsuit, Borrower agrees upon Lender's request to submit
to the jurisdiction and venue of the courts having situs in Cook or Will County, the State of Illinois. LENDER AND BORROWER HEREBY
WAIVE THE RIGHT TO ANY JURY TRIAL IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM BROUGHT BY EITHER LENDER OR BORROWER AGAINST THE
OTHER. This Note shall be governed by and construed in accordance with the laws of the State of Illinois.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>COLLATERAL;
LOAN AGREEMENT.</B> This Note is secured by the Collateral (as defined in the Loan Agreement). This Note is the Term Note referred
to in the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>SAVINGS
CLAUSE.</B> In no event shall the amount of interest or charges paid hereunder, together will all amounts reserved, charged,
or taken by Lender as compensation for fees, services, or expenses incidental to making, negotiation, or collection of the
loan evidenced hereby exceed the maximum rate of interest on the unpaid principal balance hereof, charges or compensation for
fees, services, or expenses allowable by applicable law. If any sum is </FONT>collected in excess of the applicable maximum
rate or amount, the excess collected shall be applied to reduce the principal debt. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>INDEMNITY.</B>
If the introduction of, or any change in, or in the interpretation of, or any change in its application to the Borrower of, any
law or regulation, or compliance with any guideline from any governmental authority (whether or not having the force of law) has
the effect of increasing the cost to the Lender of performing its obligations hereunder or otherwise reducing its effective return
hereunder, then upon demand from time to time the Borrower shall compensate the Lender for such cost or reduction pursuant to
a certificate reasonably prepared by the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>GENERAL
PROVISIONS.</B> Lender may delay or forgo enforcing any of its rights or remedies under this Note without losing them. Borrower
and any other Person who signs, guarantees or endorses this Note, to the extent allowed by law, waive presentment, demand for
payment, protest and notice of dishonor. Upon any change in the terms of this Note, and unless otherwise expressly stated in writing,
no party who signs this Note, whether as maker, guarantor, accommodation maker or endorser, shall be released from liability.
All such parties agree that Lender may renew, extend (repeatedly and for any length of time) or modify this Loan, or release any
party or guarantor or Collateral; or impair, fail to realize upon or perfect Lender's security interest in the Collateral; and
take any other action deemed necessary by Lender without the consent of or notice to anyone.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>LENDER'S
DISCRETION.</B> Whenever this Note requires either Lender's consent, election, approval or similar action or otherwise vests in
Lender the authority to make decisions and/or determinations, such actions shall be made or withheld in Lender's sole and absolute
discretion, unless specifically provided otherwise and the granting of any consent, election, approval or similar action by Lender
in any instance shall not constitute continuing consent, election, approval or similar action in subsequent instances where such
is required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>ILLINOIS
INSURANCE NOTICE.</B> Unless Borrower provides Lender with evidence of the insurance coverage required by the Security Agreements,
Lender may purchase insurance at Borrower's expense to protect Lender's interests in the Collateral. This insurance may, but need
not, protect Borrower's interests. The coverage that Lender purchases may not pay any claim that Borrower makes or any claim that
is made against Borrower in connection with the Collateral. Borrower may later cancel any insurance purchased by Lender, but only
after providing Lender with evidence that Borrower has obtained insurance as required by their agreement. If Lender purchases
insurance for the Collateral, Borrower will be responsible for the costs of that insurance, including interest and any other charges
Lender may impose in connection with the placement of the insurance, until the effective date of the cancellation or expiration
of the insurance. The costs of the insurance may be added to Borrower's total outstanding balance or obligation. The costs of
the insurance may be more than the cost of insurance Borrower may be able to obtain on Borrower's own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>PRIOR
TO SIGNING THIS NOTE, BORROWER READ AND UNDERSTOOD ALL THE PROVISIONS OF THIS NOTE. BORROWER AGREES TO THE TERMS OF THE PROMISSORY
NOTE AND ACKNOWLEDGES RECEIPT OF A COMPLETED COPY OF THE PROMISSORY NOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>BORROWER:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>NANOPHASE
TECHNOLOGIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">/s/ JESS A. JANKOWSKI</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">Jess
A. Jankowski</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Chief
Executive Officer</font></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Address:</font></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">1319
Marquette Drive</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Romeoville,
IL 60446</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"></FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<DESCRIPTION>PROMISSORY NOTE
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><A HREF="nanx-10q_093018.htm">Nanophase Technologies Corporation 10-Q</A></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>&nbsp;Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>PROMISSORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>(Revolving
Note)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><B>Principal
Amount: $2,000,000.00</B></TD>
    <TD STYLE="width: 50%; text-align: right; vertical-align: bottom"><B>Date of Note: November 19, 2018</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">PROMISE
TO PAY. NANOPHASE TECHNOLOGIES CORPORATION, a Delaware corporation (&#8220;Borrower&#8221;), hereby promises to pay to BEACHCORP,
LLC, a Delaware limited liability company (&#8220;Lender&#8221;), or order, in lawful money of the United States of America, the
principal amount of TWO MILLION AND 00/100 DOLLARS ($2,000,000.00) (or so much thereof as may be outstanding) together with interest
on the unpaid principal balance from the date hereof, until paid in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>LOAN.</B>
This Note evidences Borrower&#8217;s Revolving Loans under the Business Loan Agreement dated as of November 19, 2018 between Borrower
and Lender (as it may be amended from time to time, the &#8220;Loan Agreement&#8221;). Capitalized terms used herein, but not
otherwise defined herein, shall have the meaning given them in the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>PAYMENT.
</B>Borrower will repay the Loan(s) evidenced hereby in accordance with the terms of the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>INTEREST.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 -11pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Interest
on the Loans.</B>  Borrower shall pay interest on the Loan(s) in accordance with the terms of the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 -11pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 0.35in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Default
Interest. </B>Notwithstanding the above provisions, if an Event of Default is in existence, all outstanding amounts of principal
and, to the extent permitted by law, all overdue interest, in respect of each and every Loan shall bear interest, payable on demand,
at the Default Rate under the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>EVENTS
OF DEFAULT.</B>  A default in the performance of any obligation hereunder or any Event of Default under the Loan Agreement shall
constitute an Event of Default hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>LENDER'S
RIGHTS.</B>  Upon the occurrence of an Event of Default, Lender may declare the entire unpaid principal balance on this Note and
all accrued unpaid interest immediately due, without notice, and then Borrower will pay that amount, together with any Prepayment
Fee which Borrower would be required to pay. Lender may hire or pay someone else to help collect this Note if Borrower does not
pay. Borrower also will pay Lender that amount. This includes, subject to any limits under applicable law, Lender's attorneys'
fees and legal expenses whether or not there is a lawsuit, including attorneys' fees and legal expenses for bankruptcy proceedings
(including efforts to modify or vacate any automatic stay or injunction), appeals, and any anticipated post-judgment collection
services. Borrower also will pay any court costs, in addition to all other sums provided by law. <B>This Note has been delivered
to Lender and accepted by Lender in the State of Illinois. If there is a lawsuit, Borrower agrees upon Lender's request to submit
to the jurisdiction and venue of the courts having situs in Cook or Will County, the State of Illinois. LENDER AND BORROWER HEREBY
WAIVE THE RIGHT TO ANY JURY TRIAL IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM BROUGHT BY EITHER LENDER OR BORROWER AGAINST THE
OTHER. This Note shall be governed by and construed in accordance with the laws of the State of Illinois.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>COLLATERAL;
LOAN AGREEMENT.</B>  This Note is secured by the Collateral (as defined in the Loan Agreement). This Note is the Revolving Note
referred to in the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>SAVINGS
CLAUSE.</B>  In no event shall the amount of interest or charges paid hereunder, together will all amounts reserved, charged,
or taken by Lender as compensation for fees, services, or expenses incidental to making, negotiation, or collection of the
loan evidenced hereby exceed the maximum rate of interest on the unpaid principal balance hereof, charges or compensation for
fees, services, or expenses allowable by applicable law. If any sum is </FONT>collected in excess of the applicable maximum
rate or amount, the excess collected shall be applied to reduce the principal debt. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>INDEMNITY.</B>
If the introduction of, or any change in, or in the interpretation of, or any change in its application to the Borrower of, any
law or regulation, or compliance with any guideline from any governmental authority (whether or not having the force of law) has
the effect of increasing the cost to the Lender of performing its obligations hereunder or otherwise reducing its effective return
hereunder, then upon demand from time to time the Borrower shall compensate the Lender for such cost or reduction pursuant to
a certificate reasonably prepared by the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>GENERAL
PROVISIONS.</B>  Lender may delay or forgo enforcing any of its rights or remedies under this Note without losing them. Borrower
and any other Person who signs, guarantees or endorses this Note, to the extent allowed by law, waive presentment, demand for
payment, protest and notice of dishonor. Upon any change in the terms of this Note, and unless otherwise expressly stated in writing,
no party who signs this Note, whether as maker, guarantor, accommodation maker or endorser, shall be released from liability.
All such parties agree that Lender may renew, extend (repeatedly and for any length of time) or modify this Loan, or release any
party or guarantor or Collateral; or impair, fail to realize upon or perfect Lender's security interest in the Collateral; and
take any other action deemed necessary by Lender without the consent of or notice to anyone.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>LENDER'S
DISCRETION.</B> Whenever this Note requires either Lender's consent, election, approval or similar action or otherwise vests in
Lender the authority to make decisions and/or determinations, such actions shall be made or withheld in Lender's sole and absolute
discretion, unless specifically provided otherwise and the granting of any consent, election, approval or similar action by Lender
in any instance shall not constitute continuing consent, election, approval or similar action in subsequent instances where such
is required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>ILLINOIS
INSURANCE NOTICE.</B>  Unless Borrower provides Lender with evidence of the insurance coverage required by the Security Agreements,
Lender may purchase insurance at Borrower's expense to protect Lender's interests in the Collateral. This insurance may, but need
not, protect Borrower's interests. The coverage that Lender purchases may not pay any claim that Borrower makes or any claim that
is made against Borrower in connection with the Collateral. Borrower may later cancel any insurance purchased by Lender, but only
after providing Lender with evidence that Borrower has obtained insurance as required by their agreement. If Lender purchases
insurance for the Collateral, Borrower will be responsible for the costs of that insurance, including interest and any other charges
Lender may impose in connection with the placement of the insurance, until the effective date of the cancellation or expiration
of the insurance. The costs of the insurance may be added to Borrower's total outstanding balance or obligation. The costs of
the insurance may be more than the cost of insurance Borrower may be able to obtain on Borrower's own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>PRIOR
TO SIGNING THIS NOTE, BORROWER READ AND UNDERSTOOD ALL THE PROVISIONS OF THIS NOTE. BORROWER AGREES TO THE TERMS OF THE PROMISSORY
NOTE AND ACKNOWLEDGES RECEIPT OF A COMPLETED COPY OF THE PROMISSORY NOTE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>BORROWER:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"><B>NANOPHASE
TECHNOLOGIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid">/s/ JESS A. JANKOWSKI</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Jess
A. Jankowski</font></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Chief
Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Address:</font></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">1319
Marquette Drive</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">Romeoville,
IL 60446</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.15pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; letter-spacing: 0pt"></FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; letter-spacing: -0.15pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex31-1.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left;"><A HREF="nanx-10q_093018.htm">Nanophase Technologies Corporation 10-Q</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right;">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right;"><B>Exhibit 31.1</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"><B>Certification of the Chief
Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"><B>Pursuant to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Rules 13a-14(a) and 15d-14(a) under the
Exchange Act</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">I, Jess A. Jankowski, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">1. I have reviewed this quarterly report on
Form 10-Q of Nanophase Technologies Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">2. Based on my knowledge, this report does
not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">3. Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">4. The registrant&rsquo;s other certifying
officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f))
for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(a) Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(b) Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(c) Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(d) Disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent
fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">5. The registrant&rsquo;s other certifying
officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent function):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(a) All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(b) Any fraud, whether or not
material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over
financial reporting. &nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 19, 2018</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid">/s/ JESS A. JANKOWSKI</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.18in">Jess A. Jankowski</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.18in">Chief Executive Officer</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex31-2.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left;"><A HREF="nanx-10q_093018.htm">Nanophase Technologies Corporation 10-Q</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right;">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right;"><B>Exhibit 31.2</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"><B>Certification of the Chief
Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"><B>Pursuant to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Rules 13a-14(a) and 15d-14(a) under the Exchange
Act</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center;"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0">I, Jaime Escobar, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">1. I have reviewed this quarterly report on
Form 10-Q of Nanophase Technologies Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">2. Based on my knowledge, this report does
not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">3. Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">4. The registrant&rsquo;s other certifying
officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f))
for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(a) Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(b) Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(c) Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(d) Disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent
fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">5. The registrant&rsquo;s other certifying
officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent function):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(a) All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">(b) Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial
reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 19, 2018</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: Black 1pt solid">/s/ JAIME ESCOBAR</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.18in">Jaime Escobar</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.18in">Chief Financial Officer</TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>ex32.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; color: #000033"><A HREF="nanx-10q_093018.htm">Nanophase Technologies Corporation 10-Q</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; color: #000033">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Certification Pursuant to 18 U.S.C. Section
1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">In connection with this quarterly report of
Nanophase Technologies Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the quarter ending June 30, 2018 as filed with
the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), we, Jess A. Jankowski, Chief Executive Officer
of the Company, and Jaime Escobar, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &sect; 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">1. The Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">2. The information contained
in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 19, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 63%">&nbsp;</TD>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid">/s/ &nbsp;JESS A. JANKOWSKI</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.2in">Jess A. Jankowski</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.2in">Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ &nbsp;JAIME ESCOBAR</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.2in">Jaime Escobar</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.2in">Chief Financial Officer</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>nanx-20180930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: nanx_093018.xfr; Date: 2018%2D11%2D19T18:30:31Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:nanx="http://nanophase.com/20180930">
    <link:schemaRef xlink:href="nanx-20180930.xsd" xlink:type="simple" />
    <xbrli:context id="From2018-01-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_ProductAndServiceOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_ProductAndServiceOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_ProductAndServiceOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_ProductAndServiceOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_EmployeeStockOptionMember497406531">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SupplyCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_SupplyCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SupplyCommitmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_SupplyCommitmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SupplyCommitmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SupplyCommitmentAxis">us-gaap:SupplyCommitmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2199695">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2109069">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2094476">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nanx:CustomersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30_us-gaap_NonUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_NonUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_NonUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_NonUsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_LineOfCreditMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_LineOfCredit1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">nanx:LineOfCredit1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-03-01to2015-03-31_custom_LineOfCredit1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">nanx:LineOfCredit1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-03-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_LineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-07-31_us-gaap_LetterOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_LetterOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nanx:BusinessLoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-15to2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nanx:BusinessLoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-15</xbrli:startDate>
        <xbrli:endDate>2018-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nanx:BusinessLoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-15to2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nanx:BusinessLoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-15</xbrli:startDate>
        <xbrli:endDate>2018-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_us-gaap_EmployeeStockOptionMember39598154">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883107</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityCentralIndexKey contextRef="From2018-01-01to2018-09-30">0000883107</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="From2018-01-01to2018-09-30">NANOPHASE TECHNOLOGIES Corp</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="From2018-01-01to2018-09-30">10-Q</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2018-01-01to2018-09-30">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2018-01-01to2018-09-30">2018-09-30</dei:DocumentPeriodEndDate>
    <dei:TradingSymbol contextRef="From2018-01-01to2018-09-30">NANX</dei:TradingSymbol>
    <dei:CurrentFiscalYearEndDate contextRef="From2018-01-01to2018-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCurrentReportingStatus contextRef="From2018-01-01to2018-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2018-01-01to2018-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2018-11-19" unitRef="Shares" decimals="INF">33911792</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentFiscalPeriodFocus contextRef="From2018-01-01to2018-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2018-01-01to2018-09-30">2018</dei:DocumentFiscalYearFocus>
    <dei:EntityEmergingGrowthCompany contextRef="From2018-01-01to2018-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="From2018-01-01to2018-09-30">true</dei:EntitySmallBusiness>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1034000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1955000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">1779000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="-3">1070000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1917000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1115000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-09-30_custom_CustomersOneMember" unitRef="USD" decimals="-3">1196000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-09-30_custom_CustomersTwoMember" unitRef="USD" decimals="-3">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-09-30_custom_CustomersThreeMember" unitRef="USD" decimals="-3">174000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2199695" unitRef="USD" decimals="-3">1170000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2109069" unitRef="USD" decimals="-3">388000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE4234----1610-Q0001_STD_0_20150630_0_2031208x2094476" unitRef="USD" decimals="-3">149000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">2091000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1385000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">255000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">169000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">5297000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">4624000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1761000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1624000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">16000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">18000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">7074000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">6266000</us-gaap:Assets>
    <us-gaap:LinesOfCreditCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">500000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">300000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="AsOf2018-09-30_us-gaap_LineOfCreditMember" unitRef="USD" decimals="-3">500000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="AsOf2017-12-31_custom_LineOfCredit1Member" unitRef="USD" decimals="-3">300000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="AsOf2017-12-31_us-gaap_LineOfCreditMember" unitRef="USD" decimals="-3">300000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">197000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">143000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1916000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1038000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">980000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">543000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">3593000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">2024000</us-gaap:LiabilitiesCurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">496000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">416000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">361000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">410000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">189000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">184000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1046000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1010000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">339000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">338000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">98737000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">98563000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">-96641000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">-95669000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">2435000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">3232000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">7074000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">6266000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">5000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">5000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">24088</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">24088</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">42000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">42000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">33911792</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">33847793</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">33911792</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">33847793</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">11036000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2018-07-01to2018-09-30_us-gaap_ProductMember" unitRef="USD" decimals="-3">3998000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2018-07-01to2018-09-30_us-gaap_ProductAndServiceOtherMember" unitRef="USD" decimals="-3">24000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">4022000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-07-01to2017-09-30_us-gaap_ProductMember" unitRef="USD" decimals="-3">2524000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-07-01to2017-09-30_us-gaap_ProductAndServiceOtherMember" unitRef="USD" decimals="-3">261000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">2785000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2018-01-01to2018-09-30_us-gaap_ProductMember" unitRef="USD" decimals="-3">10908000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2018-01-01to2018-09-30_us-gaap_ProductAndServiceOtherMember" unitRef="USD" decimals="-3">128000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-01-01to2017-09-30_us-gaap_ProductMember" unitRef="USD" decimals="-3">9525000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-01-01to2017-09-30_us-gaap_ProductAndServiceOtherMember" unitRef="USD" decimals="-3">327000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">9852000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">8164000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">2965000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">2200000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">6862000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">2872000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">1057000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">585000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">2990000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">1513000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">416000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">494000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">1354000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">2299000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">765000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">725000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">2185000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-940000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-124000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-634000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-549000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">32000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">12000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">9000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">25000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-972000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-136000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-643000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-574000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-07-01to2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-07-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-972000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-136000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-643000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-574000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-01-01to2018-09-30" unitRef="USDPShares" decimals="INF">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-07-01to2018-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-07-01to2017-09-30" unitRef="USDPShares" decimals="INF">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-01-01to2017-09-30" unitRef="USDPShares" decimals="INF">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-01-01to2018-09-30" unitRef="Shares" decimals="INF">33858184</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-07-01to2018-09-30" unitRef="Shares" decimals="INF">33879097</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-07-01to2017-09-30" unitRef="Shares" decimals="INF">31239678</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-09-30" unitRef="Shares" decimals="INF">31234735</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-01-01to2018-09-30" unitRef="USDPShares" decimals="INF">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-07-01to2018-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-07-01to2017-09-30" unitRef="USDPShares" decimals="INF">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-01-01to2017-09-30" unitRef="USDPShares" decimals="INF">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-01-01to2018-09-30" unitRef="Shares" decimals="INF">33858184</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-07-01to2018-09-30" unitRef="Shares" decimals="INF">33879097</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-07-01to2017-09-30" unitRef="Shares" decimals="INF">31239678</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-01-01to2017-09-30" unitRef="Shares" decimals="INF">31234735</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">239000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">267000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">146000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">140000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">802000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">1147000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">706000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">104000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">84000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-53000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">872000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">333000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">386000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">166000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-921000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-866000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfMachineryAndEquipment contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">136000</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">115000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">121000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-115000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">15000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">114000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">122000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">1200000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">250000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">1000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2017-01-01to2017-09-30" unitRef="USD" xsi:nil="true" />
    <nanx:ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">29000</nanx:ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock>
    <nanx:ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">14000</nanx:ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">115000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">142000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-921000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-709000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:InterestPaidNet contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">32000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">24000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">6000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">9000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <nanx:ProceedsFromCapitalLeaseNonCash contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">248000</nanx:ProceedsFromCapitalLeaseNonCash>
    <nanx:ProceedsFromCapitalLeaseNonCash contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">307000</nanx:ProceedsFromCapitalLeaseNonCash>
    <us-gaap:BasisOfAccounting contextRef="From2018-01-01to2018-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;(1) Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;The&#13;accompanying unaudited consolidated condensed interim financial statements of Nanophase Technologies Corporation (&amp;#8220;Nanophase&amp;#8221;&#13;or the &amp;#8220;Company&amp;#8221;, including &amp;#8220;we&amp;#8221;, &amp;#8220;our&amp;#8221; or &amp;#8220;us&amp;#8221;) along with its wholly-owned subsidiary,&#13;Sol&amp;#233;sence&amp;#174;, reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management,&#13;are necessary for a fair presentation of our financial position and operating results for the interim periods presented. Operating&#13;results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected&#13;for the year ending December 31, 2018 or any interim period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;These&#13;financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended&#13;December 31, 2017, included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2017, as filed with&#13;the Securities and Exchange Commission.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:NatureOfOperations contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;(2) Description of Business&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Nanophase is a leader&#13;in advanced materials technologies, with its primary strategic focus being in developing and providing engineered solutions for&#13;various applications of micromaterials (&amp;#8220;nano&amp;#8221; and &amp;#8220;non-nano&amp;#8221; in scale) for use in protecting human skin&#13;from the harmful and damaging effects of the sun. We also produce a variety of materials for use in diverse markets other than&#13;those using our materials as active ingredients for sun protection. These other markets include: industrial coatings applications,&#13;abrasion-resistant additives, medical diagnostics, and a variety of surface finishing (polishing) applications, including optics.&#13;&lt;font style="font-weight: normal"&gt;We have expanded our offerings beyond active ingredients to include targeted full formulations&#13;of skin care products, marketed and sold by our wholly-owned subsidiary, Sol&amp;#233;sence&amp;#174;, LLC.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;We&#13;target markets in which we believe practical solutions may be found using our products. We work closely with current and potential&#13;customers in these target markets to identify their material and performance requirements and market our advanced materials to&#13;various end-use applications manufacturers, and our Sol&amp;#233;sence&amp;#174; solutions to cosmetics and skin care brands. Recently&#13;developed technologies have made certain new products possible and opened potential new markets. During 2015 we were granted a&#13;patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product development in personal&#13;care, with first revenue recognized during 2016. In addition, through the creation of our Sol&amp;#233;sence&amp;#174;, LLC subsidiary,&#13;we utilize this particle surface treatment to manufacture and sell fully developed solutions to targeted customers in the cosmetics&#13;and skin care industry, in addition to the additives we have traditionally sold in the personal care area.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;Although&#13;our primary strategic focus has been the North American market, we currently sell material to customers overseas and have been&#13;working to expand our reach within foreign markets. The Company was incorporated in Illinois on November 25, 1989 and became a&#13;Delaware corporation during November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;While&#13;product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities&#13;are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as &amp;#8220;other revenue&amp;#8221;&#13;in our Statements of Operations, as it does not represent revenue directly from our materials or fully formulated products.&lt;/font&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(3) Revenues&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On January 1, 2018,&#13;we adopted Accounting Standards Updates (&amp;#8220;ASU&amp;#8221;) 2014-09 and 2015-14, &lt;i&gt;Revenue from Contract with Customers (Topic&#13;606)&lt;/i&gt;, using the modified retrospective method applied to those contracts that were not &lt;b&gt;completed&lt;/b&gt; as of January 1, 2018.&#13;Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not&#13;adjusted and continue to be reported in accordance with our historical accounting under the Financial Accounting Standards Board&#13;(&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 605. Based on our contract evaluation, we determined&#13;that there was no need to record any changes to our opening retained earnings due to the impact of our adoption of Topic 606.&#13;The adoption of Topic 606 did not have a material impact on our consolidated condensed financial statements.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Revenues are recognized&#13;at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration&#13;we expect to receive in exchange for those goods.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We generally expense&#13;sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within&#13;selling, general and administrative expenses. Customers&amp;#8217; deposits, deferred revenue and other receipts are deferred and&#13;recognized when the revenue is realized and earned. Cash payments to customers are classified as reductions of revenue in our&#13;statements of operations.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We do not disclose&#13;the value of the unsatisfied performance obligations for contracts with an original expected length of one year or less or contracts&#13;for which we recognize revenue that we have the right to invoice for goods completed.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(4) Earnings (Loss) Per Share&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;Earnings&#13;(Loss) Per Share is computed using the Treasury Stock Method. Options to purchase approximately 1,119,000 and 820,000 shares of&#13;common stock that were outstanding as of September 30, 2018 for the three and nine months ended September 30, 2018, respectively,&#13;were not included in the computation of diluted earnings (loss) per share, as the impact of such shares would be anti-dilutive.&#13;Options to purchase approximately 750,000 and 796,000 shares of common stock that were outstanding as of September 30, 2017 were&#13;not included in the computation of loss per share for the three and nine months ended September 30, 2017, respectively, as the&#13;impact of such shares would be anti-dilutive.&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(5) Financial Instruments&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;We&#13;follow FASB ASC Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 820, &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;,&#13;which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.&#13;The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs)&#13;used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires&#13;significant management judgment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;Our&#13;financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with&#13;a promissory note with no related borrowings, any borrowings on the LB&amp;#38;T working capital line of credit, each described in&#13;Note 6. Subsequent to September 30, 2018, the Company has secured a term loan and a revolving loan, each described in Note 6.&#13;The fair values of all financial instruments were not materially different from their carrying values. There were no financial&#13;assets or liabilities adjusted to fair value on September 30, 2018 or December 31, 2017.&lt;/font&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(6) Notes and Lines of Credit&lt;/p&gt;&#13;&#13;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During July 2014,&#13;we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our obligations&#13;under our facility lease agreement. No borrowings have been incurred under this promissory note. Should any borrowings occur in&#13;the future, the interest rate would be the prime rate plus 1%, with the bank having the right to &amp;#8220;set off&amp;#8221; or apply&#13;unpaid balances against our checking account if we fail to meet our obligations under any borrowings under the note. It is our&#13;intention to renew this note annually, for as long as we need to pursuant to the terms of our facility lease agreement. Because&#13;there were no amounts outstanding at any time during 2018 or 2017, we have recorded no related liability on our balance sheet.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During March 2015,&#13;we entered into a Business Loan Agreement (the &amp;#8220;Line of Credit Agreement&amp;#8221;) with Libertyville Bank and Trust Company,&#13;a Wintrust Community Bank (&amp;#8220;LB&amp;#38;T&amp;#8221;), our primary bank. This Line of Credit Agreement was subsequently amended on&#13;April 13, 2015 and was extended on each of March 4, 2016 and February 14, 2017. Under the Line of Credit Agreement, as amended,&#13;LB&amp;#38;T provided a maximum of $300 or 75% of our eligible accounts receivable, whichever was less, of revolving credit, collateralized&#13;by a senior priority lien on our accounts receivable, inventory, equipment, general intangibles and fixtures. Interest on any&#13;borrowings was the prime rate at the time plus 1%. Availability to draw on the line required us to have at least $1 million in&#13;cash, including any amounts borrowed, at LB&amp;#38;T on the date of any advance. Advances could only occur at the beginning or end&#13;of a fiscal quarter and had to be repaid in full within five days of the advance. Borrowings on this line were $300 on December&#13;31, 2017. These borrowings were repaid in January 2018. The Line of Credit Agreement expired on March 4, 2018.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On March&amp;#160;26,&#13;2018, we executed a new Business Loan Agreement (the &amp;#8220;New Line of Credit Agreement&amp;#8221;), dated as of March 4, 2018, with&#13;LB&amp;#38;T, which replaces the Line of Credit Agreement with LB&amp;#38;T that expired on March 4, 2018. Under the New Line of Credit&#13;Agreement, LB&amp;#38;T will provide a maximum of (i) $500 or (ii) two times the sum of (a) 75% our eligible accounts receivables&#13;and (b) our cash deposited with LB&amp;#38;T, whichever is less,&amp;#160;of revolving credit to us, collateralized by a senior priority&#13;lien on our accounts receivables, inventory, equipment, general intangibles and fixtures. Interest is payable monthly on any advances&#13;at a floating interest rate of the prime rate at the time plus 1%. We must have $1 million in cash, inclusive of the borrowed&#13;amount, at LB&amp;#38;T on the date of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be&#13;repaid in full within five business days of the advance. The New Line of Credit Agreement expires in March&amp;#160;2019. While the&#13;New Line of Credit Agreement is in effect, we cannot, among other things, engage in any business activities substantially different&#13;than those in which we are presently engaged, and there are limitations imposed on our ability to, among other things, incur additional&#13;indebtedness for borrowed money, including capital leases, sell, transfer, mortgage, assign, pledge, lease or grant a security&#13;interest in or encumber any of our assets, sell with recourse any of our accounts other than to LB&amp;#38;T, cease operations, merge,&#13;transfer, acquire or consolidate with any other entity, change our name, dissolve or transfer or sell collateral outside the ordinary&#13;course of business, pay any cash dividends, loan, invest in or advance money or assets to any other person or entity, purchase,&#13;create or acquire any interest in any other entity, or incur any obligation as a surety or guarantor other than in the ordinary&#13;course of business, in each case without LB&amp;#38;T&amp;#8217;s prior written consent. We borrowed $500 on this line on September 28,&#13;2018 and repaid it on October 1st, 2018. The amount outstanding on the loan was $300 on December 31, 2017 which was paid in full&#13;on January 9, 2018.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;On November 19, 2018,&#13;we entered into a Business Loan Agreement (the &amp;#8220;Master Agreement&amp;#8221;) with Beachcorp, LLC. The Master Agreement relates&#13;to two loan facilities, each evidenced by a separate promissory note dated as of November 16, 2018: a term loan to the Company&#13;of up to $500 to be disbursed in a single advance (the &amp;#8220;Term Loan&amp;#8221;) with a fixed annual interest rate of 8.25%, payable&#13;quarterly, accruing from the date of such advance and with principal due on December 31, 2020; and an asset-based revolving loan&#13;facility for the Company of up to $2,000 (the &amp;#8220;Revolver Facility&amp;#8221;), with floating interest accruing at the prime rate&#13;plus 3% (8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable of the Company, and with all&#13;principal and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured by all the unencumbered assets&#13;of the Company and subordinated to LB&amp;#38;T&amp;#8217;s secured interest under the New Line of Credit Agreement. The Master Agreement&#13;substantially restricts the Company&amp;#8217;s ability to incur additional indebtedness during the terms of both the Term Loan and&#13;the Revolver Facility. As of the date of this filing, there were no amounts borrowed on either of the loans.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;(7) Inventories&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;Inventories&#13;consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold"&gt;September 30, 2018&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap; padding-bottom: 2.15pt"&gt;&lt;b&gt;December 31, 2017 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 65%"&gt;Raw materials&lt;/td&gt;&#13;    &lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;1,086&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;543&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;1,026&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;863&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2,112&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,406&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Allowance for excess inventory quantities&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(21&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(21&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;2,091&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,385&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During the three months&#13;ended March 31, 2018, $246 was reclassified from Prepaid Expenses to Raw Materials. For comparison purposes, $246 has been reclassified&#13;from Prepaid Expenses to Raw Materials as of December 31, 2017 in the table above. Our balance sheet as of December 31, 2017 has&#13;also been updated to reflect this reclassification.&amp;#160;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;(8) Share-Based Compensation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;We&#13;follow &lt;/font&gt;FASB ASC Topic 718&lt;font style="font-family: Times New Roman, Times, Serif"&gt;, &lt;/font&gt;&lt;i&gt;Compensation &amp;#8211; Stock&#13;Compensation&lt;/i&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;, in which compensation expense is recognized only for&#13;share-based payments expected to vest. We recognized compensation expense related to stock options of $58 and $146 for the three&#13;and nine months ended September 30, 2018, respectively, compared to $45 and $140 for the three and nine months ended September&#13;30, 2017, respectively. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of September 30,&#13;2018, there was approximately $449 of total unrecognized compensation cost related to non-vested share-based compensation arrangements&#13;granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.2 years.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;u&gt;Stock Options and Stock Grants&amp;#160;&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;During&#13;the nine months ended September 30, 2018, 63,999 shares of common stock were issued pursuant to stock option exercises for proceeds&#13;of $29,000. During the nine months ended September 30, 2017, 45,334 shares of common stock were issued pursuant to stock option&#13;exercises for proceeds of $14,000. During the nine months ended September 30, 2018, 570,500 options were granted compared to the&#13;507,600 &lt;/font&gt;stock options were granted during the same period in 2017. During the nine months ended September 30, 2018, 188,504&#13;stock options expired, and 31,601 stock options were forfeited compared to 7,000 stock options expiring and 37,568 forfeited during&#13;the same period in 2017. We had 3,428,000 stock options outstanding at a weighted average exercise price of $0.67 on September&#13;30, 2018, compared to 3,141,000 stock options outstanding at a weighted average exercise price of $0.79 on December 31, 2017.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table&#13;illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the&#13;periods presented:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;For the nine months ended&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;September 30, 2018&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;September 30, 2017&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 60%"&gt;Weighted-average risk-free interest rates:&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt; width: 13%"&gt;2.9%&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt; width: 13%"&gt;2.1%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Dividend yield:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;-&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Weighted-average expected life of the option:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;7 years&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;7 years&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Weighted-average expected stock price volatility:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;94%&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;94%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Weighted-average fair value of the options granted:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;$0.64&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;$0.55&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;As of September 30, 2018, we did not have&#13;any unvested restricted stock or performance shares outstanding. No stock options were granted in the three-month periods end&#13;September 30, 2018 and 2017.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;(9) Significant Customers and Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Revenue from our three&#13;largest customers constituted approximately 74%, 12% and 4%, respectively, of our total revenue for the three months ended September&#13;30, 2018, and approximately 74%, 8% and 4%, respectively, of our total revenue for the nine months ended September 30, 2018. Amounts&#13;included in accounts receivable on September 30, 2018 relating to these three customers were approximately $1,170, $388 and $149,&#13;respectively. Revenue from these three customers constituted approximately 58%, 0% and 8%, respectively, of our total revenue for&#13;the three months ended September 30, 2017, and approximately 67%, 0%, and 7% of our total revenue for the nine months ended September&#13;30, 2017. Amounts included in accounts receivable on September 30, 2017 relating to these three customers were approximately $1,196,&#13;$0 and $174 respectively. The loss of one of these significant customers, a significant decrease in revenue from one or more of&#13;these customers, or the failure to attract new customers could have a material adverse effect on our business, results of operations&#13;and financial condition.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We currently have exclusive&#13;supply agreements with BASF Corporation (&amp;#8220;BASF&amp;#8221;), our largest customer, that have contingencies outlined which could&#13;potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended&#13;to provide capacity sufficient to meet the customer&amp;#8217;s production needs. This outcome may occur if we fail to meet certain&#13;performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants&#13;in one of our supply agreements with BASF &amp;#8220;trigger&amp;#8221; a technology transfer right (license and equipment sale at BASF&amp;#8217;s&#13;option) in the event (a) that earnings for the twelve-month period ending with our most recently published quarterly financial&#13;statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b) of an acceleration&#13;of any debt maturity having a principal amount of more than $10 million. Our supply agreements with BASF also &amp;#8220;trigger&amp;#8221;&#13;a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment&#13;sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment&amp;#8217;s net&#13;book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the&#13;equipment&amp;#8217;s net book value, depending on the equipment and related products.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We believe that we&#13;have sufficient cash and credit availability (See Liquidity and Capital Resources in Management&amp;#8217;s Discussion and Analysis&#13;in Part I, Item 2 of this Form 10-Q for a further discussion, as well as the description of our loan and credit agreements described&#13;in Note 6) to operate our business during the remainder of 2018. If a triggering event were to occur and BASF elected to proceed&#13;with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products&#13;sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to&#13;replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer&#13;pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity&#13;would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar&#13;consequences would occur if we were determined to have materially breached certain other provisions of the supply agreements with&#13;BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities.&#13;We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Upon&#13;the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such&#13;an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including&#13;with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated&#13;investments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We expect to expend&#13;resources on research, development and product testing, and in expanding current capacity or capability for new business. In addition,&#13;we may incur significant costs in preparing, filing, prosecuting, maintaining and enforcing our patents and other proprietary&#13;rights. We may need additional financing if we were to lose an existing customer or suffer a significant decrease in revenue from&#13;one or more of our customers or because of currently unknown capital requirements, new regulatory requirements or the need to&#13;meet the cash requirements discussed above to avoid a triggering event under our BASF agreement. Given our expected growth in&#13;our Sol&amp;#233;sence&lt;sup&gt;&amp;#174;&lt;/sup&gt;&amp;#160;business, we may also have temporary working capital demands that we cannot fund with&#13;existing capital, while remaining in compliance with the covenants included in our BASF agreement described above. If necessary,&#13;we may seek funding through public or private financing and through contracts with governmental entities or other companies. Additional&#13;financing may not be available on acceptable terms or at all, and any such additional financing could be dilutive to our shareholders.&#13;If we are unable to obtain adequate funds, we may be required to delay, scale-back or eliminate some of our manufacturing and&#13;marketing operations or we may need to obtain funds through arrangements on less favorable terms. Such circumstances could raise&#13;doubt as to our ability to continue as a going concern. If we obtain funding on unfavorable terms, we may be required to relinquish&#13;rights to some of our intellectual property.&amp;#160;&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;(10) Business Segmentation and Geographical Distribution&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Revenue from international&#13;sources approximated $152 and $335 for the three and nine months ended September 30, 2018, respectively, compared to $276 and&#13;$956 for the three and nine months ended September 30, 2017, respectively. All this revenue was product revenue.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Our operations comprise&#13;a single business segment and all our long-lived assets are located within the United States.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;(11) New Accounting Pronouncements&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;During February 2016,&#13;the FASB issued ASU No. 2016-02 (&amp;#8220;ASU 2016-02&amp;#8221;), &lt;i&gt;Leases (Topic 842)&lt;/i&gt;. This standard requires the recognition&#13;of assets and liabilities arising from lease transactions on the balance sheet and the disclosure of key information about leasing&#13;arrangements. Accordingly, a lessee will recognize a lease asset for its right to use the underlying asset and a lease liability&#13;for the corresponding lease obligation. Both the asset and liability will initially be measured at the present value of the future&#13;minimum lease payments over the lease term. Subsequent measurement, including the presentation of expenses and cash flows, will&#13;depend on the classification of the lease as either a finance or an operating lease. Initial costs directly attributable to negotiating&#13;and arranging the lease will be included in the asset. For leases with a term of 12 months or less, a lessee can make an accounting&#13;policy election by class of underlying asset to not recognize an asset and corresponding liability. Lessees will also be required&#13;to provide additional qualitative and quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising&#13;from leases. These disclosures are intended to supplement the amounts recorded in the financial statements and provide additional&#13;information about the nature of an organization&amp;#8217;s leasing activities. The amendments in this standard are effective for&#13;fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, which is our first quarter of&#13;2019, with early adoption permitted. We review new accounting standards as issued. We are in the process of evaluating the impact&#13;this standard will have on our financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-weight: normal"&gt;Inventories&#13;consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold"&gt;September 30, 2018&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap; padding-bottom: 2.15pt"&gt;&lt;b&gt;December 31, 2017 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 65%"&gt;Raw materials&lt;/td&gt;&#13;    &lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;1,086&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 11%"&gt;543&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;1,026&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;863&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;2,112&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,406&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Allowance for excess inventory quantities&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(21&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;(21&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;2,091&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;1,385&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table&#13;illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during&#13;the periods presented:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;For the nine months ended&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;September 30, 2018&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;September 30, 2017&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt; width: 60%"&gt;Weighted-average risk-free interest rates:&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt; width: 13%"&gt;2.9%&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt; width: 13%"&gt;2.1%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Dividend yield:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;-&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;-&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Weighted-average expected life of the option:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;7 years&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;7 years&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Weighted-average expected stock price volatility:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;94%&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;94%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Weighted-average fair value of the options granted:&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;$0.64&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; padding-left: 5.4pt"&gt;$0.55&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1086000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">543000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1026000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">863000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryGross contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">2112000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">1406000</us-gaap:InventoryGross>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">21000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">21000</us-gaap:InventoryValuationReserves>
    <nanx:RelassificationFromPrepaidExpensesToRawMaterials contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="-3">246000</nanx:RelassificationFromPrepaidExpensesToRawMaterials>
    <nanx:RelassificationFromPrepaidExpensesToRawMaterials contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">246000</nanx:RelassificationFromPrepaidExpensesToRawMaterials>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="Pure" decimals="INF">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="Pure" decimals="INF">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="Pure" decimals="INF">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="Pure" decimals="INF">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="USDPShares" decimals="INF">0.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="USDPShares" decimals="INF">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockOptionPlanExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">146000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">58000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">45000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">140000</us-gaap:StockOptionPlanExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">449000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2018-01-01to2018-09-30">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">29000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">14000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="Shares" decimals="INF">63999</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="Shares" decimals="INF">45334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-07-01to2018-09-30_us-gaap_EmployeeStockOptionMember497406531" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="Shares" decimals="INF">570500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="Shares" decimals="INF">507600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-07-01to2017-09-30_us-gaap_EmployeeStockOptionMember39598154" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="Shares" decimals="INF">188504</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="Shares" decimals="INF">7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember627184468" unitRef="Shares" decimals="INF">31601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember689220421" unitRef="Shares" decimals="INF">37568</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <nanx:MajorCustomersNumberOfCustomers contextRef="From2018-01-01to2018-09-30" unitRef="Pure" decimals="INF">3</nanx:MajorCustomersNumberOfCustomers>
    <nanx:MajorCustomersNumberOfCustomers contextRef="From2017-01-01to2017-09-30" unitRef="Pure" decimals="INF">3</nanx:MajorCustomersNumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember" unitRef="Pure" decimals="INF">0.74</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember" unitRef="Pure" decimals="INF">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember" unitRef="Pure" decimals="INF">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-01-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember" unitRef="Pure" decimals="INF">0.67</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-01-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember" unitRef="Pure" decimals="INF">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-01-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember" unitRef="Pure" decimals="INF">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-07-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember" unitRef="Pure" decimals="INF">0.74</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-07-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember" unitRef="Pure" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-07-01to2018-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember" unitRef="Pure" decimals="INF">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-07-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersOneMember" unitRef="Pure" decimals="INF">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-07-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersTwoMember" unitRef="Pure" decimals="INF">0.00</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-07-01to2017-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomersThreeMember" unitRef="Pure" decimals="INF">0.08</us-gaap:ConcentrationRiskPercentage1>
    <nanx:EarningsTriggerUnderSupplyAgreeement contextRef="From2018-01-01to2018-09-30_us-gaap_SupplyCommitmentMember_us-gaap_MaximumMember" unitRef="USD" decimals="-3">0</nanx:EarningsTriggerUnderSupplyAgreeement>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="AsOf2018-09-30_us-gaap_SupplyCommitmentMember_us-gaap_MaximumMember" unitRef="USD" decimals="-3">1000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <nanx:PrincipalAmountDebtAcceleratedMaturity contextRef="AsOf2018-09-30_us-gaap_SupplyCommitmentMember_us-gaap_MinimumMember" unitRef="USD" decimals="-3">10000000</nanx:PrincipalAmountDebtAcceleratedMaturity>
    <nanx:EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades contextRef="AsOf2018-09-30_us-gaap_SupplyCommitmentMember" unitRef="Pure" decimals="INF">0.30</nanx:EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades>
    <nanx:EquipmentSaleNetBookValueEquipment contextRef="AsOf2018-09-30_us-gaap_SupplyCommitmentMember" unitRef="Pure" decimals="INF">1.15</nanx:EquipmentSaleNetBookValueEquipment>
    <us-gaap:Revenues contextRef="From2018-07-01to2018-09-30_us-gaap_NonUsMember" unitRef="USD" decimals="-3">152000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-09-30_us-gaap_NonUsMember" unitRef="USD" decimals="-3">335000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-07-01to2017-09-30_us-gaap_NonUsMember" unitRef="USD" decimals="-3">276000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-01-01to2017-09-30_us-gaap_NonUsMember" unitRef="USD" decimals="-3">956000</us-gaap:Revenues>
    <us-gaap:NumberOfOperatingSegments contextRef="From2018-01-01to2018-09-30" unitRef="Pure" decimals="INF">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2014-07-31_us-gaap_LetterOfCreditMember" unitRef="USD" decimals="-3">30000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="From2015-03-01to2015-03-31_custom_LineOfCredit1Member" unitRef="Pure" decimals="INF">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember" unitRef="Pure" decimals="INF">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="From2018-01-01to2018-09-30_us-gaap_LetterOfCreditMember" unitRef="Pure" decimals="INF">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="From2018-11-15to2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember_us-gaap_RevolvingCreditFacilityMember" unitRef="Pure" decimals="INF">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="From2015-03-01to2015-03-31_custom_LineOfCredit1Member">Prime rate</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember">Prime rate</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="From2018-01-01to2018-09-30_us-gaap_LetterOfCreditMember">Prime rate</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2018-09-30_us-gaap_LineOfCreditMember" unitRef="USD" decimals="-3">500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2017-12-31_custom_LineOfCredit1Member" unitRef="USD" decimals="-3">300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember_us-gaap_RevolvingCreditFacilityMember" unitRef="USD" decimals="-3">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <nanx:LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable contextRef="From2015-03-01to2015-03-31_custom_LineOfCredit1Member" unitRef="Pure" decimals="INF">0.75</nanx:LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable>
    <nanx:LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable contextRef="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember" unitRef="Pure" decimals="INF">0.75</nanx:LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable>
    <nanx:BorrowingCapacityAsMultipleOfAccountsReceivable contextRef="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember" unitRef="Pure" decimals="INF">2</nanx:BorrowingCapacityAsMultipleOfAccountsReceivable>
    <us-gaap:Cash contextRef="AsOf2018-09-30_us-gaap_LineOfCreditMember_us-gaap_MinimumMember" unitRef="USD" decimals="-3">1000000</us-gaap:Cash>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2015-03-01to2015-03-31_custom_LineOfCredit1Member">2018-03-04</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember">2019-03-04</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2018-11-15to2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember_us-gaap_RevolvingCreditFacilityMember">2020-03-31</us-gaap:LineOfCreditFacilityExpirationDate1>
    <nanx:RepaymentTerms contextRef="From2015-03-01to2015-03-31_custom_LineOfCredit1Member">P5D</nanx:RepaymentTerms>
    <nanx:RepaymentTerms contextRef="From2018-01-01to2018-09-30_us-gaap_LineOfCreditMember">P5D</nanx:RepaymentTerms>
    <nanx:TermLoan contextRef="AsOf2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember" unitRef="USD" decimals="-3">500000</nanx:TermLoan>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember" unitRef="Pure" decimals="INF">0.0825</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-11-15to2018-11-19_us-gaap_SubsequentEventMember_custom_BusinessLoanAgreementMember">2020-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-07-01to2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">1119000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-07-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">750000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-01-01to2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">820000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-01-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">796000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">3428000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2017-12-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">3141000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-12-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:SignificantSupplyCommitmentDescription contextRef="From2018-01-01to2018-09-30_us-gaap_SupplyCommitmentMember">We currently have exclusive supply agreements with BASF Corporation ("BASF"), our largest customer, that have contingencies outlined&#13;which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer&#13;intended to provide capacity sufficient to meet the customer's production needs.</us-gaap:SignificantSupplyCommitmentDescription>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>nanx-20180930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: nanx_093018.xfr; Date: 2018%2D11%2D19T18:30:31Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaGJGbP9w5dz2elBtm91HSkKryIitlOqhSjCDHGGkecB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nanx="http://nanophase.com/20180930" elementFormDefault="qualified" targetNamespace="http://nanophase.com/20180930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" id="DocumentandEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" id="ConsolidatedCondensedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" id="ConsolidatedCondensedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" id="ConsolidatedCondensedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" id="ConsolidatedCondensedStatementsOfCashFlows">
	  <link:definition>00000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/BasisOfPresentation" id="BasisOfPresentation">
	  <link:definition>00000006 - Disclosure - Basis of Presentation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" id="NotesToFinancialStatementsNatureOfOperations">
	  <link:definition>00000007 - Disclosure - Description of Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/Revenues" id="Revenues">
	  <link:definition>00000008 - Disclosure - Revenues</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/EarningsLossPerShare" id="EarningsLossPerShare">
	  <link:definition>00000009 - Disclosure - Earnings (Loss) Per Share</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/FinancialInstruments" id="FinancialInstruments">
	  <link:definition>00000010 - Disclosure - Financial Instruments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/NotesAndLinesOfCredit" id="NotesAndLinesOfCredit">
	  <link:definition>00000011 - Disclosure - Notes and Lines of Credit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" id="NotesToFinancialStatementsInventoryDisclosureTextBlock">
	  <link:definition>00000012 - Disclosure - Inventories</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/Share-basedCompensation" id="Share-basedCompensation">
	  <link:definition>00000013 - Disclosure - Share-Based Compensation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" id="NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock">
	  <link:definition>00000014 - Disclosure - Significant Customers and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" id="NotesToFinancialStatementsSegmentReportingDisclosureTextBlock">
	  <link:definition>00000015 - Disclosure - Business Segmentation and Geographical Distribution</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/NewAccountingPronouncements" id="NewAccountingPronouncements">
	  <link:definition>00000016 - Disclosure - New Accounting Pronouncements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" id="NotesToFinancialStatementsInventoryDisclosureTextBlockTables">
	  <link:definition>00000017 - Disclosure - Inventories (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/Share-basedCompensationTables" id="Share-basedCompensationTables">
	  <link:definition>00000018 - Disclosure - Share-Based Compensation (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" id="EarningsLossPerShareDetailsNarrative">
	  <link:definition>00000019 - Disclosure - Earnings (Loss) Per Share (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" id="NotesAndLinesOfCreditDetailNarratives">
	  <link:definition>00000020 - Disclosure - Notes and Lines of Credit (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/InventoriesDetails" id="InventoriesDetails">
	  <link:definition>00000021 - Disclosure - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/InventoriesDetailsNarrative" id="InventoriesDetailsNarrative">
	  <link:definition>00000022 - Disclosure - Inventories (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/Share-basedCompensationDetails" id="Share-basedCompensationDetails">
	  <link:definition>00000023 - Disclosure - Share-Based Compensation (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/Share-basedCompensationDetailNarratives" id="Share-basedCompensationDetailNarratives">
	  <link:definition>00000024 - Disclosure - Share-Based Compensation (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" id="SignificantCustomersAndContingenciesDetailNarratives">
	  <link:definition>00000025 - Disclosure - Significant Customers and Contingencies (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" id="DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation">
	  <link:definition>00000026 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20180930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20180930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20180930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nanx-20180930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
    <element id="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" name="ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_ProceedsFromCapitalLeaseNonCash" name="ProceedsFromCapitalLeaseNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_RelassificationFromPrepaidExpensesToRawMaterials" name="RelassificationFromPrepaidExpensesToRawMaterials" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_MajorCustomersNumberOfCustomers" name="MajorCustomersNumberOfCustomers" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_EarningsTriggerUnderSupplyAgreeement" name="EarningsTriggerUnderSupplyAgreeement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_PrincipalAmountDebtAcceleratedMaturity" name="PrincipalAmountDebtAcceleratedMaturity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" name="EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_EquipmentSaleNetBookValueEquipment" name="EquipmentSaleNetBookValueEquipment" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" name="LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" name="BorrowingCapacityAsMultipleOfAccountsReceivable" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_RepaymentTerms" name="RepaymentTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_TermLoan" name="TermLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomersOneMember" name="CustomersOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomersTwoMember" name="CustomersTwoMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_CustomersThreeMember" name="CustomersThreeMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_LineOfCredit1Member" name="LineOfCredit1Member" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_BusinessLoanAgreementMember" name="BusinessLoanAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="nanx_DescriptionOfBusinessAbstract" name="DescriptionOfBusinessAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>nanx-20180930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: nanx_093018.xfr; Date: 2018%2D11%2D19T18:30:31Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:href="nanx-20180930.xsd#DocumentandEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BasisOfPresentation" xlink:href="nanx-20180930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Revenues" xlink:href="nanx-20180930.xsd#Revenues" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EarningsLossPerShare" xlink:href="nanx-20180930.xsd#EarningsLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/FinancialInstruments" xlink:href="nanx-20180930.xsd#FinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NotesAndLinesOfCredit" xlink:href="nanx-20180930.xsd#NotesAndLinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensation" xlink:href="nanx-20180930.xsd#Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NewAccountingPronouncements" xlink:href="nanx-20180930.xsd#NewAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationTables" xlink:href="nanx-20180930.xsd#Share-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" xlink:href="nanx-20180930.xsd#EarningsLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" xlink:href="nanx-20180930.xsd#NotesAndLinesOfCreditDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetails" xlink:href="nanx-20180930.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetailsNarrative" xlink:href="nanx-20180930.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationDetails" xlink:href="nanx-20180930.xsd#Share-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationDetailNarratives" xlink:href="nanx-20180930.xsd#Share-basedCompensationDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:href="nanx-20180930.xsd#SignificantCustomersAndContingenciesDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:href="nanx-20180930.xsd#DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapCapitalLeaseObligationsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaapDeferredRentCreditNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRentCreditNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="loc_us-gaapAssetRetirementObligationsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAssetRetirementObligationsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfMachineryAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfMachineryAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:label="loc_nanxProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_nanxProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/BasisOfPresentation" xlink:title="00000006 - Disclosure - Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Revenues" xlink:title="00000008 - Disclosure - Revenues" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EarningsLossPerShare" xlink:title="00000009 - Disclosure - Earnings (Loss) Per Share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/FinancialInstruments" xlink:title="00000010 - Disclosure - Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NotesAndLinesOfCredit" xlink:title="00000011 - Disclosure - Notes and Lines of Credit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:title="00000012 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensation" xlink:title="00000013 - Disclosure - Share-Based Compensation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:title="00000014 - Disclosure - Significant Customers and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:title="00000015 - Disclosure - Business Segmentation and Geographical Distribution" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NewAccountingPronouncements" xlink:title="00000016 - Disclosure - New Accounting Pronouncements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:title="00000017 - Disclosure - Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationTables" xlink:title="00000018 - Disclosure - Share-Based Compensation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" xlink:title="00000019 - Disclosure - Earnings (Loss) Per Share (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" xlink:title="00000020 - Disclosure - Notes and Lines of Credit (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetails" xlink:title="00000021 - Disclosure - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryGross" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryGross" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetailsNarrative" xlink:title="00000022 - Disclosure - Inventories (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationDetails" xlink:title="00000023 - Disclosure - Share-Based Compensation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationDetailNarratives" xlink:title="00000024 - Disclosure - Share-Based Compensation (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:title="00000025 - Disclosure - Significant Customers and Contingencies (Detail Narratives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:title="00000026 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>nanx-20180930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: nanx_093018.xfr; Date: 2018%2D11%2D19T18:30:31Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:href="nanx-20180930.xsd#DocumentandEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BasisOfPresentation" xlink:href="nanx-20180930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Revenues" xlink:href="nanx-20180930.xsd#Revenues" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EarningsLossPerShare" xlink:href="nanx-20180930.xsd#EarningsLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/FinancialInstruments" xlink:href="nanx-20180930.xsd#FinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NotesAndLinesOfCredit" xlink:href="nanx-20180930.xsd#NotesAndLinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensation" xlink:href="nanx-20180930.xsd#Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NewAccountingPronouncements" xlink:href="nanx-20180930.xsd#NewAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationTables" xlink:href="nanx-20180930.xsd#Share-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" xlink:href="nanx-20180930.xsd#EarningsLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" xlink:href="nanx-20180930.xsd#NotesAndLinesOfCreditDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetails" xlink:href="nanx-20180930.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetailsNarrative" xlink:href="nanx-20180930.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationDetails" xlink:href="nanx-20180930.xsd#Share-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationDetailNarratives" xlink:href="nanx-20180930.xsd#Share-basedCompensationDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:href="nanx-20180930.xsd#SignificantCustomersAndContingenciesDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:href="nanx-20180930.xsd#DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="loc_us-gaapProductAndServiceOtherMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductAndServiceOtherMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_130" xlink:to="loc_us-gaapCostOfRevenue_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/BasisOfPresentation" xlink:title="00000006 - Disclosure - Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/Revenues" xlink:title="00000008 - Disclosure - Revenues" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/EarningsLossPerShare" xlink:title="00000009 - Disclosure - Earnings (Loss) Per Share" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/FinancialInstruments" xlink:title="00000010 - Disclosure - Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/NotesAndLinesOfCredit" xlink:title="00000011 - Disclosure - Notes and Lines of Credit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:title="00000012 - Disclosure - Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensation" xlink:title="00000013 - Disclosure - Share-Based Compensation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:title="00000014 - Disclosure - Significant Customers and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:title="00000015 - Disclosure - Business Segmentation and Geographical Distribution" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/NewAccountingPronouncements" xlink:title="00000016 - Disclosure - New Accounting Pronouncements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:title="00000017 - Disclosure - Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationTables" xlink:title="00000018 - Disclosure - Share-Based Compensation (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" xlink:title="00000019 - Disclosure - Earnings (Loss) Per Share (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" xlink:title="00000020 - Disclosure - Notes and Lines of Credit (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLineOfCreditMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_LineOfCredit1Member" xlink:label="loc_nanxLineOfCredit1Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_nanxLineOfCredit1Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaapLetterOfCreditMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLetterOfCreditMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_BusinessLoanAgreementMember" xlink:label="loc_nanxBusinessLoanAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_nanxBusinessLoanAgreementMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:label="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" xlink:label="loc_nanxBorrowingCapacityAsMultipleOfAccountsReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxBorrowingCapacityAsMultipleOfAccountsReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_RepaymentTerms" xlink:label="loc_nanxRepaymentTerms_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxRepaymentTerms_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_TermLoan" xlink:label="loc_nanxTermLoan_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxTermLoan_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetails" xlink:title="00000021 - Disclosure - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetailsNarrative" xlink:title="00000022 - Disclosure - Inventories (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationDetails" xlink:title="00000023 - Disclosure - Share-Based Compensation (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationDetailNarratives" xlink:title="00000024 - Disclosure - Share-Based Compensation (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_120" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:title="00000025 - Disclosure - Significant Customers and Contingencies (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="loc_us-gaapSupplyCommitmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSupplyCommitmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="loc_us-gaapSupplyCommitmentArrangementMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSupplyCommitmentAxis" xlink:to="loc_us-gaapSupplyCommitmentArrangementMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="loc_us-gaapSupplyCommitmentArrangementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSupplyCommitmentAxis" xlink:to="loc_us-gaapSupplyCommitmentArrangementMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentMember" xlink:label="loc_us-gaapSupplyCommitmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplyCommitmentArrangementMember" xlink:to="loc_us-gaapSupplyCommitmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersOneMember" xlink:label="loc_nanxCustomersOneMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersOneMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersTwoMember" xlink:label="loc_nanxCustomersTwoMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersTwoMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersThreeMember" xlink:label="loc_nanxCustomersThreeMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersThreeMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_MajorCustomersNumberOfCustomers" xlink:label="loc_nanxMajorCustomersNumberOfCustomers_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxMajorCustomersNumberOfCustomers_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_260" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_260" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantSupplyCommitmentDescription" xlink:label="loc_us-gaapSignificantSupplyCommitmentDescription_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSignificantSupplyCommitmentDescription_260" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EarningsTriggerUnderSupplyAgreeement" xlink:label="loc_nanxEarningsTriggerUnderSupplyAgreeement_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEarningsTriggerUnderSupplyAgreeement_260" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments_260" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:label="loc_nanxPrincipalAmountDebtAcceleratedMaturity_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxPrincipalAmountDebtAcceleratedMaturity_260" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:label="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_260" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EquipmentSaleNetBookValueEquipment" xlink:label="loc_nanxEquipmentSaleNetBookValueEquipment_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleNetBookValueEquipment_260" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:title="00000026 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaapNonUsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapNonUsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaapNumberOfOperatingSegments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNumberOfOperatingSegments_60" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>nanx-20180930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: nanx_093018.xfr; Date: 2018%2D11%2D19T18:30:31Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US">Product Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductAndServiceOtherMember" xlink:to="us-gaap_ProductAndServiceOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductAndServiceOtherMember_lbl" xml:lang="en-US">Other Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="us-gaap_SupplyCommitmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplyCommitmentAxis" xlink:to="us-gaap_SupplyCommitmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplyCommitmentAxis_lbl" xml:lang="en-US">Supply Commitment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentMember" xlink:label="us-gaap_SupplyCommitmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplyCommitmentMember" xlink:to="us-gaap_SupplyCommitmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplyCommitmentMember_lbl" xml:lang="en-US">BASF [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Greater than [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Less than [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersOneMember" xlink:label="nanx_CustomersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersOneMember" xlink:to="nanx_CustomersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomersOneMember_lbl" xml:lang="en-US">Customers One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersTwoMember" xlink:label="nanx_CustomersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersTwoMember" xlink:to="nanx_CustomersTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomersTwoMember_lbl" xml:lang="en-US">Customers Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersThreeMember" xlink:label="nanx_CustomersThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersThreeMember" xlink:to="nanx_CustomersThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_CustomersThreeMember_lbl" xml:lang="en-US">Customers Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="us-gaap_NonUsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonUsMember" xlink:to="us-gaap_NonUsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonUsMember_lbl" xml:lang="en-US">International Sources [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditMember" xlink:to="us-gaap_LineOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditMember_lbl" xml:lang="en-US">New Line of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_LineOfCredit1Member" xlink:label="nanx_LineOfCredit1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LineOfCredit1Member" xlink:to="nanx_LineOfCredit1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_LineOfCredit1Member_lbl" xml:lang="en-US">Line of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LetterOfCreditMember_lbl" xml:lang="en-US">Letter of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_BusinessLoanAgreementMember" xlink:label="nanx_BusinessLoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_BusinessLoanAgreementMember" xlink:to="nanx_BusinessLoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_BusinessLoanAgreementMember_lbl" xml:lang="en-US">Business Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US">Credit Facility [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US">Asset-Based Revolving Loan Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_DocumentAndEntityInformationAbstract" xlink:label="nanx_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DocumentAndEntityInformationAbstract" xlink:to="nanx_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity's Reporting Status Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade accounts receivable, less allowance for doubtful accounts of $5 on September 30, 2018 and December 31, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Equipment and leasehold improvements, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">Line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="us-gaap_CapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsCurrent" xlink:to="us-gaap_CapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="us-gaap_CapitalLeaseObligationsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="us-gaap_CapitalLeaseObligationsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsNoncurrent_lbl" xml:lang="en-US">Long-term portion of capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xml:lang="en-US">Long-term deferred rent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsNoncurrent" xlink:to="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationsNoncurrent_lbl" xml:lang="en-US">Asset retirement obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.01 par value, 42,000,000 shares authorized;33,911,792 shares issued and outstanding on September 30, 2018 and 33,847,793 on December 31, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expense:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net income/(loss) per basic shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of basic common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net income/(loss) per diluted share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of diluted common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustment to reconcile net income loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities related to operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfMachineryAndEquipment_lbl" xml:lang="en-US">Proceeds from disposal of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Acquisition of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xml:lang="en-US">Principal payments on capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Payments on line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:label="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:to="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock_lbl" xml:lang="en-US">Proceeds from exercise of stock options and sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Decrease in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental non-cash investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Accounts payable incurred for the purchase of equipment and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_ProceedsFromCapitalLeaseNonCash" xlink:label="nanx_ProceedsFromCapitalLeaseNonCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ProceedsFromCapitalLeaseNonCash" xlink:to="nanx_ProceedsFromCapitalLeaseNonCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_ProceedsFromCapitalLeaseNonCash_lbl" xml:lang="en-US">Proceeds from capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_DescriptionOfBusinessAbstract" xlink:label="nanx_DescriptionOfBusinessAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DescriptionOfBusinessAbstract" xlink:to="nanx_DescriptionOfBusinessAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_DescriptionOfBusinessAbstract_lbl" xml:lang="en-US">Description Of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes and Lines of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Share-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Significant Customers and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Business Segmentation and Geographical Distribution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions used to calculate Black-Scholes option Pricing Model for options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Letter of credit and related promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Basis spread variable interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xml:lang="en-US">Variable interest rate basis</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:label="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:to="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_lbl" xml:lang="en-US">Borrowing capacity as percentage of accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" xlink:label="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" xlink:to="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable_lbl" xml:lang="en-US">Borrowing capacity as multiple of accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Minimum amount of cash on hand before advance is given</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Facility, expiration date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LinesOfCreditCurrent_2_lbl" xml:lang="en-US">Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_RepaymentTerms" xlink:label="nanx_RepaymentTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_RepaymentTerms" xlink:to="nanx_RepaymentTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_RepaymentTerms_lbl" xml:lang="en-US">Repayment Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_TermLoan" xlink:label="nanx_TermLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_TermLoan" xlink:to="nanx_TermLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_TermLoan_lbl" xml:lang="en-US">Term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Fixed annual interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Inventory gross, Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Allowance for excess inventory quantities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_RelassificationFromPrepaidExpensesToRawMaterials" xlink:label="nanx_RelassificationFromPrepaidExpensesToRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_RelassificationFromPrepaidExpensesToRawMaterials" xlink:to="nanx_RelassificationFromPrepaidExpensesToRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_RelassificationFromPrepaidExpensesToRawMaterials_lbl" xml:lang="en-US">Relassification from prepaid expenses to raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted-average risk-free interest rates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted-average expected life of the option</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Weighted-average expected stock price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average fair value of the options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted-average period over which unrecognized compensation is expected to be recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Common stock issued pursuant to option exercises (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Stock options expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Stock options forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Stock options outstanding, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_MajorCustomersNumberOfCustomers" xlink:label="nanx_MajorCustomersNumberOfCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_MajorCustomersNumberOfCustomers" xlink:to="nanx_MajorCustomersNumberOfCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_MajorCustomersNumberOfCustomers_lbl" xml:lang="en-US">Number of major customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Revenue from customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantSupplyCommitmentDescription" xlink:label="us-gaap_SignificantSupplyCommitmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantSupplyCommitmentDescription" xlink:to="us-gaap_SignificantSupplyCommitmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantSupplyCommitmentDescription_lbl" xml:lang="en-US">Supply Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EarningsTriggerUnderSupplyAgreeement" xlink:label="nanx_EarningsTriggerUnderSupplyAgreeement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EarningsTriggerUnderSupplyAgreeement" xlink:to="nanx_EarningsTriggerUnderSupplyAgreeement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_EarningsTriggerUnderSupplyAgreeement_lbl" xml:lang="en-US">Earnings trigger under supply agreeement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash, cash equivalents and investments trigger under supply agreeement</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:label="nanx_PrincipalAmountDebtAcceleratedMaturity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:to="nanx_PrincipalAmountDebtAcceleratedMaturity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_PrincipalAmountDebtAcceleratedMaturity_lbl" xml:lang="en-US">Accelerated debt maturity - principal amount debt</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:label="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:to="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_lbl" xml:lang="en-US">Equipment sale - original book value of equipment and upgrades</link:label>
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EquipmentSaleNetBookValueEquipment" xlink:label="nanx_EquipmentSaleNetBookValueEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleNetBookValueEquipment" xlink:to="nanx_EquipmentSaleNetBookValueEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="nanx_EquipmentSaleNetBookValueEquipment_lbl" xml:lang="en-US">Equipment sale - net book value equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue from international sources</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of business segments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_DocumentAndEntityInformationAbstract" xlink:to="nanx_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:to="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock_doc" xml:lang="en-US">Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement and from the additional capital contribution to the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_ProceedsFromCapitalLeaseNonCash" xlink:to="nanx_ProceedsFromCapitalLeaseNonCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_ProceedsFromCapitalLeaseNonCash_doc" xml:lang="en-US">The value of the noncash consideration received from capital lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_RelassificationFromPrepaidExpensesToRawMaterials" xlink:to="nanx_RelassificationFromPrepaidExpensesToRawMaterials_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_RelassificationFromPrepaidExpensesToRawMaterials_doc" xml:lang="en-US">The amount reclassified from prepaid expenses to raw materials during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersOneMember" xlink:to="nanx_CustomersOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomersOneMember_doc" xml:lang="en-US">Customer one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersTwoMember" xlink:to="nanx_CustomersTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomersTwoMember_doc" xml:lang="en-US">Customers two.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_CustomersThreeMember" xlink:to="nanx_CustomersThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_CustomersThreeMember_doc" xml:lang="en-US">Customers three.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_MajorCustomersNumberOfCustomers" xlink:to="nanx_MajorCustomersNumberOfCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_MajorCustomersNumberOfCustomers_doc" xml:lang="en-US">Represents number of significant customers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EarningsTriggerUnderSupplyAgreeement" xlink:to="nanx_EarningsTriggerUnderSupplyAgreeement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_EarningsTriggerUnderSupplyAgreeement_doc" xml:lang="en-US">Earnings for twelve month period ending with the most recently published quarterly financal statements as defined in supply agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:to="nanx_PrincipalAmountDebtAcceleratedMaturity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_PrincipalAmountDebtAcceleratedMaturity_doc" xml:lang="en-US">The total prinicipal amount of accelerated debt maturity, as defined in supply agreement financial convenants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:to="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades_doc" xml:lang="en-US">Percentage of equipment's original value, including upgrades; to be sold to customer after a triggering event as stated in the supply agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_EquipmentSaleNetBookValueEquipment" xlink:to="nanx_EquipmentSaleNetBookValueEquipment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_EquipmentSaleNetBookValueEquipment_doc" xml:lang="en-US">Percentage of equipment's net book value to be sold to customer after a triggering event as stated in the supply agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LineOfCredit1Member" xlink:to="nanx_LineOfCredit1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_LineOfCredit1Member_doc" xml:lang="en-US">A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_BusinessLoanAgreementMember" xlink:to="nanx_BusinessLoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_BusinessLoanAgreementMember_doc" xml:lang="en-US">Represent the information of business loan agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:to="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable_doc" xml:lang="en-US">Line of credit facility maximum borrowing capacity as percentage of accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" xlink:to="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_BorrowingCapacityAsMultipleOfAccountsReceivable_doc" xml:lang="en-US">The multiple of accounts receivable available to be borrowed as defined in line of credit agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_RepaymentTerms" xlink:to="nanx_RepaymentTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_RepaymentTerms_doc" xml:lang="en-US">Number of business days the payment under the line of credit must be repaid of the advance, in CCYY-MM-DD format.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="nanx_TermLoan" xlink:to="nanx_TermLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="nanx_TermLoan_doc" xml:lang="en-US">Represent amount of term loan disbursed in a single advance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_2_lbl" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xml:lang="en-US">Repayments of Lines of Credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_2_lbl" xml:lang="en-US">Inventory, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>nanx-20180930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: nanx_093018.xfr; Date: 2018%2D11%2D19T18:30:31Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:href="nanx-20180930.xsd#DocumentandEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:href="nanx-20180930.xsd#ConsolidatedCondensedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/BasisOfPresentation" xlink:href="nanx-20180930.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsNatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Revenues" xlink:href="nanx-20180930.xsd#Revenues" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EarningsLossPerShare" xlink:href="nanx-20180930.xsd#EarningsLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/FinancialInstruments" xlink:href="nanx-20180930.xsd#FinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NotesAndLinesOfCredit" xlink:href="nanx-20180930.xsd#NotesAndLinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensation" xlink:href="nanx-20180930.xsd#Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NewAccountingPronouncements" xlink:href="nanx-20180930.xsd#NewAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:href="nanx-20180930.xsd#NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationTables" xlink:href="nanx-20180930.xsd#Share-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" xlink:href="nanx-20180930.xsd#EarningsLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" xlink:href="nanx-20180930.xsd#NotesAndLinesOfCreditDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetails" xlink:href="nanx-20180930.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/InventoriesDetailsNarrative" xlink:href="nanx-20180930.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationDetails" xlink:href="nanx-20180930.xsd#Share-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/Share-basedCompensationDetailNarratives" xlink:href="nanx-20180930.xsd#Share-basedCompensationDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:href="nanx-20180930.xsd#SignificantCustomersAndContingenciesDetailNarratives" xlink:type="simple" />
    <link:roleRef roleURI="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:href="nanx-20180930.xsd#DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DocumentandEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_DocumentAndEntityInformationAbstract" xlink:label="loc_nanxDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaapCapitalLeaseObligationsNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaapDeferredRentCreditNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredRentCreditNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent" xlink:label="loc_us-gaapAssetRetirementObligationsNoncurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="loc_us-gaapProductAndServiceOtherMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductAndServiceOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfMachineryAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfMachineryAndEquipment" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfMachineryAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:label="loc_nanxProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_nanxProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_ProceedsFromCapitalLeaseNonCash" xlink:label="loc_nanxProceedsFromCapitalLeaseNonCash" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_nanxProceedsFromCapitalLeaseNonCash" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/BasisOfPresentation" xlink:title="00000006 - Disclosure - Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaapBasisOfAccounting" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccounting" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" xlink:title="00000007 - Disclosure - Description of Business">
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_DescriptionOfBusinessAbstract" xlink:label="loc_nanxDescriptionOfBusinessAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nanxDescriptionOfBusinessAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Revenues" xlink:title="00000008 - Disclosure - Revenues">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EarningsLossPerShare" xlink:title="00000009 - Disclosure - Earnings (Loss) Per Share">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/FinancialInstruments" xlink:title="00000010 - Disclosure - Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NotesAndLinesOfCredit" xlink:title="00000011 - Disclosure - Notes and Lines of Credit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" xlink:title="00000012 - Disclosure - Inventories">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensation" xlink:title="00000013 - Disclosure - Share-Based Compensation">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock" xlink:title="00000014 - Disclosure - Significant Customers and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" xlink:title="00000015 - Disclosure - Business Segmentation and Geographical Distribution">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NewAccountingPronouncements" xlink:title="00000016 - Disclosure - New Accounting Pronouncements">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" xlink:title="00000017 - Disclosure - Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationTables" xlink:title="00000018 - Disclosure - Share-Based Compensation (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/EarningsLossPerShareDetailsNarrative" xlink:title="00000019 - Disclosure - Earnings (Loss) Per Share (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives" xlink:title="00000020 - Disclosure - Notes and Lines of Credit (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaapLineOfCreditMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLineOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_LineOfCredit1Member" xlink:label="loc_nanxLineOfCredit1Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_nanxLineOfCredit1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaapLetterOfCreditMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapLetterOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_BusinessLoanAgreementMember" xlink:label="loc_nanxBusinessLoanAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_nanxBusinessLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:label="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxLineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_BorrowingCapacityAsMultipleOfAccountsReceivable" xlink:label="loc_nanxBorrowingCapacityAsMultipleOfAccountsReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxBorrowingCapacityAsMultipleOfAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_RepaymentTerms" xlink:label="loc_nanxRepaymentTerms" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxRepaymentTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_TermLoan" xlink:label="loc_nanxTermLoan" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxTermLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetails" xlink:title="00000021 - Disclosure - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/InventoriesDetailsNarrative" xlink:title="00000022 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_RelassificationFromPrepaidExpensesToRawMaterials" xlink:label="loc_nanxRelassificationFromPrepaidExpensesToRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_nanxRelassificationFromPrepaidExpensesToRawMaterials" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationDetails" xlink:title="00000023 - Disclosure - Share-Based Compensation (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/Share-basedCompensationDetailNarratives" xlink:title="00000024 - Disclosure - Share-Based Compensation (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives" xlink:title="00000025 - Disclosure - Significant Customers and Contingencies (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentAxis" xlink:label="loc_us-gaapSupplyCommitmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSupplyCommitmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentArrangementMember" xlink:label="loc_us-gaapSupplyCommitmentArrangementMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplyCommitmentAxis" xlink:to="loc_us-gaapSupplyCommitmentArrangementMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplyCommitmentMember" xlink:label="loc_us-gaapSupplyCommitmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplyCommitmentArrangementMember" xlink:to="loc_us-gaapSupplyCommitmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersOneMember" xlink:label="loc_nanxCustomersOneMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersTwoMember" xlink:label="loc_nanxCustomersTwoMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_CustomersThreeMember" xlink:label="loc_nanxCustomersThreeMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_nanxCustomersThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_MajorCustomersNumberOfCustomers" xlink:label="loc_nanxMajorCustomersNumberOfCustomers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxMajorCustomersNumberOfCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantSupplyCommitmentDescription" xlink:label="loc_us-gaapSignificantSupplyCommitmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSignificantSupplyCommitmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EarningsTriggerUnderSupplyAgreeement" xlink:label="loc_nanxEarningsTriggerUnderSupplyAgreeement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEarningsTriggerUnderSupplyAgreeement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_PrincipalAmountDebtAcceleratedMaturity" xlink:label="loc_nanxPrincipalAmountDebtAcceleratedMaturity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxPrincipalAmountDebtAcceleratedMaturity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:label="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleOriginalBookValueOfEquipmentAndUpgrades" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nanx-20180930.xsd#nanx_EquipmentSaleNetBookValueEquipment" xlink:label="loc_nanxEquipmentSaleNetBookValueEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_nanxEquipmentSaleNetBookValueEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation" xlink:title="00000026 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaapNonUsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapNonUsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaapNumberOfOperatingSegments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNumberOfOperatingSegments" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex10-1_report.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-1_report.jpg
M_]C_X1, 17AI9@  34T *@    @ # $   ,    ! ](   $!  ,    ! 04
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   >    M $R  (    4    TH=I  0    !    Z    2  "  (  @ #J8
M   G$  .I@   "<0061O8F4@4&AO=&]S:&]P($-3-2XQ(%=I;F1O=W, ,C Q
M.#HQ,3HQ.2 Q,SHU-SHQ-P     $D   !P    0P,C(QH $  P    '__P
MH ( !     $   .SH , !     $   !=          8! P #     0 &   !
M&@ %     0   6X!&P %     0   78!*  #     0 "   " 0 $     0
M 7X" @ $     0  $7H         2     $   !(     ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1"  0 * # 2(
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M1QP"   "GW@ .$))300E       0>:J\+XL]M0'4J(&*NSLQX3A"24T$.@
M    TP   !     !       +<')I;G1/=71P=70    $     %!S=%-B;V]L
M 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N
M0FET8F]O;      +<')I;G1E<DYA;65415A4    +P!< %P <P!E '( =@!E
M '( ,  P #$ 7 !+ 'D ;P!C &4 <@!A "  10!# $\ 4P!9 %, ( !- #8
M-0 S #4 8P!I &0 ;@ @ $, ;P!L &\ <@ @ $X 90!W    .$))300[
M  &R    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    2     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!8
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D        X0DE- ^T      !
M8     $  0!@     0 !.$))300F       .             #^    X0DE-
M! T       0    >.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ !
M &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M   ! #4    ! "T    &       !.$))30/X      !P  #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      -/    !@              70   [,    -
M &4 >  Q #  +0 Q %\ <@!E '  ;P!R '0    !
M      $              [,   !=                      $
M                $     $       !N=6QL     @    9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   !=     %)G:'1L;VYG   #LP    9S;&EC
M97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L
M;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%
M4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%
M4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG    70    !29VAT;&]N9P   [,    #=7)L5$585     $       !N
M=6QL5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     $X0DE-! P     $98    !    H
M !    '@   >    $7H &  !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@               0  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
MQ@#+ -  U0#; .  Y0#K /  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%%
M 4P!4@%9 6 !9P%N 74!? &# 8L!D@&: :$!J0&Q ;D!P0') =$!V0'A >D!
M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+!
M LL"U0+@ NL"]0,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#
MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C :=!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-
M^ X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D >:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_ D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9 YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE
M3FY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"
M](-7@[J$'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT
M O_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( !  H ,!(@ "$0$#$0'_W0 $  K_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MZ7Z?\Y_P:G3@Y3 UMUC;B'AQL=HZ X/VAM3:Z_;M_=24_P#_V3A"24T$(0
M    60    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <
M !4 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -0 N #$
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M :(    & @,!              <(!@4$"0,* @$ "P$   8# 0$!
M    !@4$ P<"" $)  H+$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R(
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MRV,X=IQ4FVOE1WYNOLZ?=WQJQN&[J[.?H&#?G473/Q\[23L;$[)ZLH]A_&G
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M[KW7O^'+?CK_ ,^Y^?W_ *:@_FE?_<<^_=>Z]_PY;\=?^?<_/[_TU!_-*_\
MN.??NO=>_P"'+?CK_P ^Y^?W_IJ#^:5_]QS[]U[KW_#EOQU_Y]S\_O\ TU!_
M-*_^XY]^Z]U[_ARWXZ_\^Y^?W_IJ#^:5_P#<<^_=>Z]_PY;\=?\ GW/S^_\
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MQ:X-O=>ZY_\ #EOQU_Y]S\_O_34'\TK_ .XY]^Z]UQ_X<M^.XO?K;Y_6%_\
MNE!_-+N>7 ^OPW5?586YN2?\/?NO==G^9;\=P1_QC?Y^Z3I /_#47\TJ_(9C
M<?[)Q:_   +'4;$#W[KW7?\ PY;\=?\ GW/S^_\ 34'\TK_[CGW[KW7C_,L^
M.X^O7'S\ U,O_;J+^:2QNK.G&CX<.#=EXY^AO_K^Z]U[_ARWXZ_\^Y^?W_IJ
M#^:5_P#<<^_=>Z]_PY;\=?\ GW/S^_\ 34'\TK_[CGW[KW7O^'+?CK_S[GY_
M?^FH/YI7_P!QS[]U[KW_  Y;\=?^?<_/[_TU!_-*_P#N.??NO=>_X<M^.O\
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M[KW7O^'+?CK_ ,^Y^?W_ *:@_FE?_<<^_=>Z]_PY;\=?^?<_/[_TU!_-*_\
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M+.Y'XW9.D?.T5=-UW%'NQ9142H)$IH]'NO= CV)_/3SF$I?C_C.M/BKMC?\
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M_*T_^^5>_=>Z]_LY/R)_[U/?/_\ ]&+_ "M/_OE7OW7NO?[.3\B?^]3WS_\
M_1B_RM/_ +Y5[]U[KW^SD_(G_O4]\_\ _P!&+_*T_P#OE7OW7NO?[.3\B?\
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MO'YF?(<&W_#4'S\O^ W8_P#*U6Y*N]N?YE%[A%N1^H WM[]U[KP^9?R(//\
MPT_\_K @$_Z1?Y6QM<V%P/YE!8'Z7%M0O]/?NO=<_P#9R?D3_P!ZGOG_ /\
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M48B]@54D'\>_=>ZY_P"SD_(G_O4]\_\ _P!&+_*T_P#OE7OW7NO?[.3\B?\
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MB>?^Q4'S\N#:P[&_E<<"P*DL?YDH0BQYTEK'@7Y]^Z]UW_LY/R)_[U/?/_\
M]&+_ "M/_OE7OW7N@][8_F.=G]'=6]E=U=I?RN_G[M?K+J#8&\^T.Q=RG>?\
ML_-?W=V/U_M_(;JW7F_X/M[^8MEL]F#B]OXJHJ/M:"EJJVH*>.GAFE8)[]U[
MH0#\R_D/^/Y4/S]M<C5_I&_E:@'ASZ?^QE/)]//TL.3:Q]^Z]U[_ &<OY$_0
M_P I[Y_ \7OV+_*V"\DKPQ_F46/K %OJ;W /OW7NN/\ LYGR(-M/\J#Y]M?D
M =C_ ,K:Y6X!;G^9,% (_2+ZB0186)]^Z]UR_P!G*^17'_8J#Y]$V!X[(_E;
MZ;7;59C_ #)0#Z5NOTU CZ<V]U[KK_9R_D1P/^&G_G]SI_YJ+_*WL68L-(/_
M  Y/9CZ;\7%N20.??NO=<A\ROD3S_P!BH/GY<&UAV-_*XX%@5)8_S)0A%CSI
M+6/ OS[]U[KO_9R?D3_WJ>^?_P#Z,7^5I_\ ?*O?NO=![VQ_,<[/Z.ZM[*[J
M[2_E=_/W:_674&P-Y]H=B[E.\_Y9^:_N[L?K_;^0W5NO-_P?;W\Q;+9[,'%[
M?Q514?:T%+55M04\=/#-*P3W[KW0A?[.3\B?^]3WS_\ _1B_RM/_ +Y5[]U[
MKW^SD_(G_O4]\_\ _P!&+_*T_P#OE7OW7NO?[.3\B?\ O4]\_P#_ -&+_*T_
M^^5>_=>ZXI\R_D0XN/Y4/S[L02K#L?\ E;,K H'BLX_F3:6\H-O3< _4VY]^
MZ]UR_P!G)^1/_>I[Y_\ _HQ?Y6G_ -\J]^Z]U[_9R?D3_P!ZGOG_ /\ HQ?Y
M6G_WRKW[KW70^97R()(/\J#Y^BVGG_2)_*X^CE;>D_S)@_I5[MQ8$$7-O?NO
M==?[.5\B;J#_ "G_ )_ -P">Q?Y6WU^MB%_F3L4&F_+:>;#ZD#W[KW71^9GR
M( );^5!\_%T_6_8W\K< <%A=F_F3!1Z+$DG2#=;EA8^Z]UY?F9\B#:_\I_Y_
M6;E2O8O\K:164@E2I3^90U]2VY' O]??NO=<_P#9R?D3_P!ZGOG_ /\ HQ?Y
M6G_WRKW[KW7O]G)^1/\ WJ>^?_\ Z,7^5I_]\J]^Z]T7W:?<W8O;7\TSXPG?
MWQ/[]^+YV[\ OYAXQ8[TW+\6MP?WW&6^1/\ *T.0.US\:/DG\B!2';"XR+[T
M9K^#^3^(4WVGW-JG[;W7NK@??NO=?__6W^/?NO=5]?RH(M?\K3^6LQ8@'X!_
M#9M-KK8?'7KIM)U7++ZR+&XMR+-ZO?NO=6"6']!_MA[]U[KUA_0?[8>_=>Z]
M8?T'^V'OW7NO6']!_MA[]U[KUA_0?[8>_=>Z]8?T'^V'OW7NM>C^9I_,W[+^
M,GR_ZAV1U5N#?E'U'\<,+U_W+\Y\5M3XW;R[BVON#J?N/LS$]>T6(WGVCM7K
M3>V.^.D'5_6F&W9OP93*97;,.57&TU+'45://"ONO=##V+_-B[.PVZ.S(^L/
MC7T[O7KS:_S+Z^^ ^PMT[Y^5.].MMU[R^0N_Z?K^MHLANK9F%^)'9V"Z_P"F
MA1;OJWI<]#N+.9:O:CIECPJ_?J8/=>Z3'R7_ )P';_QHS?;U!FOB1U5N['?%
MW:?Q/R?R;JL!\N<Y19>EW=\K]Y9;:.W]J?&C!9WXK8X=_P!%M9\:):G(9BJV
M#)53>:FBI!/3N#[KW4.H_G4[@S6P-CY_K7XN;9W;OCL7J'^6[V)MG:><^1=1
MMC;<>YOYB7:&X>K\1LW/;SQ71&\LIC,=U57X2.IJLK%@JJ7*QS,BT-(T7[GN
MO=2>@/YHWR9^0?RQ^*_3.+^/W0>SMA]D8WYTXCOJ"K[N[%W=O#9>^?AIWK@>
MFLW-U+N).CMF8?>&W*A<K35M)!F,%A:C*Q9-HY*G$OC@,O[KW1!_E#_-+^<W
MQV^2GS.VWF-ZT,?Q\W+\O^D_B?\ $W>>+Z_V!)D.DNX,'%\9-^[[ZRW()]IY
M&7>&-^0?4?;&XY,7E<RM9)B:_;LM/3RPF>!Q[KW1IMQ?SWMYTO9VY>JMB?%#
M8'9^3RN[]C;7Z&WIA^\_D=L?JCM6'>ORPVQ\43F,CV+V_P#R^.NL0^*PFY=V
M05T^2Z[7M+;\HIJFGBR;:(9Y_=>ZRUO\]+M'K[:6^-[=X?"3:VU\#A>O/F5G
M=DMU5\G=T=P9/=O8'PM[GV5T7OC:V:PU7\4>N<EM79.[=X;VAJ<3GJ6/-9$8
MJ%YZC"0R7@7W7NK4_@S\I>ROE=UGN[>?:7QRW7\<=P[7[%R6RJ' ;CQ?>^*Q
M6]L%3;;VMN"@W]LW_9D_C9\3.VZG;=94[BGQCO7[(Q\8R.+JEII:N ).WNO=
M':L/Z#_;#W[KW7K#^@_VP]^Z]UZP_H/]L/?NO=>L/Z#_ &P]^Z]UZP_H/]L/
M?NO=>L/Z#_;#W[KW5?O\RJ,_[+SUTS,6'^S_ /\ *A]-VMZOYI'PV"BVLI96
MYMI^GTLQ+'W7NJTOG;\I/E?UM\A/YA>X>MOE[E.E=@_!?X6_&SY.;%ZCRO77
MQZW+U%VSO3=>Z^\)-R=?=KYC>G7$_=;XKM"+KG'[<HVVSO?;U5CZW()+2F:4
MBF;W7NDWW]_/_P!Y_'O96\.WMS?"S#9#J':/?]'\2:MZOY+U>T^\I/D#4] X
MON*K7*=*9KX\OAL+TSMS.90XO+;D&[*G*T>(IILS'@YXU6C;W7NCG=[?S.>Q
M_BWC\SC^]_CSU/2;_P !\+_DS\P<CA>KOD_G][[+:#H#=?5N$Q/75%O?>'QH
MZKRT^0WMA>T::OJJ^3 P_P (DA\$-+DTD%0GNO=!+NK^;3\EW[MR_575/PBZ
M?WE@3\F3\4=H[NWS\S]T];9;.=DT?Q8Q7RNS.7SNTL5\-NQZ3;.Q\;M&NEQJ
MU4.7R>0FR$<3?8I!,98O=>Z#+:?\^3>/9&X.J:#K#X%]E;VPVY.E_C!VUVS5
MX7(=_P"Y:[K)?DE09?+2)BL[UM\.NQ.C\AL?K##XEZS*[AWGOGKL5=-#5?94
M<TM'-$/=>Z#K<'\[[Y9Y?I&AW9L[X?\ QUV)VON+;'\N+N39NW-V?)WLOL_9
M.5Z5^>W<U=UCCJ?<^:P/QCZKK=K=EX"HH84GBH(\]CZ.'(_Q%7R'V Q=?[KW
M1QOYL/R+^<O1.,^$5/\ #Q=NMVWO[N_<M?V/U+)18+=./[GV7T_\?^RN\-\=
M#[;W;NS;%-78.IWY2;$EQV*W#3T>.R$-2*>240HTR)[KW1-OCM_/:J-P].=V
M]OY3;G^F/9]-L3^89\K>I<YE]T;>ZIJH>I?B_P!F]7;9V/T?7XG&=<Y&5<M+
MA^RM%1FZEJVOI):!UG@KB^N+W7NE)-_/1^2TVR<IV;AOY?\ T_D-BP]8?-;N
M[#/6?.?=6,W97=6_!/LZ'K'M>JRN 'PAK<1A][;HKJJ.JVWB8LM74U5"DRUM
M?CV2+S^Z]T\[/_F\]T]>]]?(6#M/KO;'9_QI/S('2?7.<V]VKAZ#Y ]6T<WP
M1VS\JJ3:-'\?L#TRF+[&VL7PV5EFSE5OYLW'499E2BDHJ*)%]U[I6]:_SI^\
MNP_CQ6=W-_+YS^WJ_<>^/AGLGI7'[FW]\@^M>MNS:SYC[]7K_%(_:W??P;Z5
MJ9*KJROK:"JSM3M#;^^=NST>0A?'Y>J+*K>Z]T>WIN7,U/\ ,O\ EC/N7'XW
M%[AJ_P"7=_+&J<]C<+F*K<>$QN7J._\ ^:N<MCL1N"OPFVZS/8JCKI)8Z6KG
MQM!+5Q()&IH PA3W7N@W_G ;U[]Z@^+M/W1\>_DMVA\?MU[4[5Z0V55T6Q-H
M?'+>&!WGC.Z>^^K>K<HVZ:3O3H_MZMAR.V\'NBIGQ+XFHQ2"LF#5J5T2B'W[
MKW03Y#^8]V]U%@_DYMVMZVVMV3B_B?WKUI\1MJ=K=T=R;_7N'Y9=Y[OVEUGO
M*1*;I+X5?R[NWLEC\MDMK]B^2*':>T\@U;744L:8JAH1+7T_NO=%_P"N/Y\V
M_P#LF';6[,=\,-J8?JV@K/BEA>YMQ[@^2N]</OK96X_E+\H.Q/BUC<?U_P!7
M9'XCTN2WW#M+=/7-3DIEW%7;$R=10SI')0TE4DL"^Z]TI^P/YW?8W7D?<&W-
MQ_%#8.V>\^L.R-V[>QGQHW9V7\WY^\=V]9;7QW:F8A[=H]K]5?RLNW*6OVKN
M'"=:?Q"ES>WJG<W7U-05C2UVZZ1XHXJGW7NLG?'\X7ON3I#Y%=H_$[XW]'Y6
M'X]?!_I?Y>;XS'R-[^W[LROP=3\@>LMT=G[+V_LWK#K;H+>=+W/B\)CML/'6
M2R[VV6,GD2])'/3B*2H7W7NHE;_-/^1VT_EUL3XQCI3:.^>^^[^D^A-]8[K_
M ')\G\;L#XC];UF=ZL^0?978U9M_M7$_!W.=Y2Y48[J:FC^TS$6X(<C)6:Z2
MFP\..K)J[W7NN]N?SS-\[M3K3>&'^'>UJ+I_-[(^!&ZNU=U[C^3F3H=];)KO
MG=W+N3I+;V.Z[Z_P7QMW-@^V</L3<6UYZV7*5.Y-L0Y/&2121QP2.(1[KW0]
M?.;LGY%57S8Z?^/G5?S$W;\0.N,E\(OEA\A=U;NVKL#XW;PQL6\NGMW=-XC:
M.;W])\@NJ>P5AZUV_B]Z5TN4IL1D-OO51J2]=2A1*/=>Z)_M;^>IV]_HY^)L
MF0^.'6>]-^]Z=9_'Z3L&;![U^3NV*3K+M7Y"4.Y*;KB7>%-0?##L?H+8FP-]
M5.&H\Q04N6[=I]TU6W\BT^/QN2$4#UONO=9-G?SO_D^O1GPSS6?^#>,[L[]^
M1_Q=R_RFW+M'XXY/Y9[KP='U_!NO;6T]OT.QL=UM\,?D5G<5V!NFIS,YJL=N
MS(X':6"DIZ>*;>%0:R.1/=>ZV5:2H%5!!/X)*?SPI,(:A E1%K%]$T:ZU1@/
M]J//OW7NB#_RU4'^R[]C?X_/S^:\GT&JR_S2OF4?UBSDEC?ZW_V-R?=>ZL!L
M/Z#_ &P]^Z]UZP_H/]L/?NO=:Z'SM^4GROZV^0G\PO</6WR]RG2NP?@O\+?C
M9\G-B]1Y7KKX];EZB[9WINO=?>$FY.ONU\QO3KB?NM\5VA%USC]N4;;9WOMZ
MJQ];D$EI3-*13-[KW0_4O\XJAH*S^';S^/U?@\CC?D=N3X][JPU+V(*_=V*.
MT_@C'\V<UN.GV=-L+'U]9FZ:-I-KG!R2T["=/OON])^U'NO=*_X3?S&>W/FI
MTKW5V1N#XM[Q^-L&U>EMI]I]6;SR%%\@*W:.^(.Q-E[RW%!0X;+?(?XE?%B+
M<&X=B3;=I6R,NWJ/=NU*F+*4TE%FZM7(/NO=5R?'?^8W\GNB]B_%#L[OOY,X
MWY38CY1_RT,]\QNP]O\ =VV>MNJWZ [$V&>MTV_5X?=7P_\ C5D=\)TUW1NG
MM([7HL?7; WMN1=PXV%<34UL\\M!+[KW0J=1_P Z[Y%]K?(W9NQ:KXJ=:["Z
MJVOLOYHYWY!8_-[W^1--W#CJOXHXOIW=-57=3[3[:^*WQ_WPSUFVNUJ1*7 [
MOV3MO(Y>JGF J\;%012YCW7NK!?Y:W\P3LWYY[?W5N???Q-WA\==OTFR^HM_
M]?[GR=/\AI]H]B87M?%[BRCXG#YWO_XF?%*7-[BV33XBD?)5&UJ;=FU9H<K3
M2T6<JD:Y]U[JT2P_H/\ ;#W[KW7K#^@_VP]^Z]U7]_,J0?[+OUS_ (?/S^5"
MGT&JS?S2OAJ?UF[@AA?ZW_V-B/=>ZL!L/Z#_ &P]^Z]U19G>Q/E-NNK_ )W?
M3V_/DC(B]%=<;"WE\<=V]<;1H>D:GHF'>716\>S<324>:PV5S^[\Q4X/,;>Q
MT^1R>:S%6M=,*N6*FH<=4+C8?=>Z47>/RU[RWCUK_*:V[L?L^3XQUW\PK<>Q
MZ+M'O#'[:V!N+=G7HF^/F2[H.Q.L\=VYA-X=5478/:NYL6NW<;59C#YY(UJ)
M/ML=5U;0^+W7NH_;_P#,ZG^($?</5FYL>_R>W)\<<7\+<;6=LYKL'8>PMR=R
MUORS[T[$Z7$V>VWUYU-!L3;NZ.LVV/\ <9'^#X^GH,K7^>**APRZ8F]U[J-U
MI_-C[OWOC?C#F\[\--D;:P_?_P 1.S_G=N>3%?*7+;OR/6'QOZZCZWJ*:.FQ
M]+\9L4O87=6YJ;L:'Q[;HYJ3%TLT'CDS9\JLONO=!QUQ_.C[W[$^/-1W7#_+
M]R.W,IN??7PSV5TI0;W[$^2'5/5G9DOS%WVNQ\:[]O=Y? GJ:LEJ>KWK**MS
M%1M#;F^=NU=+7PM09BH5U8^Z]TJ>@/YHWR9^0?RQ^*_3.+^/W0>SMA]D8WYT
MXCOJ"K[N[%W=O#9>^?AIWK@>FLW-U+N).CMF8?>&W*A<K35M)!F,%A:C*Q9-
MHY*G$OC@,O[KW1W/YK\6C^5I_,I8,2!\ _F2VFUEL?CKV*VD:;%5] %A86Y-
MV]7OW7NB_P#\T?M+Y';'R70.S/A[\C-X;2^4W9V_=LX;J7XS[;ZSZ?WYM#N'
M"8K?^S\GW-O?OK,;_P"MMY;UV!TAUMU+_$/XAFL#F=IU%!65T,<517Y"JQE
MWNO=")\&-W=R[XZ@^8O5J]G-D-_=&?,'Y0])]6=M=D8W-]L4U#AX\Q0;\Z^?
M<=#6;KVEFM^4O6/^D%,#]G)FZ.H\&#6D:K4QF4^Z]T6[KSYL?*+:/\C'<GS@
MRF6V7W=\F>MNB>[>PJG.=E8JCV)LK>F7ZLWWO[#)E,]MSJ3"82AAI8ML;9$X
MQF,CQHK)X%IWJZ19FK(O=>ZA;L_FW]W=<Y^7 [I^*O566@ZHVU\%JSY-9C!_
M*C<>.S&*W3\X-\Q;*VYC/C9L7.?&:'_3I1;3I*NFR%4V7RVR#4U4LF/I1/+
M\[>Z]T(/\Y'NKY/?&;I?;7R ^/G8O;77V$V!NC9DG9&9P&U_BSN?H#;FULGV
MWUUBMR[F^35%VSM_>'R8SFT1L[*5U-BL?TY0G<0J99'G*+]N\'NO=%Z_EO\
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M-_\ Q2[8^,Z_*3"=2;[W-2_'/=&*CR'5>]MW;7P] FW-N=V_(ZFRO8FP8\#
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M17RV^#?8&XNR^Y\YU/W@O?WRIV2.QNAJ?I_>%5L*AZ@^1O8FTL#M;9&2[/\
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M_21_-+_[PW^ /_IROY$__>G_ '[QK?\ WZ?V?[/7J=>_TD?S2_\ O#?X _\
MIROY$_\ WI_W[QK?_?I_9_L]>IU[_21_-+_[PW^ /_IROY$__>G_ '[QK?\
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MY"YBIP>8WY#1Y;'1;URN(G_DSR8S);KAQV=K*=,C-"]8L-7.GD*S.#[QK?\
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M:W_WZ?V?[/7J=,<?0OR7A[KD^2D'\I;^3Q3_ "+EJY\A)W[!\O=^Q]UO7U6
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M\(@RC*LE>U!]ZL-)Y_M8?>-;_P"_3^S_ &>O4Z5O5W0WSBZ:[=SG<'7/P;^
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MU;U#VW',"344'5ACHG[;*^=MS_SD=\3#_P"66]Q?\3\^S[,5>"G=&W[1_P!
M]*E9*#'^K]G7'^Y'SS_[R4^*/_I%G;7_ -WK[>\;:_\ HWR_\YA_UJZU]7;_
M /1I;_G,/^@.O?W(^>?_ 'DI\4?_ $BSMK_[O7W[QMK_ .C?+_SF'_6KKWU=
MO_T:6_YS#_H#KW]R/GG_ -Y*?%'_ -(L[:_^[U]^\;:_^C?+_P YA_UJZ]]7
M;_\ 1I;_ )S#_H#KW]R/GG_WDI\4?_2+.VO_ +O7W[QMK_Z-\O\ SF'_ %JZ
M]]7;_P#1I;_G,/\ H#KW]R/GG_WDI\4?_2+.VO\ [O7W[QMK_P"C?+_SF'_6
MKKWU=O\ ]&EO^<P_Z Z]_<CYY_\ >2GQ1_\ 2+.VO_N]??O&VO\ Z-\O_.8?
M]:NO?5V__1I;_G,/^@.O?W(^>?\ WDI\4?\ TBSMK_[O7W[QMK_Z-\O_ #F'
M_6KKWU=O_P!&EO\ G,/^@.O?W(^>?_>2GQ1_](L[:_\ N]??O&VO_HWR_P#.
M8?\ 6KKWU=O_ -&EO^<P_P"@.O?W(^>?_>2GQ1_](L[:_P#N]??O&VO_ *-\
MO_.8?]:NO?5V_P#T:6_YS#_H#KW]R/GG_P!Y*?%'_P!(L[:_^[U]^\;:_P#H
MWR_\YA_UJZ]]7;_]&EO^<P_Z Z]_<CYY_P#>2GQ1_P#2+.VO_N]??O&VO_HW
MR_\ .8?]:NO?5V__ $:6_P"<P_Z Z]_<CYY_]Y*?%'_TBSMK_P"[U]^\;:_^
MC?+_ ,YA_P!:NO?5V_\ T:6_YS#_ * Z]_<CYY_]Y*?%'_TBSMK_ .[U]^\;
M:_\ HWR_\YA_UJZ]]7;_ /1I;_G,/^@.O?W(^>?_ 'DI\4?_ $BSMK_[O7W[
MQMK_ .C?+_SF'_6KKWU=O_T:6_YS#_H#KW]R/GG_ -Y*?%'_ -(L[:_^[U]^
M\;:_^C?+_P YA_UJZ]]7;_\ 1I;_ )S#_H#KW]R/GG_WDI\4?_2+.VO_ +O7
MW[QMK_Z-\O\ SF'_ %JZ]]7;_P#1I;_G,/\ H#KW]R/GG_WDI\4?_2+.VO\
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M_P"<P_Z Z]_<CYY_]Y*?%'_TBSMK_P"[U]^\;:_^C?+_ ,YA_P!:NO?5V_\
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MW[QMK_Z-\O\ SF'_ %JZ]]7;_P#1I;_G,/\ H#KW]R/GG_WDI\4?_2+.VO\
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M_P"<P_Z Z]_<CYY_]Y*?%'_TBSMK_P"[U]^\;:_^C?+_ ,YA_P!:NO?5V_\
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MW[QMK_Z-\O\ SF'_ %JZ]]7;_P#1I;_G,/\ H#KW]R/GG_WDI\4?_2+.VO\
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M_P"<P_Z Z]_<CYY_]Y*?%'_TBSMK_P"[U]^\;:_^C?+_ ,YA_P!:NO?5V_\
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C?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (G JT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**YOXE
M:O=:!\/?$FI6,OD7MII\\\,A4-M=4)4X/7D5G4FJ<'-[)7+A%U)*"ZG245\&
M_#+]H#XO^&OA/X8\0:_/-K&O^-]2MM,T>3Q%):#38BY<M-MM0LB+A<;7.:WO
M W[;GC36=4-CK.@^'[?R8=9$UU:RS>2TUD6"!"QZ-MY[^E;5(^RYN;[-[_)7
M?W&=/]XHRCL[6^;:7WV?W'VI17P)X/\ VO/%%YOUG2O#^BV^O>(K_3K-VOKZ
MZ>T1ILKNV%\(!C^'&>];=K^VQ\1]>0:;I.@^%EUNQAU=M1N+A[@VDC6++DP;
M6W%74G&>]/E=F^U_P5W]UT%-^T=H?U>]OOLS[@HKX-UK_@H)XS\*VFGP:OX7
MTEM4\1:99:GHO]G17-PD*3N$*SQJ=SL"<@)C/2M*Z_;5^*<FCWDL7@G2=&O-
M(TI]5U!->@NK<W$<;A6,$9;<H8'Y=_3!S2E%P;4M+77W*[^ZVOX"C)2:BMW;
M\6DOOO\ YGW!17S%^SC\7OB'\3OC;X_@U?4=&?P;9VNGW-CI\4#K=6_GP[U
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MWW>?<ARLVK=;?E^.NW;4^IZ***S+"BBB@ HHHH **** "BBB@ HHHH ****
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M<=;D^'%AX;L/B!\.?#NB6\=M?0VNB07+W=P&&[S%,H_<8_BSW/%;SZY\:_\
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MC+ 'R_+3@;>G/-=]6DX\DG%]#.,N>*DNH4445!84444 %%%% !1110 4444
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MR6#YX/:IC?E5^R];W^[R>FBM;5.]>[S>5W^$=//>VO779-6].^+W[0EC\*_
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M('8<L"/,ZCUS6RBG!2\K_/EC)_GRI=6GZ!;?UM\KM?I?T:/O>BOSV^(GP_\
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M1TFQUB\U&QGLK*XE6R\EX=.16@>!7!=2.[ELGZ<YK1VW_#Y_HOO,?>2MN_\
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M>FQ^.M5%KJ[6GRXW!(W623DG'''>OKI_!F@R:;<Z>VC6+6-R09[8VZ&.0@
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M )IB@+'@\A >M;Z_LAZ"_C"'7[GQ+K]V?M,6HW5C)-&+>\U")=L=Y(H0'S%
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M)89DZ,I'!H6JNM@>ED^I<HJO?:C::9")KRYAM(BRH))Y BEB< 9)ZD\ 58H
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M.037IU6XM:M?TB5)/9^?W[!1114C"BBB@ HHHH **** "BBB@ HHHH ****
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M33\T_FE9?@$O>5GV:^]W?XGF'[/OP9@^"/@Z\T:*'3HWN=0FO&;38?*0AR"
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M[E'4J.IR#C%6[/4+74D=[2YAND1BC-#('"L.H.#P?:@"Q1110 4444 %%%%
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MW2M;C_ED6/=:@TO]AOX7:/\ #:]\#6MKJT>A7EO]FF']IR><8]Y?'F=>I/\
M*J>L?M6ZS"^JBP^'=[]EB2ZALM0O+^)%FNX8FD,3Q?>084Y/MBJ'Q$^)GCCQ
M7\'_ (97\-Y+\,];\4ZK9VUW)I\L%ZT$4O4HS@IR,'D9&<=:E0<HI):/E7WN
MR_7^FA.2IIS>EKO[E=_D>@>#_P!EWP'X'\%Q>%M,M+T:1'9FP"37;R.8BX<@
ML>2<@<UE1_L?^!(])UC25N=?_L?4)1<)IQU60V]C,'W^;;)TB?=SN%><:;^U
MAJOPQ\)ZC'XF;3O%O]E^(I]"769M5M]->ZC0KAPCC$LG/*Q^E.UO]N/6O"'A
MJ;5-5^%VHZA<WFL-INA:;HM['<7&H*!N+LH!,9"<X/7M3<KMV=[_ *V:_&5_
MO\Q\CBN1KOIZ)W_".ODD?0_@7X<6W@*&.*VUK7-41(%@ U;4&N<@$G><_P 9
MSRWH!775R/P]\;:CXXTNTU*Y\-7GA^TNK2.X1-0D43K(V=\3Q#E2N.IX.>*Z
MZG-24K2W(C)25X[!1114%A1110 4444 %%%% !1110 4444 %%%% 'CEY^RW
MX4\1>+=:UGQ9=ZIXVM-0.8=%\071N;&RR<L(8CPH)Q],51N?V,?A4N@MI.D:
M%-X7A-ZU\)]!NGM9UD9=K .#D*5^4KTQQ7MEUYOV:7R&19MAV-("5#8X)]LU
M\G7'Q.^)<?P"^(>J_P#"5Z=_PDFA:I<1_;UMU\M8D;[D2^OH6S4II/D71?A>
M*_-IL<FU'G;W?X\LG^2:/7;[]G72=4\+R>'9]?UZUT19E:WL],O3:K#"%QY/
MRYW*>2<]=U8U]^QC\,+[6H;QM,O(K!8HXI-#AO'73;C8A16D@'RLP4GFDUSQ
M)XB\>76C>'M'\43>&DBT)-3UG5[.&-YXV=%,>S>K(,D.3Q7*^ _%WC73/AG&
MO_"877BC5O$>M?9?#^H:M:PI)]E#9,C+$H4YC5R./2M>67,UU_-WY?\ @Z]%
M<S5N2+6WY*W-^7:^]CO_  -^R]X/^';7DNC76NQ7=S)'_IDNJ22310QG*6R,
M?NP G_5CBG6?[,?A6TT+Q/I_]H^()[GQ$GDWNKS:H[7_ )7_ #R2;&Y4Y(P.
MQKP3X@?%#XA^"]>UN'0O'-WKWA74-1L-$&N7EO;!M+NYIBDOV?:H#JB8.7!
M;(J;1/C%\2+>^\)V$GC&UU/3++XA2>%KV_>VC%SJMNJ%E9B!L7W* =!5PIRK
M):[Z?E_G'UOZG0X2C=]KO[DW^C]&M;'U'\*_AEI7P?\ !-AX5T2YU&YTNQ!6
MW.IW;7,J+GA-[<[1T ["NNKY:^'OQ6\1ZI^T;>V-[XQ-YX?N[RYLK.P$$7V*
M3RE)*0L!YGFH1\VXD=<5]2U#<IQC5E]I7_X<R:Y9RI]F%%%%0 4444 %%%%
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M&E*]G8:WU/GG0_VQ?#>@_!_5/'WQ(N+7POIUIKMWHT?V99)O-\J4HA"@%BQ
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M (DQYM>;N_NOI^ 4445)84444 %%%% !1110 4444 %%%% !7F7QD_:&\+?
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M\CXV_:<^%OB+XN_'+PWI^@V%K<3C1!(FNWES-;_V6_FY^T0*@VO)C^%JH?\
M#4'CG2_C)XM\'Z?=WFO67ANRDN[EK[PXUK&J0%!(L=QO/G,5+$' Y'%?8.H^
M+]#TC3M1O[[6+&SL=.)%Y<SW")';$ $B1B<+P1U]:J07WAWXI>$YC8:E:ZYH
M6H1M$;C3KD21R*>" Z'^1K./-"/+'5+F?SEJK^2]->YL[2=Y];+Y))/SUMWT
M/F?7/C-\7_$5G:ZYX:NM/TG29=/75HK6ZTAIY)X)+C9$FX,-K>60QZUQWQ/_
M &C_ (Z^")](T2VG\.0/'J\MK?>*=8TV>.TN(PL;I$D<8<HQWE0W0[:^X=*T
MRVT73+33[.(0VEK$L$,8Z*B@ #\A5JK]V,O=6E^OK_7_  2%>4??WMT_'^ON
MZ'R=JWQ#^,>I1ZA<V^KV-K87S7VFVEK::0[2V\D<#NEPLI/S E0 "!U%<M\4
M/$%CXN_9H^%.I_$#69/%ND-K=G_;M\NF7%N'16Q(LD,8W_*05)Z$C/>OMJBE
M=))6V<7KK\+O^/\ 70)>]%QO:]]O-6_#^MSX OOC=X@^!/PVANO#EUKMGX:U
M'Q+<1^'+1] ?4VET_*[%^9E:&+KM)R?:G>-?VBOC3X'\(ZPVF>(M+U'6Y=;5
M)IM:T6:*UT"UD3>F\QJQE#9"@@'!ZU]^T4GJVV_ZT_.VOKTUO2>VBZ[:*[O^
M5]%Y:W/,_@SXRU7Q;IMG-K6MZ;?:E)IEO<7%GIEK(D,;MNS(DC@%E;'"D C%
M>F4454Y*4FTK&<(N,4F[A1114%A1110 4444 %%%% !1110 4444 %%%% %;
M4FBCTVZ::5X(5B8O+&2&1<'+#'<"OSZ;QEX1G_9C^*=E#XEUZ1+76YFM93%=
M_:+EF;]V&/E[G#=>,"OT.HJ>7WG+RM_Y,G^@W:4.7SO^#7ZGS'9S>'?CK:V#
MZDDFM^!_#WA]#=6_[P1W=R\8#1NG#;DV=#SEJQ? 7@.T\-> -'\)Z%82>&9/
M&VJ'59]/MI7633[%6W@89B0,*J'_ 'J^H+@Z)X.L=2U6?[#HUHS&ZOKR39"A
M. #)(QP,X Y/I69H?B;P;XNM5\6Z1J>C:O;Q(ULNM6DT4JJNX;D$H)P,XR,]
M:V<ES2DEIU^]O7NKVWZ*WI"BU",6]MG\K:=M+O3J[GP'XVU+PGKGB#QEJ?@C
M[5I&AKJ%G9>(_#UM:W:R75C'<'[7=R@KC!&5PA)( -2VNN:'X7_X5Q?#4=>T
MWPXOQ#EN/#FGM%=- -&V[1(4"$A YP-YSSTK[TM/BUX)O[?5I[;Q=HD\.DC=
MJ$D=_$5M!ZRG=\GXXIL?Q>\#2?V/L\8:&W]LY&FXU"+_ $S!P?*^;Y^?3-71
MJ.GRI*]K?I_EIVO+OIM*=T]--?R:^_75];*_G\I_"35].N/VO=4DM].U,ZK<
MWEVMP\L4Z7$$*J=IN'8>6T#<>6%Y'%?;58.F^//#>L>(KW0+'7]-O-<L1NNM
M-@ND>X@'J\8.Y?Q%;U8I_NX0716,Y:U)S[L****0!1110 4444 %?,'[8OQN
M\3_"?5_"=MH'B-?#T=\D[L?[(&H&ZD3&R$_\\E8G!?M7T_7.^(/ /A_Q3JEM
M?ZKIT=Y>6\$MM$\C'B.08=< X.14M.Z:Z/\ K^OP>Q<6E>YX'HO[<^AR^+F\
M)WOA;Q!<:KI^F)=:KJFFV1FTRWN?)$K0><#C//!/'O6WX>_:\@UKQ%#I5Q\/
MO$^D@RQI/=W:P>5;I*"8)'Q(3MDVG&!QCG%=A;_LQ_#FRUAM2M="DM9WMOLD
MD<%_<)#+'LV8>(2;&.WC)!/O712_"/PE--=3/H\;27*0I*WF/\RP@B,=?X0Q
M_.M&UO;7_@_Y;?KN8V:5D_ZM_GO_ $CRBW_:NT_6M6GLWL=2\/W6F7<BW%KF
MTO/M421,Y.Z.1@@..^&SVI9/VIH=5TY+B;1=?\(2V]Y:R>1>6L$KWUK*6"E?
MG(56*D9^\,=*Z/P7^R5\(? TVIR^'O"=K9R:A,\UVT=S*^]W4JQ.7.,ACP/6
MNNU+X+^#=7:,W>B1S&..")<R/PL))B'WOX<FI6D?/3[_ .OEOH:NW-Y?I?\
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M45NS9HKX=M_^"DK:/HK7_BGPE8V,,=Q9F:ZTW5?M5M%;W DP6D"#$JF/F/\
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M/? -P_UK$CVJ?M1B]$TVGZ67KK=6[F\;RBW'5IVM\F_31)W['Z-45\5>&_\
M@H?J_BO2[6&R^%DT/BB2>XBET>ZUF)%B6*)9=_FA"""K>G:H/ ?[:]WXB_:(
MTK2([>ZFTOQ?I5A=:=I]W.D5MI[-&6ES+M^9S@X7OVJXPE*2BEO_ )-K\$_U
M!Z0=1[)7^7,H_F_FMC[<HHHJ "BBB@ HHHH **** "BBB@ HHKPK]HW]J*R_
M9ZUKPQ87VFK>G7S)!:L9_++7 P(X@,'[S$#/:E?5+J]!I-W\CW6BO$=6_:Z^
M'G@4?V3XU\1Z;HGC>VTW^T+[PW;S-//#B/>R*0H#,!GCJ:X._P#^"C'PNO\
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MQVKT*AJUO/7[]0TU2Z:?=H%%%%( HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J"^LK?4K.>TNH4N+:=#'+#(NY74C
M!!'<$5/7)_%J:6V^%_BN6"22*9-,N&22(D,I\LX((Y!K*K)0IRDU>R9I3BYS
MC%.UV<W#^R_\)+:.!(?AUX=B6";[1$$L$&R3.=PXX/ JW<?LZ_#"ZNM7NI?
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M=L:*0%( &%Z#Z4^H*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M."FZ3%N2#G P.U=-X#^$/Q:TWX[:]KWB2^\;7F@7%O+'9Z=:ZS;?V:ML4Q'
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MG=J:W]T\=R6!4M)F/*!%("HN0.:TGRJ$G'5V_'3_ .V7R3V)=KQMY7^Y_P#
M]-4?1_AW7;7Q1H.G:Q8ES9W]O'=0F1=K;'4,N1V.#6C7'_"'0]<\,_#/PYH_
MB-+&/6-/LH[2;^S9'> [%"@J7 ;D 'D=Z["JJJ,:DE!Z7T]#"DY2IQ<UK;7U
M"BBBLC4**** "BBB@ HHHH *R?%BW,GAG519ZDNCW7V:3RM09%86[;3AR&X(
M'7FM:LWQ)H>F^)M!O]*UBW2ZTJ\A:&YAD8JKQD88$@CC'O433E%I%P:4DV?G
M3_PV!\3O$_PYEU^Y\6R>&)K37;70+BWTK1X[NYDB_>[[V*)U)82;5V@#'RMB
MNJ\/_M&?$/Q%XG^%FFZKXSU;3+#5[*XN&G\/Z!%?7%_LNECB:Y38WV?<A^?
M&T^E?7,G[/\ \-K[5M-UC_A$]-DOK!8!:7**1Y8A!$6,'!VACC/K5[PO\%/
M_@K7CK>A^&[/3=5Q,OVJ'=NQ*_F2@9. &;DBNN,X*5VNM_PM^+U[+:ST);3C
M9=OS?Z+2^[WT=[]K'GRUR2QQU(QFG5&MQ$\S1+(C2J,L@8;@/<5)7.2%%5KC
M4K2TN(8)[J&&:8XCCDD"L_\ N@GG\*LT#"BBB@ HHHH **** "BBB@ HHHH
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MA^&FA_#N[_X1W0+2UC@U>Z\0>&+Z4W%R& :W&(BR #/S\#GKQ72/^TU\0_\
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MB.ZDLY+VY=5EC.49"TA,>T] A KM1\/_  \/%&G>(_[,C.N:?9M86MZ68O'
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M3TS@=JIN%K):_P# 7_!!<]]=O^'_ . :U%%%9F@4444 %%%% !1110 4444
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M7<W?!KBO#OPK^)'AZP^+@\8_#?3-9M]<T:-#_86H-=3ZK=XD4-ME"<_,"V2
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MIG@SP9J%P=>L-!T.>XO '.I064)>8=03(%RWYU*3TY_._P"-AQOOOJONTO\
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M&48035E;0B2:J2<MW_PWYIKU04445F(**** "BBB@ KYD_:T^$?C#XH>*/#
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M%_G8ESBI1CU:3^35_P!3UZBBBLS0**** "BBB@ HHHH **** "BBB@ HHHH
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M",QRR7#;<JC2*64@CM6B@VVNW]?U_P !DIW5_P"MK_H_Z:/H2BBBLR@HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "LWQ)KUOX7\/ZEK%TLCVUC;O<R+$,L5522
M /7BM*L/QQH$OBKP=K6C0RI;RW]G+;)+("50NI7) ^M9U.90DX;VT]32GRN:
M4]KZG ?"O]I3PY\3+75)+FSO_!MQIZ13S6OB01V[>3+GRI00Y7:VTXYSQTKO
M[KQUX:L9(4N?$.E6[S)YD:RWL2ETQG<N6Y&.<BOD/Q9_P3QDU+P'_P (S8:W
M:WFFM+:WD]AK$MR\5U<1[@ZR2JWF>4<@JH/RD<5UT?[$EA=:!:VM[:>'TNK<
M:>D"I#+/';10;?-BC>4E]K@$<GH<&NEJ,I66BNE^&K^_\/N.=.2C=KI?YZ:?
M=_EKN?1I\>>&_P#00/$&EL]^-UFHO8LW/_7/YOG_  KAYO#_ ,,O%7B_1O%>
MOZ+HUGXS&$L7U.6$7O&0H4!SN[XQFO&OB%^QWXQUC4O"]OX4\0^&- \-Z3>2
M7#VDVC+).L;2;A'!+C,0 R/E(ZUTR_LAI-9O)>7&E7>LPVUG#I^H26I:2T:*
M3<[HQY4L.,CGFLH>]RS>FOS7F:R6DH[_ )/7_AF>V:3\1-'OC##?7-OHM_//
M)##87]W"L\NUBNY5#G(.,C'//(%:-KXNT/4-0GT^TUG3[O4( 3+9P72/,F.N
M4!R/Q%> 0_LAQ_:K[4KR72KW6/M@N["]:U)EM!]I,Q",>5)'RY%>=?L6> 7\
M-_%3QG>3^ %TS4[X3&^\17-E=P71D,K80M,?+DW YS#@<#-4DI-I=$W]VW_!
M^2ZBE[L>?S2^_?\ X'XGKG@K]K#P-\7/%FO>#KK2K[3K>R6X\^[UCR%M)5AD
MV.21(2@W=-X7->D0_%CPG;:DNFQZG9QV$6GK>KJ0N(Q9"+>4 $N[;G*U\W:=
M^QCXVT^X\1R6NL^#M.EN'OIK&ZM])=Y+IKARP%^KY694!X&.M2>%_P!COXA^
M'_A9J^BOXN\,77B6]LOLL=U)HJM81'S6?(MBNS&&Q@+C/.*B_N72ULOF]?Z_
MX<(ZM\W>WHM-?S/J>X\:>&E@L_.U[2EBU 8M2]Y&!<@\?N_F^?/MFJNDZYX/
M\.PW>EZ?JFCV,>G9DN;6*ZB7[-N.2TB[ODR3U..M?._AG]BV\'@'3]+\5:EH
MNMZ]9:<UK;ZA'8;$M9C*K^9 G2/ ! VXQFN?U3]AOQ#KGPZ\4^#=0OO"LUK?
MW0NX=7CM9XM1U#]]YA@OYE.7BQ\N%.>!5-)7M_6MORU_(E:I-K^K+\]OEJ?8
M&GZ]IFKLHL=1M+TM&)0+>=9,H> W!Z'!YJ_7D/[/?P;N/@UX;LM%.E>&]/M+
M:T6%3HXN'D#;V)7S)B6,8R,*3P2:]>JIJ*=HNZ"-[:A1114%!1110 4444 %
M%%% !1110 4444 %%%% 'A?A/XH6.J?%3QY/X?\ AMJ-P+.+[/>^)K40@ZA<
M0# M@I<,64-\I; ZU:7]JOPU;_"O6?&NI:3K.D_V1</9W>BW,"F^693S&%5B
MK'OPW ZUS^L?"GXJZO\ $+Q-K>FW?A7PHJ021:/=:?'.6O&D_CO8\[69<=1S
MD\5@7'[*/CKQ1\,[;0]3\<6'A36K,7.RY\+V9E@O&F0J\EP+D,Q9B3DJ1@'B
MB#;BN;LO7?\ RTMTT[.].SGOI?\ "W^?7KKMI;U?XH?M Z1\+_!WA[7[G2M0
MU,:[+##9V5J84E+2+N 8RR(@P.OS5DZC^U)X?T_QC9^&%TK4+C5S8K?ZA!')
M;AM,1HS(HE!E!8E0?]6'K(\1?"?Q[XB^%*>#+BV\(:])8A+.'4/%MDUSY\8C
M"FX$<?"29)V^FWFO-=,_8+O_  [XMTB^LM:TC4;2WAM7N-0U6T>34Q-;QE%2
M*4<+"^?F4\XJ[1YI*^E]/2WZ;]WMH1JH<W6VWG?OMY=NNI] ?!?XW6GQLT:^
MU73M"U+2[&WD,<4MZ\#?:/=?*D?'T;!]JY#5OVNM#\.V/C!]:\+^(-'U#PUY
M+3:;=QPK+<QRL5CDB;S-FUB#]YEZ56^%?P+\7_#S7O$?B6.3PCI>KZP\4+:7
MH-E-;Z7'"K$M+Y><F=L_>/%9_A7X*_$[3]!\9Q>(A\.O%.KZY*)1<ZC874L5
MQAOE2X1B045?NJO -3*VZ[+[]/\ @^7D-;.^]]/3S\OQ\SW#P#XN/CKPI8ZV
M=+NM'%VN\6EXT;2*,\$F-V4YZ\,:Z&O-?V?/A-<?!GX<P^'[N^BOKIKF:[E^
MRH4MH6D<L8H$/*Q+G"CL!7I57445-J.Q,;VU"BBBLR@HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\9>(/\
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M4G<ZJG3=G[O08XKK:J?*I/DV,X.3BG-:A1114%A1110 4444 %%%% !1110
M4444 %%%% 'EZ_&B?_A=EUX!?PU>111:7)J4>I.P N"C %(T[_>ZY%9/A/\
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M1^#-!\97?BS3_#.FV?B2[3RY]3A@ F=?0M^%==2E*+A&*5K"D^:;DE9?\/\
MI9?*_4****S$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
*444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747659312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Nov. 19, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NANOPHASE TECHNOLOGIES Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NANX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,911,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6748009408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,034<span></span>
</td>
<td class="nump">$ 1,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade accounts receivable, less allowance for doubtful accounts of $5 on September 30, 2018 and December 31, 2017</a></td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">2,091<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,297<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Equipment and leasehold improvements, net</a></td>
<td class="nump">1,761<span></span>
</td>
<td class="nump">1,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, net</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,074<span></span>
</td>
<td class="nump">6,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease obligations</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">980<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,593<span></span>
</td>
<td class="nump">2,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Long-term portion of capital lease obligations</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Long-term deferred rent</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsNoncurrent', window );">Asset retirement obligations</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">1,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value, 42,000,000 shares authorized;33,911,792 shares issued and outstanding on September 30, 2018 and 33,847,793 on December 31, 2017</a></td>
<td class="nump">339<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">98,737<span></span>
</td>
<td class="nump">98,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(96,641)<span></span>
</td>
<td class="num">(95,669)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">2,435<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 7,074<span></span>
</td>
<td class="nump">$ 6,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45023-112735<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6747729472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">24,088<span></span>
</td>
<td class="nump">24,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">42,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">33,911,792<span></span>
</td>
<td class="nump">33,847,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">33,911,792<span></span>
</td>
<td class="nump">33,847,793<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746034240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,022<span></span>
</td>
<td class="nump">$ 2,785<span></span>
</td>
<td class="nump">$ 11,036<span></span>
</td>
<td class="nump">$ 9,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">2,965<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">8,164<span></span>
</td>
<td class="nump">6,862<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">2,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">1,513<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="nump">765<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(634)<span></span>
</td>
<td class="num">(940)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before provision for income taxes</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(643)<span></span>
</td>
<td class="num">(972)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (136)<span></span>
</td>
<td class="num">$ (643)<span></span>
</td>
<td class="num">$ (972)<span></span>
</td>
<td class="num">$ (574)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income/(loss) per basic shares</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of basic common shares outstanding</a></td>
<td class="nump">33,879,097<span></span>
</td>
<td class="nump">31,239,678<span></span>
</td>
<td class="nump">33,858,184<span></span>
</td>
<td class="nump">31,234,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income/(loss) per diluted share</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of diluted common shares outstanding</a></td>
<td class="nump">33,879,097<span></span>
</td>
<td class="nump">31,239,678<span></span>
</td>
<td class="nump">33,858,184<span></span>
</td>
<td class="nump">31,234,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,998<span></span>
</td>
<td class="nump">$ 2,524<span></span>
</td>
<td class="nump">$ 10,908<span></span>
</td>
<td class="nump">$ 9,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 261<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6748126512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (972)<span></span>
</td>
<td class="num">$ (574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net income loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities related to operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(802)<span></span>
</td>
<td class="num">(1,147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(706)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(84)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(921)<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment', window );">Proceeds from disposal of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of equipment and leasehold improvements</a></td>
<td class="num">(115)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(115)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Principal payments on capital leases</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from line of credit</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on line of credit</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock', window );">Proceeds from exercise of stock options and sale of common stock</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Decrease in cash and cash equivalents</a></td>
<td class="num">(921)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">1,955<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">1,034<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable incurred for the purchase of equipment and leasehold improvements</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_ProceedsFromCapitalLeaseNonCash', window );">Proceeds from capital leases</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_ProceedsFromCapitalLeaseNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash consideration received from capital lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_ProceedsFromCapitalLeaseNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement and from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_ProceedsFromExerciseOfStockOptionsAndSaleOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sale of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739148176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(1) Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">The
accompanying unaudited consolidated condensed interim financial statements of Nanophase Technologies Corporation (&#8220;Nanophase&#8221;
or the &#8220;Company&#8221;, including &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221;) along with its wholly-owned subsidiary,
Sol&#233;sence&#174;, reflect all adjustments (consisting of normal recurring adjustments) which, in the opinion of management,
are necessary for a fair presentation of our financial position and operating results for the interim periods presented. Operating
results for the three and nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected
for the year ending December 31, 2018 or any interim period.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">These
financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended
December 31, 2017, included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017, as filed with
the Securities and Exchange Commission.</font></p>



<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6628623616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_DescriptionOfBusinessAbstract', window );"><strong>Description Of Business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(2) Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nanophase is a leader
in advanced materials technologies, with its primary strategic focus being in developing and providing engineered solutions for
various applications of micromaterials (&#8220;nano&#8221; and &#8220;non-nano&#8221; in scale) for use in protecting human skin
from the harmful and damaging effects of the sun. We also produce a variety of materials for use in diverse markets other than
those using our materials as active ingredients for sun protection. These other markets include: industrial coatings applications,
abrasion-resistant additives, medical diagnostics, and a variety of surface finishing (polishing) applications, including optics.
<font style="font-weight: normal">We have expanded our offerings beyond active ingredients to include targeted full formulations
of skin care products, marketed and sold by our wholly-owned subsidiary, Sol&#233;sence&#174;, LLC.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">We
target markets in which we believe practical solutions may be found using our products. We work closely with current and potential
customers in these target markets to identify their material and performance requirements and market our advanced materials to
various end-use applications manufacturers, and our Sol&#233;sence&#174; solutions to cosmetics and skin care brands. Recently
developed technologies have made certain new products possible and opened potential new markets. During 2015 we were granted a
patent on a new type of particle surface treatment (coating), which became the cornerstone of our new product development in personal
care, with first revenue recognized during 2016. In addition, through the creation of our Sol&#233;sence&#174;, LLC subsidiary,
we utilize this particle surface treatment to manufacture and sell fully developed solutions to targeted customers in the cosmetics
and skin care industry, in addition to the additives we have traditionally sold in the personal care area.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">Although
our primary strategic focus has been the North American market, we currently sell material to customers overseas and have been
working to expand our reach within foreign markets. The Company was incorporated in Illinois on November 25, 1989 and became a
Delaware corporation during November 1997. Our common stock trades on the OTCQB marketplace under the symbol NANX.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">While
product sales comprise the majority of our revenue, we also recognize revenue from other sources from time to time. These activities
are not expected to drive the long-term growth of the business. For this reason, we classify such revenue as &#8220;other revenue&#8221;
in our Statements of Operations, as it does not represent revenue directly from our materials or fully formulated products.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739221024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Revenues</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 1, 2018,
we adopted Accounting Standards Updates (&#8220;ASU&#8221;) 2014-09 and 2015-14, <i>Revenue from Contract with Customers (Topic
606)</i>, using the modified retrospective method applied to those contracts that were not <b>completed</b> as of January 1, 2018.
Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not
adjusted and continue to be reported in accordance with our historical accounting under the Financial Accounting Standards Board
(&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 605. Based on our contract evaluation, we determined
that there was no need to record any changes to our opening retained earnings due to the impact of our adoption of Topic 606.
The adoption of Topic 606 did not have a material impact on our consolidated condensed financial statements.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues are recognized
at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration
we expect to receive in exchange for those goods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generally expense
sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within
selling, general and administrative expenses. Customers&#8217; deposits, deferred revenue and other receipts are deferred and
recognized when the revenue is realized and earned. Cash payments to customers are classified as reductions of revenue in our
statements of operations.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not disclose
the value of the unsatisfied performance obligations for contracts with an original expected length of one year or less or contracts
for which we recognize revenue that we have the right to invoice for goods completed.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6613287728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) Earnings (Loss) Per Share&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">Earnings
(Loss) Per Share is computed using the Treasury Stock Method. Options to purchase approximately 1,119,000 and 820,000 shares of
common stock that were outstanding as of September 30, 2018 for the three and nine months ended September 30, 2018, respectively,
were not included in the computation of diluted earnings (loss) per share, as the impact of such shares would be anti-dilutive.
Options to purchase approximately 750,000 and 796,000 shares of common stock that were outstanding as of September 30, 2017 were
not included in the computation of loss per share for the three and nine months ended September 30, 2017, respectively, as the
impact of such shares would be anti-dilutive.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739137232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(5) Financial Instruments&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">We
follow FASB ASC Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, <i>Fair Value Measurements and Disclosures</i>,
which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs)
used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires
significant management judgment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">Our
financial instruments include cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, along with
a promissory note with no related borrowings, any borrowings on the LB&#38;T working capital line of credit, each described in
Note 6. Subsequent to September 30, 2018, the Company has secured a term loan and a revolving loan, each described in Note 6.
The fair values of all financial instruments were not materially different from their carrying values. There were no financial
assets or liabilities adjusted to fair value on September 30, 2018 or December 31, 2017.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739164528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Lines of Credit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes and Lines of Credit</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">(6) Notes and Lines of Credit</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During July 2014,
we entered into a bank-issued letter of credit and related promissory note for up to $30 in borrowings to support our obligations
under our facility lease agreement. No borrowings have been incurred under this promissory note. Should any borrowings occur in
the future, the interest rate would be the prime rate plus 1%, with the bank having the right to &#8220;set off&#8221; or apply
unpaid balances against our checking account if we fail to meet our obligations under any borrowings under the note. It is our
intention to renew this note annually, for as long as we need to pursuant to the terms of our facility lease agreement. Because
there were no amounts outstanding at any time during 2018 or 2017, we have recorded no related liability on our balance sheet.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During March 2015,
we entered into a Business Loan Agreement (the &#8220;Line of Credit Agreement&#8221;) with Libertyville Bank and Trust Company,
a Wintrust Community Bank (&#8220;LB&#38;T&#8221;), our primary bank. This Line of Credit Agreement was subsequently amended on
April 13, 2015 and was extended on each of March 4, 2016 and February 14, 2017. Under the Line of Credit Agreement, as amended,
LB&#38;T provided a maximum of $300 or 75% of our eligible accounts receivable, whichever was less, of revolving credit, collateralized
by a senior priority lien on our accounts receivable, inventory, equipment, general intangibles and fixtures. Interest on any
borrowings was the prime rate at the time plus 1%. Availability to draw on the line required us to have at least $1 million in
cash, including any amounts borrowed, at LB&#38;T on the date of any advance. Advances could only occur at the beginning or end
of a fiscal quarter and had to be repaid in full within five days of the advance. Borrowings on this line were $300 on December
31, 2017. These borrowings were repaid in January 2018. The Line of Credit Agreement expired on March 4, 2018.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;26,
2018, we executed a new Business Loan Agreement (the &#8220;New Line of Credit Agreement&#8221;), dated as of March 4, 2018, with
LB&#38;T, which replaces the Line of Credit Agreement with LB&#38;T that expired on March 4, 2018. Under the New Line of Credit
Agreement, LB&#38;T will provide a maximum of (i) $500 or (ii) two times the sum of (a) 75% our eligible accounts receivables
and (b) our cash deposited with LB&#38;T, whichever is less,&#160;of revolving credit to us, collateralized by a senior priority
lien on our accounts receivables, inventory, equipment, general intangibles and fixtures. Interest is payable monthly on any advances
at a floating interest rate of the prime rate at the time plus 1%. We must have $1 million in cash, inclusive of the borrowed
amount, at LB&#38;T on the date of any advance. Advances may only occur at the beginning or end of a fiscal quarter and must be
repaid in full within five business days of the advance. The New Line of Credit Agreement expires in March&#160;2019. While the
New Line of Credit Agreement is in effect, we cannot, among other things, engage in any business activities substantially different
than those in which we are presently engaged, and there are limitations imposed on our ability to, among other things, incur additional
indebtedness for borrowed money, including capital leases, sell, transfer, mortgage, assign, pledge, lease or grant a security
interest in or encumber any of our assets, sell with recourse any of our accounts other than to LB&#38;T, cease operations, merge,
transfer, acquire or consolidate with any other entity, change our name, dissolve or transfer or sell collateral outside the ordinary
course of business, pay any cash dividends, loan, invest in or advance money or assets to any other person or entity, purchase,
create or acquire any interest in any other entity, or incur any obligation as a surety or guarantor other than in the ordinary
course of business, in each case without LB&#38;T&#8217;s prior written consent. We borrowed $500 on this line on September 28,
2018 and repaid it on October 1st, 2018. The amount outstanding on the loan was $300 on December 31, 2017 which was paid in full
on January 9, 2018.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 19, 2018,
we entered into a Business Loan Agreement (the &#8220;Master Agreement&#8221;) with Beachcorp, LLC. The Master Agreement relates
to two loan facilities, each evidenced by a separate promissory note dated as of November 16, 2018: a term loan to the Company
of up to $500 to be disbursed in a single advance (the &#8220;Term Loan&#8221;) with a fixed annual interest rate of 8.25%, payable
quarterly, accruing from the date of such advance and with principal due on December 31, 2020; and an asset-based revolving loan
facility for the Company of up to $2,000 (the &#8220;Revolver Facility&#8221;), with floating interest accruing at the prime rate
plus 3% (8.25% minimum) per year, with a borrowing base consisting of qualified accounts receivable of the Company, and with all
principal and accrued interest due March 31, 2020. The Term Loan and Revolver Facility are secured by all the unencumbered assets
of the Company and subordinated to LB&#38;T&#8217;s secured interest under the New Line of Credit Agreement. The Master Agreement
substantially restricts the Company&#8217;s ability to incur additional indebtedness during the terms of both the Term Loan and
the Revolver Facility. As of the date of this filing, there were no amounts borrowed on either of the loans.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739100816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(7) Inventories</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">Inventories
consist of the following:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">September 30, 2018</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap; padding-bottom: 2.15pt"><b>December 31, 2017 </b></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 65%">Raw materials</td>
    <td style="width: 8%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td style="text-align: right; width: 11%">1,086</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td style="text-align: right; width: 11%">543</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">1,026</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">863</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,112</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,406</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Allowance for excess inventory quantities</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">(21</td>
    <td style="text-align: left; padding-bottom: 1pt">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">(21</td>
    <td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: black 2.5pt double; text-align: right">2,091</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: black 2.5pt double; text-align: right">1,385</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three months
ended March 31, 2018, $246 was reclassified from Prepaid Expenses to Raw Materials. For comparison purposes, $246 has been reclassified
from Prepaid Expenses to Raw Materials as of December 31, 2017 in the table above. Our balance sheet as of December 31, 2017 has
also been updated to reflect this reclassification.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739152016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(8) Share-Based Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">We
follow </font>FASB ASC Topic 718<font style="font-family: Times New Roman, Times, Serif">, </font><i>Compensation &#8211; Stock
Compensation</i><font style="font-family: Times New Roman, Times, Serif">, in which compensation expense is recognized only for
share-based payments expected to vest. We recognized compensation expense related to stock options of $58 and $146 for the three
and nine months ended September 30, 2018, respectively, compared to $45 and $140 for the three and nine months ended September
30, 2017, respectively. </font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of September 30,
2018, there was approximately $449 of total unrecognized compensation cost related to non-vested share-based compensation arrangements
granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 2.2 years.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><u>Stock Options and Stock Grants&#160;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">During
the nine months ended September 30, 2018, 63,999 shares of common stock were issued pursuant to stock option exercises for proceeds
of $29,000. During the nine months ended September 30, 2017, 45,334 shares of common stock were issued pursuant to stock option
exercises for proceeds of $14,000. During the nine months ended September 30, 2018, 570,500 options were granted compared to the
507,600 </font>stock options were granted during the same period in 2017. During the nine months ended September 30, 2018, 188,504
stock options expired, and 31,601 stock options were forfeited compared to 7,000 stock options expiring and 37,568 forfeited during
the same period in 2017. We had 3,428,000 stock options outstanding at a weighted average exercise price of $0.67 on September
30, 2018, compared to 3,141,000 stock options outstanding at a weighted average exercise price of $0.79 on December 31, 2017.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during the
periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center">For the nine months ended</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">September 30, 2018</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">September 30, 2017</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt; width: 60%">Weighted-average risk-free interest rates:</td>
    <td style="width: 7%">&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt; width: 13%">2.9%</td>
    <td style="width: 7%">&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt; width: 13%">2.1%</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">-</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">-</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Weighted-average expected life of the option:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">7 years</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">7 years</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Weighted-average expected stock price volatility:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">94%</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">94%</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Weighted-average fair value of the options granted:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">$0.64</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">$0.55</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of September 30, 2018, we did not have
any unvested restricted stock or performance shares outstanding. No stock options were granted in the three-month periods end
September 30, 2018 and 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739169136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Customers and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Significant Customers and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(9) Significant Customers and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue from our three
largest customers constituted approximately 74%, 12% and 4%, respectively, of our total revenue for the three months ended September
30, 2018, and approximately 74%, 8% and 4%, respectively, of our total revenue for the nine months ended September 30, 2018. Amounts
included in accounts receivable on September 30, 2018 relating to these three customers were approximately $1,170, $388 and $149,
respectively. Revenue from these three customers constituted approximately 58%, 0% and 8%, respectively, of our total revenue for
the three months ended September 30, 2017, and approximately 67%, 0%, and 7% of our total revenue for the nine months ended September
30, 2017. Amounts included in accounts receivable on September 30, 2017 relating to these three customers were approximately $1,196,
$0 and $174 respectively. The loss of one of these significant customers, a significant decrease in revenue from one or more of
these customers, or the failure to attract new customers could have a material adverse effect on our business, results of operations
and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently have exclusive
supply agreements with BASF Corporation (&#8220;BASF&#8221;), our largest customer, that have contingencies outlined which could
potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended
to provide capacity sufficient to meet the customer&#8217;s production needs. This outcome may occur if we fail to meet certain
performance requirements, certain other obligations and/or certain financial condition covenants. The financial condition covenants
in one of our supply agreements with BASF &#8220;trigger&#8221; a technology transfer right (license and equipment sale at BASF&#8217;s
option) in the event (a) that earnings for the twelve-month period ending with our most recently published quarterly financial
statements are less than zero and our cash, cash equivalents and certain investments are less than $1 million, or (b) of an acceleration
of any debt maturity having a principal amount of more than $10 million. Our supply agreements with BASF also &#8220;trigger&#8221;
a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment
sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment&#8217;s net
book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the
equipment&#8217;s net book value, depending on the equipment and related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that we
have sufficient cash and credit availability (See Liquidity and Capital Resources in Management&#8217;s Discussion and Analysis
in Part I, Item 2 of this Form 10-Q for a further discussion, as well as the description of our loan and credit agreements described
in Note 6) to operate our business during the remainder of 2018. If a triggering event were to occur and BASF elected to proceed
with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products
sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to
replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer
pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity
would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar
consequences would occur if we were determined to have materially breached certain other provisions of the supply agreements with
BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities.
We believe that our employees are a critical component of our success and it could be difficult to replace them quickly. Upon
the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such
an event and its impact on us. Finally, any shortfall in capital needed to operate the business as management intends, including
with respect to avoiding this triggering event as described above, may result in a curtailment of certain activities or anticipated
investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to expend
resources on research, development and product testing, and in expanding current capacity or capability for new business. In addition,
we may incur significant costs in preparing, filing, prosecuting, maintaining and enforcing our patents and other proprietary
rights. We may need additional financing if we were to lose an existing customer or suffer a significant decrease in revenue from
one or more of our customers or because of currently unknown capital requirements, new regulatory requirements or the need to
meet the cash requirements discussed above to avoid a triggering event under our BASF agreement. Given our expected growth in
our Sol&#233;sence<sup>&#174;</sup>&#160;business, we may also have temporary working capital demands that we cannot fund with
existing capital, while remaining in compliance with the covenants included in our BASF agreement described above. If necessary,
we may seek funding through public or private financing and through contracts with governmental entities or other companies. Additional
financing may not be available on acceptable terms or at all, and any such additional financing could be dilutive to our shareholders.
If we are unable to obtain adequate funds, we may be required to delay, scale-back or eliminate some of our manufacturing and
marketing operations or we may need to obtain funds through arrangements on less favorable terms. Such circumstances could raise
doubt as to our ability to continue as a going concern. If we obtain funding on unfavorable terms, we may be required to relinquish
rights to some of our intellectual property.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739110272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segmentation and Geographical Distribution<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segmentation and Geographical Distribution</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(10) Business Segmentation and Geographical Distribution</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue from international
sources approximated $152 and $335 for the three and nine months ended September 30, 2018, respectively, compared to $276 and
$956 for the three and nine months ended September 30, 2017, respectively. All this revenue was product revenue.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operations comprise
a single business segment and all our long-lived assets are located within the United States.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739222400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(11) New Accounting Pronouncements&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During February 2016,
the FASB issued ASU No. 2016-02 (&#8220;ASU 2016-02&#8221;), <i>Leases (Topic 842)</i>. This standard requires the recognition
of assets and liabilities arising from lease transactions on the balance sheet and the disclosure of key information about leasing
arrangements. Accordingly, a lessee will recognize a lease asset for its right to use the underlying asset and a lease liability
for the corresponding lease obligation. Both the asset and liability will initially be measured at the present value of the future
minimum lease payments over the lease term. Subsequent measurement, including the presentation of expenses and cash flows, will
depend on the classification of the lease as either a finance or an operating lease. Initial costs directly attributable to negotiating
and arranging the lease will be included in the asset. For leases with a term of 12 months or less, a lessee can make an accounting
policy election by class of underlying asset to not recognize an asset and corresponding liability. Lessees will also be required
to provide additional qualitative and quantitative disclosures regarding the amount, timing and uncertainty of cash flows arising
from leases. These disclosures are intended to supplement the amounts recorded in the financial statements and provide additional
information about the nature of an organization&#8217;s leasing activities. The amendments in this standard are effective for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, which is our first quarter of
2019, with early adoption permitted. We review new accounting standards as issued. We are in the process of evaluating the impact
this standard will have on our financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6739833632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-weight: normal">Inventories
consist of the following:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td></td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; font-weight: bold">September 30, 2018</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; white-space: nowrap; padding-bottom: 2.15pt"><b>December 31, 2017 </b></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 65%">Raw materials</td>
    <td style="width: 8%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td style="text-align: right; width: 11%">1,086</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td style="text-align: right; width: 11%">543</td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">1,026</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">863</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,112</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1,406</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Allowance for excess inventory quantities</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">(21</td>
    <td style="text-align: left; padding-bottom: 1pt">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right">(21</td>
    <td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: black 2.5pt double; text-align: right">2,091</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: black 2.5pt double; text-align: right">1,385</td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6623205360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to calculate Black-Scholes option Pricing Model for options granted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
illustrates the various assumptions used to calculate the Black-Scholes option pricing model for stock options granted during
the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center">For the nine months ended</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">September 30, 2018</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">September 30, 2017</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt; width: 60%">Weighted-average risk-free interest rates:</td>
    <td style="width: 7%">&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt; width: 13%">2.9%</td>
    <td style="width: 7%">&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt; width: 13%">2.1%</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Dividend yield:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">-</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">-</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Weighted-average expected life of the option:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">7 years</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">7 years</td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Weighted-average expected stock price volatility:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">94%</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">94%</td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; padding-left: 5.4pt">Weighted-average fair value of the options granted:</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">$0.64</td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 5.4pt">$0.55</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6887853456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="nump">1,119,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">820,000<span></span>
</td>
<td class="nump">796,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6749241600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Lines of Credit (Detail Narratives) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2018</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Jul. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Business Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_TermLoan', window );">Term loan</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed annual interest rate</a></td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Business Loan Agreement [Member] | Asset-Based Revolving Loan Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread variable interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Facility, expiration date</a></td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">New Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Variable interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable', window );">Borrowing capacity as percentage of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_BorrowingCapacityAsMultipleOfAccountsReceivable', window );">Borrowing capacity as multiple of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Facility, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  04,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_RepaymentTerms', window );">Repayment Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">New Line of Credit [Member] | Greater than [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Minimum amount of cash on hand before advance is given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=nanx_LineOfCredit1Member', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Variable interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable', window );">Borrowing capacity as percentage of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Facility, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  04,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_RepaymentTerms', window );">Repayment Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Letter of credit and related promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Variable interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prime rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_BorrowingCapacityAsMultipleOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The multiple of accounts receivable available to be borrowed as defined in line of credit agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_BorrowingCapacityAsMultipleOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility maximum borrowing capacity as percentage of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_LineOfCreditFacilityMaximumBorrowingCapacityAsPercentageOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_RepaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of business days the payment under the line of credit must be repaid of the advance, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_RepaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_TermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent amount of term loan disbursed in a single advance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_TermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=nanx_BusinessLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=nanx_BusinessLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=nanx_LineOfCredit1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=nanx_LineOfCredit1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632135168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 1,086<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory gross, Total</a></td>
<td class="nump">2,112<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Allowance for excess inventory quantities</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,091<span></span>
</td>
<td class="nump">$ 1,385<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890236032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_RelassificationFromPrepaidExpensesToRawMaterials', window );">Relassification from prepaid expenses to raw materials</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">$ 246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_RelassificationFromPrepaidExpensesToRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount reclassified from prepaid expenses to raw materials during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_RelassificationFromPrepaidExpensesToRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6735222784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Details) - Stock Options [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rates</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life of the option</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted-average expected stock price volatility</a></td>
<td class="nump">94.00%<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of the options granted</a></td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average expected volatility rate of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6748537632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Detail Narratives) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted</a></td>
<td class="nump">$ 449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which unrecognized compensation is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued pursuant to option exercises (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,999<span></span>
</td>
<td class="nump">45,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">570,500<span></span>
</td>
<td class="nump">507,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Stock options expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,504<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Stock options forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,601<span></span>
</td>
<td class="nump">37,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Stock options outstanding, end of period</a></td>
<td class="nump">3,428,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,428,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,141,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6749240368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Customers and Contingencies (Detail Narratives)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_MajorCustomersNumberOfCustomers', window );">Number of major customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nanx_CustomersOneMember', window );">Customers One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,196<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nanx_CustomersOneMember', window );">Customers One [Member] | Customer Concentration Risk [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue from customers</a></td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nanx_CustomersTwoMember', window );">Customers Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 388<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nanx_CustomersTwoMember', window );">Customers Two [Member] | Customer Concentration Risk [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue from customers</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nanx_CustomersThreeMember', window );">Customers Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=nanx_CustomersThreeMember', window );">Customers Three [Member] | Customer Concentration Risk [Member] | Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue from customers</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember', window );">BASF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantSupplyCommitmentDescription', window );">Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">We currently have exclusive supply agreements with BASF Corporation ("BASF"), our largest customer, that have contingencies outlined
which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer
intended to provide capacity sufficient to meet the customer's production needs.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades', window );">Equipment sale - original book value of equipment and upgrades</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_EquipmentSaleNetBookValueEquipment', window );">Equipment sale - net book value equipment</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember', window );">BASF [Member] | Greater than [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_PrincipalAmountDebtAcceleratedMaturity', window );">Accelerated debt maturity - principal amount debt</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember', window );">BASF [Member] | Less than [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nanx_EarningsTriggerUnderSupplyAgreeement', window );">Earnings trigger under supply agreeement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents and investments trigger under supply agreeement</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_EarningsTriggerUnderSupplyAgreeement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings for twelve month period ending with the most recently published quarterly financal statements as defined in supply agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_EarningsTriggerUnderSupplyAgreeement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_EquipmentSaleNetBookValueEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equipment's net book value to be sold to customer after a triggering event as stated in the supply agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_EquipmentSaleNetBookValueEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equipment's original value, including upgrades; to be sold to customer after a triggering event as stated in the supply agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_EquipmentSaleOriginalBookValueOfEquipmentAndUpgrades</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_MajorCustomersNumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of significant customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_MajorCustomersNumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nanx_PrincipalAmountDebtAcceleratedMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total prinicipal amount of accelerated debt maturity, as defined in supply agreement financial convenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nanx_PrincipalAmountDebtAcceleratedMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nanx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantSupplyCommitmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excluding long-term commitments, description of arrangements in which the entity must commit resources to supply goods or services to one or more customers, which may include identification of the goods or services to be furnished, identity of the buyer, pricing, effects on pricing (such as penalties) of failing to deliver minimum quantities required to be furnished, cancellation rights, and termination provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantSupplyCommitmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nanx_CustomersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nanx_CustomersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nanx_CustomersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nanx_CustomersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nanx_CustomersThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nanx_CustomersThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplyCommitmentAxis=us-gaap_SupplyCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6883850208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segmentation and Geographical Distribution (Detail Narratives)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International Sources [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from international sources</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 335<span></span>
</td>
<td class="nump">$ 956<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>42
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_>%W$7;!V*W]Q\9G0=G!K[N07U!+ P04    " !IB7--F5R<(Q &  "<)P
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MX-QH_8CBK:_LZ _RUT9C#^-TF_G[_G*:O31&=UI.ZLGU[X+-/U!+ P04
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M_C?6!D INQL<H0X_V&(H:$(\OL>SF\9L,H+MYQ_$EF]<_@902P,$%     @
M:8ES36I1N/2T 0  T@,  !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6Q]
M4VUOVR 0_BN('U 2XC519%MJ.DV=M$E1JZV?B7U^48%S <?=OR]@U_,V:U^
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M_&"+H:#VX?@)SW8:L\GPII]_$%N^<?$'4$L#!!0    ( &F)<TU(P6(ALP$
M -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;'U386_<( S]*X@?
M4.Y(VE6G)%*OU=1)FW3JM/4SES@)*H0,R*7[]S,DS=(NVA? QN_YV9AL-/;%
MM0">O&K5N9RVWO<'QES9@A;NRO30X4UMK!8>3=LPUUL0501IQ?AN=\.TD!TM
MLN@[V2(S@U>R@Y,E;M!:V-]'4&;,Z9Z^.9YDT_K@8$76BP:^@__1GRQ:;&&I
MI(;.2=,1"W5.[_:'8QKB8\!/":-;G4FHY&S,2S"^5#G=!4&@H/2!0>!V@7M0
M*A"AC%\S)UU2!N#Z_,;^.=:.M9R%@WNCGF7EVYS>4E)!+0;EG\SX"',]UY3,
MQ7^%"R@,#THP1VF4BRLI!^>-GEE0BA:OTRZ[N(_339+.L&T GP%\ =S&/&Q*
M%)4_""^*S)J1V*GWO0A/O#]P[$T9G+$5\0[%._1>BGW",W8)1'/,<8KAZY@E
M@B'[DH)OI3CR?^!\&YYL*DPB/'FG,-DF2#<)TDB0_K?$K9CT0Q*VZJD&V\1I
M<J0T0Q<G>>5=!O:.QS?Y&SY-^S=A&]DY<C8>7S;VOS;& TK97>$(M?C!%D-!
M[</Q$Y[M-&:3X4T__R"V?./B#U!+ P04    " !IB7--^H&N"[4!  #2 P
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MX-F-8S8:P7;3#V+S-RY^ 5!+ P04    " !IB7--)??Y[+8!  #0 P  &0
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M=SBF(3X&_.Q@M*LS"96<$9^"\:7*:1($@832!0;AMPO<@Y2!R,MXGCGIDC(
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MSY'&,CU3F"0%!L;TG*>#054;B:4OB(^I]T&>T,0>B2)+'LOJ0H!%;+' P!)
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M=A5C$I1A\*!2U>HBG@<4*JF[F>KS\3H:!Y+UTTV+YNN^_ =02P,$%     @
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M]O^\8- 8-]W:N0I=$!9&#E.#D_DO4_X#4$L#!!0    ( &F)<TV\?)(M"0(
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MET-+&19:=&.W)%/+SO\!4$L#!!0    ( &F)<TV.;83$! ,  -L+   9
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MYLZK5+J_*KJ@@Y1*:/'^DQ9_TJUW/8C%09G;L;[/ROZS'"AYKGIKKV[PE_\
M4$L#!!0    ( &F)<TW*JI8!%@(  /4%   9    >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;(U4T6[;(!3]%<L?4&(<DC9R+#5)JTW:I*A3UV?BW,16P7A
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M"@C0N3@5&DY%K_^/$^25.T620EW$Y/:RT4V@8U&[275/\F4>+DE&L;*-")C
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MIL]M'5$8.B"%/IMI]P1!Z%^12WE(4=:VO4BNOG<7Q+='A&(I"O@,1-OO6!(
MRU6<2I;TMBU1=HKJ4:</;0O ML^[YO:YN$72HTCF]"25@(L+W'JEB'[;.])K
MB+-PDN*?NLA=RZ0D5+OOAJ! U5R(I&3Z5FIRLRPE./$]Y1"O?786QKW)N2(4
M![' *3);[A9Z@6.;?YB**#([[-LM) *R[CHYYM%[I\&Z.VW=CZ&:)..D5Q9)
M#?2T+IAL\6IAYAI%)(/K(.'VQ]9*H<?$W-<R4O4BM\6'<GX#*#>(/W ^GI=P
MI.7*"+E[<)7Q04@25!R/I:BI-=OQ=J:K8)+GWZR!+"0WX_08!R0/]]ULUXKA
M3S!Q?Z]L0*+Y2[A!.=Z3@K.]F$G_'8*Q%=.$!U;0"Y:W"QIF%KJ5>6H_\^+5
MCS;]S+8?VI35!RRL/9G7%%R;0E2_U&G[5J,JA7:).4H.Z]4DA#]KV[;'*7?[
MRH>#'5&OFCN4>-H%86Q9)BQ^/A$WJO<C]9X84!VX0+%]%.*O]FD02U5NI9%4
M2.*A$O$UX_8##*RC;)#?GJ=A!5<1';B*Z)WFO2W=TKQ^/%P"&[%0@ABG[Z<]
MM"EF"Q:4(@D"@AE/IRYP8GSWP!6W^@+3WM^*X)Q+&2EL280ZV0,3LK==9$6^
M#%.Z'Q=\,QH1C3"6%4SD@ DC8&9I&N ;YG^M[O-'E-UXNZ"725(!OKWD]VPQ
MHS>)!JF8J73O^"H/3,V3(4F7&4WSTDF;#/U,R$/ WN;1]IW0Y@&9!DV5Q*F,
M)+#Y[=@@=4Y(XZR.+QJ"=G4MM_FMW*8L6(7?;)N>%MM2-)$QDLD6YH(9EU2Q
M!1.P@%#)XBH#.< \J9,T=K9'( BF:YF0N<QO$UB98TI%=!/M<5:._\X38]X\
M*$<T2YZW=##(ZPIANX#,/_\>.:BD.<*",QY<K!JYGA7?CF&:CC7N@F6[K6[T
M>@(FW/NLXQ4CQKT Z;WIT:>= C")X%&$Z$,CV%EGI<DWW349C:4_]^I!OFDT
MA(?3J7E=C\P</5^D^5+KDE.#:-FF\^;S))).03CR_"A&2TQR(9N;R!WH)$X2
M>4X"L3'BQD89$M!,&M@S\>@0=3])!)#YZBW-D\PCBHB^P67Y0BNQ<\<8+S0W
M XH]T*""67'.NAA!%S04P;?"122%E1R,]_(;RI]C#_89B0?!%SFDLWG8\KVP
M10 E_& U"%Z>L<U,&0F(/>XAXCIUAND^+ZHIDJ/-*\9L#.O8EZ.5UW$-LFS>
M@#*6N/\R26"J>TK;&AL^Y/*033]7AIX<MP(1MG=#'2%<(,)':D6&)4NO0HO?
M5Z+[3/"2!/2!L^%8:3:-NIR90->IU78YW$-YKW74>AG"O,+#+?*5O.<F5@ +
MCX4I&;&/B3CW Z8]_7W2)/;A-C8-Z_Z;$:@"P5DED]MR:[E;EU_>0>T%[VT3
MKP04\L\"$#199<+T;*3C*;O(O83"[VKX+T+2Y 6>GD&Y#MN#@B! P7T*GN1K
MWO_S)$>5B_X F7TW%0!.)_$#.RB.V] 7#]J^N%CHS7,-A6M^QJ4[-[C.OF7Y
M8T.P;<<+V"[T#%%I)%A;+['8F(@T9 2-;PB;J372V"B6)!T=]UD)3<Y%S/(F
MV_\K<RM+'QOG->\8D._8?1=$R<,@G;?Y+.O=ZMG</:N&*_U5YV2!+NY9CKU%
MMW8RJ7L?-I69WF]PK'N&;W]'/6//=B"-H^I9: H4+;-Y(2"$?(X/)/9S>'C\
MVW3.MC. !Z?<:1%LG1^?_"8-HGBS)+7I9#DLEX 9*6$^$\^MB>ZXIS4"5]/D
MI&EI+H:]BS0U%F\VVTV3!U>B(FYH'H55VQ?[DG&E-3]9T:VL0"&*UPCZJ2 ]
M66?1T!.J:P:+G]"\>-L:R.YLNCY\/A[OJ/4[F'27ZXE!E\R(-2DWM9J$VL7M
M%[+S]_C;W?T#_R4*^UD3X/K %:[F?0EU=G2PL^9-71K&1>.=,;<PA&H)5B6#
M;_#VUZ7\WZM#V;1D8B-TKD\H]B83/YEDXD>73%Q)>G7>5_[?EN!DFO[_!.=O
MGN#<^ 4+M?T6QG6*5QT+>=UD9_!WSMHE#4.OK%\0Z]CG &Q5?$_><;C;V(#4
M0%1N_OSZQ[!PO[C4P<*?Z]1]>33T<SW]G=1>/_L5FSGV].H_!TN5AQ!T9ZN
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M=YU2<(:P]N+UJ?%'[.-;YQXG%\]2/2ZD?"2_&B[T*%H;LSF/8UVMH:'ZJ]R
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M;W!S+V%P<"YX;6Q02P$"% ,4    " !IB7--=D1.S>X    K @  $0
M        @ &9 0  9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !IB7--
MF5R<(Q &  "<)P  $P              @ &V @  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( &F)<TVNC@HXC0(  $8)   8              "
M ?<(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !IB7--
M0@A],X #   Z$   &               @ &Z"P  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ :8ES3:X%<*)4 @  , @  !@
M     ( !< \  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M &F)<TU^7TN<*00  %T4   8              "  ?H1  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " !IB7--3GNK5]4#  #?$0  &
M            @ %9%@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ :8ES34YW$,JN 0  T@,  !@              ( !9!H  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( &F)<TT,).8YM $  -(#
M   8              "  4@<  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " !IB7--:E&X]+0!  #2 P  &               @ $R'@
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ :8ES3:Y5Q#"S
M 0  T@,  !@              ( !'"   'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( &F)<TU(P6(ALP$  -(#   9              "
M 04B  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ :8ES
M3?J!K@NU 0  T@,  !D              ( ![R,  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " !IB7--)??Y[+8!  #0 P  &0
M        @ ';)0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( &F)<TU8X7VSLP$  -(#   9              "  <@G  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ :8ES38ZXJ*BS 0  T@,
M !D              ( !LBD  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " !IB7--]FB)X[4!  #2 P  &0              @ &<*P
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( &F)<TU;:NT6
MM0$  -(#   9              "  8@M  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ :8ES3<N6^#VV 0  T@,  !D
M ( !="\  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !I
MB7--=WUNM+,!  #2 P  &0              @ %A,0  >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &F)<TT(\KL-#@(  )D%   9
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M970R,RYX;6Q02P$"% ,4    " !IB7--CFV$Q 0#  #;"P  &0
M    @ &Q/P  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M &F)<TU!![)36@,  .P/   9              "  >Q"  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ :8ES3<JJE@$6 @  ]04  !D
M             ( !?48  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    " !IB7--^ -26N,E  #E@0  %               @ '*2   >&PO
M<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " !IB7--[:&I8R\"  !\"0
M#0              @ '?;@  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &F)
M<TVR\DQ( P,   H2   /              "  3EQ  !X;"]W;W)K8F]O:RYX
M;6Q02P$"% ,4    " !IB7--1V40-E8!  #3$   &@              @ %I
M=   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !IB7--
M\5QQ9WL!  "P$0  $P              @ 'W=0  6T-O;G1E;G1?5'EP97-=
:+GAM;%!+!08     (P C &<)  "C=P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.10.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>68</ContextCount>
  <ElementCount>136</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>19</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/ConsolidatedCondensedBalanceSheets</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/ConsolidatedCondensedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/ConsolidatedCondensedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/ConsolidatedCondensedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Earnings (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/EarningsLossPerShare</Role>
      <ShortName>Earnings (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Notes and Lines of Credit</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nanophase.com/role/NotesAndLinesOfCredit</Role>
      <ShortName>Notes and Lines of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/Share-basedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Significant Customers and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock</Role>
      <ShortName>Significant Customers and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Business Segmentation and Geographical Distribution</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock</Role>
      <ShortName>Business Segmentation and Geographical Distribution</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/Share-basedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nanophase.com/role/Share-basedCompensation</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Earnings (Loss) Per Share (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/EarningsLossPerShareDetailsNarrative</Role>
      <ShortName>Earnings (Loss) Per Share (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/EarningsLossPerShare</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Notes and Lines of Credit (Detail Narratives)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nanophase.com/role/NotesAndLinesOfCreditDetailNarratives</Role>
      <ShortName>Notes and Lines of Credit (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/NotesAndLinesOfCredit</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Inventories (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/InventoriesDetailsNarrative</Role>
      <ShortName>Inventories (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/Share-basedCompensationDetails</Role>
      <ShortName>Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/Share-basedCompensationTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Share-Based Compensation (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/Share-basedCompensationDetailNarratives</Role>
      <ShortName>Share-Based Compensation (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/role/Share-basedCompensationTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Significant Customers and Contingencies (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/role/SignificantCustomersAndContingenciesDetailNarratives</Role>
      <ShortName>Significant Customers and Contingencies (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSignificantCustomersAndContingenciesTextBlock</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nanx-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Business Segmentation and Geographical Distribution (Detail Narratives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nanophase.com/taxonomy/role/DisclosureBusinessSegmentationAndGeographicalDistributionAdditionalInformation</Role>
      <ShortName>Business Segmentation and Geographical Distribution (Detail Narratives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nanophase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock</ParentRole>
      <Position>26</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>nanx-20180930.xml</File>
    <File>nanx-20180930.xsd</File>
    <File>nanx-20180930_cal.xml</File>
    <File>nanx-20180930_def.xml</File>
    <File>nanx-20180930_lab.xml</File>
    <File>nanx-20180930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>48
<FILENAME>0001387131-18-006333-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001387131-18-006333-xbrl.zip
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M_1UL+!.8]6]Q=)M> UUF3EA_T0TEL&2X>:B7L#Z!<@=K0TOCK "L,(H"HGU
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M#.H18[@^!OQ\XTD/6N4MGL:K#Z76Q/KM?K\&%$P13E2NX-8BWBIN_U6#;XI
MK4EW=HA C6L'CTV<9;=H'HUN-;+P&\?MC3/S4R?X()Q$7%P%_H1*I&R]A=FE
M'6PYF.V1JJ?!NITMD%*6XB?G'LW$!OSI:H^P./[F6-0C2:M3;<NOQ"+.A/?!
M=ZXPI<$76S/,:#CG#U5#V J56C3IE=BD-BH-DJ/3&W5*LMP,]%H4:+=*=L]J
MZ MDJ0'+IUN*G*R$U AJ]8QF>TO4WHJQ@ ?>9WC&:KH!@G5*9O0R(-LB5)-,
MK8T1(EOLLTC]F%*XFF4M>SB:-_Q6 &L*P9HV=X7]NR:"ANPV0;)6M[](-32
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MCZ5W0;HD\ORQ#YC&(HVC!$4<17M*%4W87F>1YTB!*V')\#<9N2A?.EJ&BBI
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M#$_0R150.R"+D,U,\+[3G(UB3YY<R=AXPB5FCQ62'.\ME)E56,.(>M,SCM1
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M ,Q O**-F=#XB)#[I]9E=I7 5.7Q>)7%8V2<TC%H@BFAZ'Y:=&X31$XHLZG
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MR*.IA;N" J-QSI8X6[G 5HLQ'U47+#X<,_95XG15,1HCJE.VS*R"52:#RX5
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M\ /Z+=NJP R(-Q9^>7X#KN4T/Z#J<=09'/?Z0^-KK\BEE;.C)C7P[7&W/:P
M4+XMK%6RI52R6G-9:077NG7:'Q32C\U-?UBT)#K'=M=N#O!@5)F-?,@O7H'/
M%S.!B1U:PL0/@HQ[)' 6H&Z09=3=4:5V7"=PJ0HZO?D:(S@GE^YUA/>0E#T
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M4H!F$VX+CM5 4N(7 SW.#UB$H@$-V_#-1*':5$Z74@%UH]/RH^]U>[CW7HG
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M,S N>'-D[5QM;R(Y$OY\)]U_\"&=E-6)$))Y"YOLB@#)Y)9 !&1O=5]6IMN
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MASU]LH?TTVI($[WCC&$+"T;96+:YE(]$]">PL(GBF5MCC^WE:FP3#'2B47Y
M@(,,T'$&.TT)]TPJ8?9N<>?-K;$&NWJV&NP4 V5 CC/0)@77F=O6V1$6)X+
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M_^?WA'\50[X'QTAM?=HEC&])U>#^Y3W!76">]Y&B4[NE*F*;H5:#]\L[@[?
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MZW:".8\[1EVZ+<U):M/]%3,A([#8$/IWA)4QN&-=8A4LZ]PYCDP7T3OTB+P
MW2#Y9FQ1<GTZ0E[UPJI*\/O ;5>J.5/I[%I5?!HV^8 SJY9(C8\^Z'I1G3)Z
M'@.:M8?KMY\$T<DB*8VY4D;/K2WMWKB5>[84*KGTK4.1E/Y<R=%S!QKM=C_K
MH\2;1V12CX,+^B,E>?WY*Z-'U?MZG!YJ8!+/\:;TGCC3*2)?/2ADA:T_)0BA
M>7%U8K(JHAIS4DX%3=<=33IC_P_^#* ]< $M._T_FF$2ON%Y%8;AA#<I";HO
MY3PT)G-+7:J>6',JV2UQ/,M9F&Y_SMIO]G0A-.7(180],!F_7<BI9FK"&G-3
M5@D>*=N&R_):/O"1!0/.)@I#:  <SW3/,/X>7GX\G"3?@P=]74R):1?&%H;-
MR!99:4[8]BIQ=X!KI ^&00FVY L5L@H%=XD:@0+<_>+F8]5\<XD]/']>!:VM
MP\S. LJ>\::CU9+-*G+/LS\C#!ZUF,%(R87$/G$>@O KVPZAF.Z5-\%D;J:'
MC=EPM@^;X6QQ44:ZK#"<+5V:D2YN']JV#VW;X= VI=-B"=YT+>"?EQ0DUW23
M10RZD;4--2)6'IAI^@3']@3)FS\]*3<P5@'>S"Y)HVQHN0]2%6,Z[WC<8.\K
ME>USI!(U'6FF5!.P"*V>R[+1AHM@:!*G&&L[R"X"JN>&1;R[,ERPB;3C32.?
M$IB?*Z(]'V+D"M6!-]N)/F=_L1MMX)/_ U!+ P04    " !IB7--K2M)]O8M
M  !L6@( %0   &YA;G@M,C Q.# Y,S!?;&%B+GAM;-U];7/D-I+F]XNX_X#K
MW0O;$9*[V^W=<??,[(;>VJ=8O9VDGCF?X\+!(E$ECEE$&20EU?SZ0P(DBR\
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M>CECNHIUGONB@Q9618/60Q3=KT/4VWM5,D0)3=+9)P7G8+#B+ R27VC S>;
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M+^,QN&&W OU[2PRNF[KO(.<QE>I&/;OHHF'G2,#ZU"69U""/I8)8ZY9I*7F
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M#+560<]'K0I"]MEP#G(MI7F39C7'<+B9Y7:,R8G<//;I(G9!-1W ZMGD-#$
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M?5K[U@-AH4>#G]^<O'WWQB*!0UTO6/[\YNO\:#(_N[IZ8X61';BV3P/R\YN
MOOGK__SG?UC\?S_]U]&1=>D1W_UDG5/GZ"I8T+]8-_::?+(^DX P.Z+L+]8O
MMA^+G]!+SR?,.J/KC4\BPG^1?OB3]?W;]]_;UM$1H-]?2.!2]G5V5?2[BJ+-
MI^/CQ\?'MP%]L!\I^Q:^=2BLNSF-F4.*O@([>/KMW<</[TY^?/NTX+R?VQ'_
M\7O^[_]^?WYR(O[S\>[DQT\?WGWZ</)_P&]$=A2'Q3?>/;W+_I>2_^1[P;=/
MXC_W=D@LCD@0?GH*O9_?E"1[_/"6LN7Q^W?O3H[_]\OUW%F1M7WD!0(9A[S)
MJ40O;70G'S]^/$Y^FS=MM'RZ9W[^C0_'.3M%S_RWGJ)]B9/0^Q0F[%U3QXX2
MP])^QI*V$/\ZRIL=B1\=G;P_^G#R]BETW^3*3S3(J$]F9&&)/[E]%%_EF-+-
MBE-SHU@?1_83#>CZ^5@T.^90Q6L2"/.^""(O>A:XL77"-A<EZ7?%R(*;/;>,
M(V$'PCK$Q_\ H8V>-]QE0D]8_!OKN >_"9MG- BI[[G<&%W^=Y<$(7%/;5]H
M?+XB) IUS,)[V!O+MS;CVEN1R'-L?W?^6[L;4QCAUD080#A=3#=BL./ ]P-"
MW=6^A#BSP]6E3Q]WEZ'1TT BG-JAQ[N_9204C@?Q4@7)[DQ5!Y,;&I'PCL]R
MO)'CV?Y6(S=\ F"DBYGTZ6L@)<_( PEBHF6QWFZ@SU_8+.#+C_":AN$M8?,5
M]VL=*RJ:@=@JD+CB,QU+!GZMAE0T [&5V,DD<*^]@ C'8\3U(I!QR8CVYQ57
M 3<@OD)\/O="QZ<A-^L[\A2=^M3YUM\_(+T.I/S$SH[$PL05BUH^#(*&) W9
M_@"8>\O 6_#Y,HC.XC"B:[X>YV;!A_2(>Q/?"'B<<'=$>GUFCUH@2_'GC&PH
M$PP-:HT=.A]J1""/$\>A<:+<6\95$/,U$FB\ I#B&!WN['M?/T$-T?>X(P5,
M#A#QB+/O.8ELS^<+#R86' ^]9F-9'V-.@^DWBT_"[ 7:R4",YY;(A\!,13HN
MY12CL01&'D ZKD,!=0BCW@>K<.OLV,U0S /F[LZ2[-#GT///=@(XC4/A]_F,
MG2B7<_69T"6S-RL15>"-(^;=Q\FO7#XX\#_%XAX>,AKE:RJ=;$K[7CZN?:N0
M\"F/\-V[FW<D-#)8V(S_6/26A3I/K",KIRK_E?=@I5U8Y3XR&7(I^+Q<8=P7
MD47*=.I.HKGYIR8MO$[NN8IMI]C[^/8]\9/N?Q.T,-+C/LP*)8=<RTFP,R3.
MVR5].':)=RP$$']))#EZ=Y*%.O_ ?_1;RL09YX@)0W#)T]_)<POOO*VD:9W7
MLGE,F&-1YA+&0<L[M9E3,8IF?#9K<;Q)PF]'SLKS"WM:,+KNJLU,<U0G25G#
MG(?]PS C2^&@?! 347X5"O660!!.\*'0+K,1$'(Y[GB_[<JOM@ J_3TFI;?)
M:$39$\Z%*SBY].UEN[9K38#J_H!)W:U2&C5NOGOR*)?!%<>0:BNO-07J_WM,
M^E=*;02'.V:+H_#Y\_J>^NWZKS4!ZOT'3'IOE=*(OL]B)F2\Y,MDV_\'L9G2
M].6M@2C\"1,*.MD-+G4RUHH@9IK0H%QX2BB P/P9$S 0'1@$)TFJ.>.&LJ1,
MN1FH-01"\2,^*%HE-ND>=+VFP3RBSK<D2!-.XRC)F.)FHG02)1T0GX_X\('H
MP^BR*AUCTV7&)?^99"A3- =OX3"AHQ4? 2ABX@-#4FH,!035IEHCNL$A[6)-
MV)*[ZV=&'Z.5B#?;@7)RD1! 84&U[0:HP" T\[7M^WGX6 5)K2$4"E1;<H7(
M+1#\=-R0[)K_8)2 >,>\S&HT_+UU9!6GT?SO9].;^?3ZZGQR=W$N_G%^<3/G
M?SN=7$]NSBZL^=\N+N[FUG=? SMV/?ZM/_8*D&=R)! N[/ ^P3$.CY:VO4D-
MC_A1F/^D;H'9CW\K^)XNBI/U6QIZFGAZ1@ZC[NU3NXLW"4,.FUZ0>CM3D?5.
M>JWZET22X4:XH=#(]EY04!K-C07<U1IN@T$B*@XT1%JO.*CE?US\*_8>;)^S
M&DZB,YNQ9SY5)A<<Y.@ R8U%ZD% T#XB80(QR_ *9\0AG.%[G]R0*)-6X5E*
M*F/1_AZ00>3'@521I<89E"-3;64L[M\#B3;Y<&C^EI&-[;D73R+-AG 'GT8K
MPBJRR0$!$1L[)^B!4P=MX( /"%0_2(8_-.@SB&F4SWE?$/Y+]SJ56LIAPEY$
M(]M/6AKV.KHA+'J^Y?NG9*/(9]2-6-,JQS\UE;$#ARY+/XC@.#RKY/DW-'!T
M'B9I;NSHH0LH2E%QH)%RIQO@#!XE=-__O)2Q[-JS[SV?;[^3C/+D+&1%?:[F
M4#AW]*S?R\)[,'<8L7OPH:N><#A>B6MP;$)%8^[THB\,4A11!S"NRS<[M.O#
M]M;FCC3@RJZC(Y<:!RYG]L83PS:Q0S*]][UE>K%9BY".SMR91U^L8)K @5H>
M2;FUGT48!1Q#JK>'HC1:T*(S2FK)T:##8KYH:LBF!$A& L5HM(!%'XS4\N.
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M9WT>_J157JM=E\NIPU:Y-1+C94!'-1"MKA"."S!(%23&:X'NS^<UD.[=P[F
M3PG([SY^>)= +'Y2<=F+)\(<CX]-B^2MU.DF%3IPTWU7Z1G5%O!%;WT[,UYJ
M=!RSV$4EF,8 N':&6"_"S6'?H=-A1HGNVCSTO8@0EUNY^$/LU!^XM8M3)\(\
M<<6V>@@AMZ!NO1@O:-MC7]%'3R_3-B;<11A[YMZ@*\@*(T=0-'<@:Y!HIK<9
M;!+KXNRQZ-_#&'Y[CZ)H[SCF((0;Q" N @3;R7F\V?B)FFP_5]-5L*!L;0.+
M^4$[0% KN+-!=-0.CJ5D_NR&*'#,%T*J)(Q:0_-U@3OJN_U!HIK@.%#)Q;FA
M@</_N@V+!V[+LO3<"QV?AC$C>@_<O6<$U89[C=5#Z!.+=21ARR1[T/6B6!2]
M"1Q1,-,]C:,;&OV#)&:ML@)H#\9K#@\&7=TBNNEP5^0!T9YR-)I+*P0'A'5:
MJ:"HC1;6&QHUD-12I/9^R5Z\MQ%.%[>E/@OV*K?I_V0=65OI^3\22HLNK JM
MP:?QV-(.LCMIVZ<#TOMJ919+1:"VCPD 'K(>IGN#@W$&=9:ZJWP0HZ6IX0OQ
M@Z);&V&EBC'LH)']1 .Z?DX]E8_T)+RC+>+=V&)6T-?X^G/=A<])Z# OB24+
M1SZ-0W'T$/9R8LFT4?K$=)%_0.%M@DA#8S*<+=5T2]BZI:TI)P)HM3W@++<L
M!'-77G:AW=I_K%M[T1QMJ0QP#1-]!WCK@=QQF$_]]I- F)2E'@S/2AWQ[%8/
MI*$H##Z7/PPF+J W*@17_.]CW?]R4NL[0?Q'BY-;*3V>M]WT'BBG0/1$'<#'
M%"2&G4J'B>:I.I1N4ZS:K@(N3%Q]%[CL-B?OZFY3D%IE6G.V=FE[+#DQV'()
MV#ZIJ0RZ3AMC /?1D!EV(0A&-3<"Z0&#*R7[(+[KNVY-DZKXTDG=EQ):RPY<
M*Z$6FYZ,WN231?=1E[BXK+W15Y?*+ &\1TI@V&_46#0>1U)*?2#!@_QAB&>5
M*!6O>E_WJO+;$B;/!QN"0-X$4A 9/>S4HP*2!H]O ?!I''P"3!/!C)0L.X_N
MI2]H5;SG0]U[4NKD_2VK0FYP/"_X2U)+"Y9FQ$\?XPVC,&$[D3F_8P>8NG;L
MU^04!V7]M,PZ9"K<M6/34^8@ME*?6H?1]H%,P7-O&7@+S[&#*(_]B 5NFB"\
M)+QUVU*\,JI\WQA5MGU:1:?)RK?2K<E8J!=^$V)^#1S"(ML+8,^^:LB,UE_E
M+ 51&B@7;'::NV'4IN.=$,P:!5OA:CD4AR5+\>>,;,0SJ,$2O'3^H7&(GIW#
M6%F7B0B)FWXF=,GLS8J[L"]H(N;=QX;7!76Y 6F44@JC]43!\.DEPNBF.IP:
MY43AYHQ@N7U#'K='];>,>VS,1QA%2+61NL)[L+9=6+4^3-Z6DDHFU@,KFT_;
M8?'X6M+&XT/3QH=,G(-T;O0J66_^ 6X]3.^&_7Y ^VG</!M.^0<RR:NB#W?B
MT4/):-/(LBF%QZSO4DJ3!65>5)QL[JR(&XLKL 6'9R(U-H@214/F<W /!Q<_
MZZH<#).[)):F<KA&HH\LHH;!^UY#:PH?;H1T)H\V<R_6&Y\^$Y)<;[^-F2,L
M1KS?)8XK4^\+PWB=7HGO[O8C?/0EAN3V@!*&\:<MO^F<1+;GAS<V$T&,A_9\
MIQ-XOI/U7=:C571I<DAZ(3E0Q<KM3OU@=[V=SED;MCF*SW9,>JH+47XR&@,&
MU_6RE H<2FUQ8-%N23($2NR7'YLQ68>-[\!<4>"3#RQSXL0LN;IT\>3X,1\)
MTW33]2;.+TPTJBL_MW<P>?(4<([ZT0.RBU'U4*I<B,Z^;NPU.:=KVU-4V])3
MXD!Z#QX$,INR9K:+1I.)QN557OH*U1<B2@HK%@MR$M.%.J&&7,\XUBD!Q^7K
M'8UXLA:AO-$&_+Q[TT<ET$+:@VH3AX&TU@:750;?%B24FT3O#DT/!+N54X>K
M#,,.MS5_.MV0%MO1]DC;^\;=!&D^=;[%W>YPS4;=#C_'^K"WMYT2JU\WMZ8W
M,8@WM_,599%X$EN8U!W_FGI;*FE^2%BT2X!C*]A@3K<#E!(@041E73I@4.W4
MA.?FL[MNB];6UOB23&U9-2SDTH[T'%+Y@R=2_8JFK2U-UY ':E?*/Z9MS#6)
M(L+ MM[:VG3%WX[6KI!X%$Q"%I7PX/^J8\%_]-M,) %)9F/^^]*OD8SURMFW
MRG&Q^#&C5:E1YUQ"[7ADS5:5UJ[0G-4Q9DF01K]X@;>.URJ=UIH8FPOK.FMH
MM%46',/R/+X/R;]B+MV%2#X"+-5E!(<P7.AD*$WHN##1+MCE)$AP4=N9'B!4
MR_8:?[K5C*2YZ8KC6CM3HX)Q.!,R3!<3QL1XG&0]*0<S27,D+@,9RB029*;S
MO>$CZ"U;(I9]0P-[^Y,[_K?0=I),,YT#=>X(!X)*:ZR?7'45<<>!4+)CSJ^Z
M75,[F"P923ZOW#DK*4P/<3TML+RS!F@$Q]B7[C,O;<?SO>A9/?"UM<7A,Z!1
MKXW]S)1^,#OD53G3+=O:6^, 0FY.2C!0K=-FY('Z#UZPK/*HFVXT9-"-YFA1
M5Y61-5^OU&L Q_A51-=.*6/T4>1E $XHRHT/)4M%(2D.*$1\<_N.8?+R]IPK
MTW:GP2\V\\3(/..RGJC/YF$]&#_"@*+652D8H:P\+UWF.A$'"J>N%W"Y3UR0
MPI2# ];KTGE/,:C;3R+,6 PJ9_:&_R9ZAATIZGLQ?AP&A;6/<O9P JEC92+R
M$,4K+/:2%(4.PAEQB/<@22>J'_WM_@D@R.-7SI."/+S,HUI "S]?8C\2M^X[
M@-RY%R".XQ>\4^+84SDXQF!)1:5\D=ZE<M)X1>V@8Z:FY!&2*>[B:>.E;U2=
MJ]>?(&+C^02[3&@25>#!KDA;SIXS4(/5; U$9[1*<9W0D0E;@J-;F=8'PNYI
M2'8ITBJ9D&9DD]X(%SO0MC6_:%5O9#J0"YM.VD4;:6(7WQ!!88D&M[\&[W#-
M*J\N#XZ1I+I%RZNLBEU9(I6[7=M!=Z_J/HP']WIN7B&:P8CH%U&\2D0Q.<M0
M!*LT4,2PA1O:),=P]:CT$E;V D;!7>6>4:-N0^4)K8ST]0VMH869V8_<<@CS
M;%\1L),T/[C7L91BXQC/"A8OO< +5\3]3*D+@:;6WG0@? =P6B5'ALYG1D,(
M*ED[TS'L'="H2-I[ Q)141!YA^W'P/@5+U3-.!"L=/M5@64+C>D@]@ZX2C70
M'>./*<8!68J5(B*4;PAD;DY:F8Y4[X!D2<I!_1/!6E']_MI[55DB9"^N(5D^
M2J,XOAV&2?$(@:1XVN*6D8WMN1=/XBU!\5ZN9JF81DRZ=G,X2\A^\N'9B$E>
M655NRL"%BU#LT%[?67UI+TB,\JCIZTL3IB],X7UI(GG65G]MK=;L@'1?XQS+
MBQ+YZ\)E+R]GVY\^M[] O!4G<,7#PY '"<?Y&@X;:+7?1K[H&/*CR-!^64\5
MCND6A_F\H58C,H44E:Y+#Y*+NF27C)#R6=<.H\;NGSZ<A/,]H? "C4[L$QV^
M=CWW'CR7[]_V:'3MGS8^R!FQ.A4,B*RNL5MOBGO?15R1E*%(<QOSFZ9/0+K9
MV:B*1V1@0_E3[8W47RC?H"=YA7L<WS0\F#ZJ,3/0@8 Y<(-,UZOA9]Y0E'"[
M)<RC;DWPY)<B-Z90T@A6V9<1TV=/XYOF;A"A#Y_K'E%NENK6Q-&QO*'\&E&'
M5"[KNCW7!>.'^P2.J-3>BI/UU!*6(X"^HRODR&" OG$8T^ ..-0<]WJ:<4@P
MOQZ$O!Z$O!Z$#'H0,MZUT]>#D$:V0,&>$"O+/E)E#+2W-WWD,-B*IY%BH-(/
M#@P+4R/LP7-(NRYN:,#W@&*3+,0.[T2:9OGW8NU\0Z-_D&A&'+H,O-^)6Q)>
M,>OOZ?/&SQ?&,K&]PO?"+3:-!UU2EOU(M%.<4^R;#^-G%P=GPTI <1CS+:,.
M(6XHDGC++G?Q1)CCA=O(8-/^ *3&3QO&,AFPVG"@G+!X%88Q<<]CY@7+U#+3
MNGT=8>_3E_'0_J@KK%Z*16(8@QYE:*X#CO(QXV\RC69:XT'S,FQO^UA/(>5X
MMM?Z,?01 5.VIX#F9=@>7],MB!?%'/#Q;:_U8\;?V<)J>PIH$-E>G]2J3,!B
M)Y+68,Z.!G3S[A@?-/Z:V*@V.!Y$B.QP!T<KU?NNY;#DB]U;QK?3XXV+8 :,
M/[2&=:SL""&*#"1O&217CX/H+ XCNB9,5"$YHT'$I2"!4UR;UZ4C_=!(1]IV
M;15])S7>*[TCRTX25P>$!KX&#F&<+\XI 20?:<@PW $]R-NZ(#A>+^,BNQ"*
M^#+N/-YL_&<^OJ^]*!F_-:4DVUH?$A*M B!)3*GSMIUH]>4*M:1(0%*8FPZJ
MIDPHTD#J?';%"LU-6*CY:7!Z+9O]6C8;R:#S[UTV>_AS3T1ELV&J3>N+*%5;
M;6+L*%&OVC993*KVGY1MM\C28;:MW8&,MVVLCU)N'*1PD54Y751XDN8>\_:*
MYN8'9;GQE-2OD&"<0KH%0]- /L.)EFT-C06KU9JJ:E7&_#"#B4ZM=X\4IM92
M0V.QU=YJ;4@YNEIY,Z"]5IJ:JW'17[=-47$<=IS10!1N2 ^E18SN]%E_)4A)
M= AS)$0.'&7M&RP*!K6EGE5$./ !V)T.K+)0*.(IN;<W.-4%5K2$T!%OM$1!
M@!G6X8(I ^TH>$H"9[6VV;?.0V&-$H>_]1T/:\(@*7S?X#/GLO/(V*#$ 1?4
M(+4 UL5#,5#.;9^$,_) @IC<$'W<N;TYOD%18H;UL+-*^I'6W-5]:YY]4_Q
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M,#$X,#DS,%]D968N>&UL4$L! A0#%     @ :8ES3:TK2?;V+0  ;%H" !4
M             ( !Z&P  &YA;G@M,C Q.# Y,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( &F)<TV.&HBFHAX  /+/ 0 5              "  1&;  !N86YX+3(P
D,3@P.3,P7W!R92YX;6Q02P4&      8 !@"* 0  YKD

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
